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 Summary 
 
A rapid screening procedure for the identification of chiral Diels-Alder catalysts by ESI MS 
was developed. Screening of the retro reaction made it possible to indirectly determine the 
catalyst’s enantioselectivity for the forward, product-forming reaction. 
We were able to monitor positively charged catalytic intermediates for the retro-Diels-Alder 
reaction. Use of mass-labelled quasienantiomers allowed the intermediates A and B to be 
distinguished by mass spectrometry. The ratio of the mass peaks of A and B reflected the 
catalyst’s intrinsic enantioselectivity. It was crucial to evaluate the influence of the mass 
labels on the reactivity of the two quasienantiomers. Sufficiently strong binding between the 
substrates and the metal catalyst was necessary to allow detection.  
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The method was used for the screening of bis(oxazoline), phosphinooxazoline and bis(imine) 
ligands in the copper-catalysed retro-Diels-Alder reaction to identify highly selective ligands. 
The selectivities were confirmed by product analysis (HPLC). In accordance to the principle 
of microscopic reversibility the ratios observed for the retro-Diels-Alder reaction correlated 
with those obtained for the preparative forward-Diels-Alder reaction.  
 The method was extended to organocatalytic retro-Diels-Alder reactions. Monitoring mass-
labelled iminium ions C and D allowed direct determination of the catalyst’s intrinsic 
enantioselectivity. This versatile method allowed not only rapid screening of imidazolidinone 
and proline-based organocatalysts but also of oligopeptide-catalysts. The results obtained by 
ESI MS were confirmed by preparative reactions. 
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After establishing a reliable protocol for the screening of organocatalysts, the procedure was 
successfully applied to multi-catalyst screening. The catalytic intermediates originate from 
different organocatalysts with different masses allowing facile assignment of the catalytic 
intermediates. After optimising the conditions, multi-catalyst screening showed excellent 
correlation with the single catalyst screening.  
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1 
1 Introduction 
The importance of asymmetric catalysis for the synthesis of enantiomerically enriched 
compounds has been highlighted by awarding SHARPLESS, NOYORI and KNOWLES the 2001 
Nobel Prize in Chemistry.[1-3] 
The discovery of new, highly efficient chiral catalysts is often costly and time-consuming. In 
recent years, many high-throughput screening methods have been developed for a variety of 
catalysed transformations.[4-8] Analysis is usually product-based, which has potential pitfalls 
as the enantioselectivity of a reaction is often lower than the catalyst’s intrinsic selectivity. 
MARKERT and PFALTZ developed a screening method for determining the intrinsic 
enantioselectivity of a catalyst using ESI MS. This method was used to rapidly evaluate 
enantioselective catalysts for the palladium-catalysed kinetic resolution of allylic esters.[9] 
This work was based on an ESI MS screening method by CHEN, which allowed identification 
of the most effective catalyst in a palladium-catalysed polymerisation (Section 1.1.5).[10, 11]  
1.1 Electrospray Ionisation Mass Spectrometry 
1.1.1 Historical Perspective and Development 
Electrospray ionisation (ESI) allows the transfer of low-volatile and decomposable organic 
compounds “gently” from solution into the gas-phase, enabling analysis of large fragile 
biomolecules and organometallic complexes.[12, 13] ESI is not an ionisation technique in the 
sense that neutral species become charged. Instead ions from solution are transferred to the 
gas-phase by nebulisation.[14]  
The electrospray process was developed more than 80 years ago for applications ranging from 
painting to printing. In the late 1960’s DOLE realised that electrospraying of a polymer 
solution into an evaporation chamber resulted in production of intact gaseous macroions.[15] 
This pioneering work by DOLE led FENN and co-workers, 15 years later, to considerably 
improve the method by coupling an ESI source with a quadrupole mass analyser.[16, 17] In 
contrast to classical techniques ions were transferred to the gas-phase without fragmentation 
and therefore allowed analysis of the intact molecules.[16] Before the implementation of 
ESI MS biomolecules could not accurately be analysed as their molecular weight exceeded 
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the mass range of most mass analysers. FENN discovered that under electrospray conditions 
large, non-volatile biomolecules such as proteins (“molecular elephants”, FENN[18]) became 
multiple charged ions leading to mass-to-charge ratios below m/z ≤ 2000.[12] Application of a 
deconvolution algorithm made analysis of molecules with up to 100 000 kDa possible.[18]  
FENN was awarded the 2002 Nobel Prize in Chemistry for his contributions along with 
TANAKA, who introduced MALDI (matrix assisted laser desorption ionisation), another “soft” 
ionisation technique in mass spectrometry.[18, 19] 
ESI MS is not limited to the analysis of large biomolecules. This method can also be used for 
the analysis of non-covalent and non-volatile organometallic complexes, usually not 
amenable to standard ionisation techniques.[20-22] Recently, ESI MS has become a powerful 
tool in probing the reaction mechanism of transition metal- and organocatalysed reactions (see 
Sections 1.1.3 and 1.1.4). As the ions are transferred directly from solution to the gas-phase, 
this technique is ideal to monitor short-lived reaction intermediates.  
1.1.2 Electrospray Ionisation Process 
In ESI MS a dilute solution of an analyte is pumped through a capillary at continuous flow. A 
high voltage (2-5 kV) is applied to the capillary. The resulting electric field gradient between 
the capillary and the counter electrode leads to the formation of the so-called 
“TAYLOR cone”[23] of the emerging liquid. If the imposed field is high enough, the protruding 
liquid is dispersed in a fine spray of charged droplets towards the counter electrode. An 
excess of anions or cations, depending on the applied field, accumulates on the surface of the 
droplets resulting in a conical spray of charged species due to COULOMB repulsion.[24] 
Evaporation of the solvent molecules by a counter-flow of an inert gas leads to accumulation 
of charge density in the droplets up to the point where the magnitude of the charge is 
sufficient to overcome the surface tension holding the droplet together, termed the “RAYLEIGH 
limit”.[25] The droplet then fragments into smaller daughter ions, referred to as “COULOMB 
explosion” (Figure 1.1). 
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Figure 1.1: Schematic representation of the electrospray ionisation process. 
Generation of bare, gaseous analyte ions has been proposed to occur by two possible 
pathways (Figure 1.2): 1) Continuous COULOMB explosions and evaporation of solvent 
molecules eventually result in the formation of droplets containing only a single ion. This is 
called the “charged residue model (CRM)” and was first proposed by DOLE.[15] 2) Two 
meteorologists, IRIBANE and THOMSON, suggested that before the droplets become small 
enough to contain only one analyte ion, the field strength of the droplet surface becomes 
strong enough to “evaporate” a surface ion from the droplet into the gas-phase. This is 
referred to as “ion evaporation model (IEM)”.[26] The relative importance of the CRM and 
IEM remains a topic of discussion as both proposed models have yet to be confirmed by 
experimentation.  
evaporation of 
solvent molecules
Coulomb 
explosion
residue charge model ion evaporation model
 
Figure 1.2: After solvent evaporation Coulomb explosion leads to fragmentation of the droplets. The 
two proposed models for the transfer of single ions from the liquid to the gas-phase are shown. 
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The continuous flow of charged ions from the capillary to the counter electrode leads to an 
accumulation of ions of the opposite charge, which must be charged balanced for the 
electrospray process continually to operate. KEBARLE and co-workers have described the ES 
ion source as “an electrolytic cell of a somewhat special kind”.[27, 28] Electrochemical 
reactions are therefore likely to occur during the electrospray process and can have an 
influence on the analyte solution. This is of special importance when examining 
organometallic complexes as the oxidation state of the metals can be affected.[29]  
1.1.3 Detection of Organometallic Reaction Intermediates by ESI MS 
When using ESI MS the analyte has to be injected into the mass spectrometer as a liquid. This 
allows direct investigation of reaction products and/or reaction intermediates. To allow 
detection of intermediates the species must be charged and have a sufficiently long lifetime. 
The relatively gentle transfer of ions from the liquid to the gas-phase ensures a close relation 
between the gas-phase ion and solution species.[30]  
Early ESI MS investigations of ionic reaction intermediates were conducted for phosphine-
mediated Wittig, Mitsunobu and Staudinger reactions.[31] Ionic intermediates were detected 
and used to confirm the proposed mechanisms. The disappearance and appearance of ionic 
species further allowed the reaction progress to be studied.  
As ionic reaction intermediates are often involved in homogeneous transition metal catalysed 
reactions, ESI MS has become the technique of choice for mechanistic investigations and 
high-throughput screenings of such reactions.[30] WILSON and WU reported one of the first 
investigations involving the detection of nickel(I)-derived complexes in Raney-nickel 
catalysed C-C-coupling reactions.[32] Since then ESI MS has been widely applied in the study 
of palladium-catalysed transformations such as the Heck reaction, [33] the Suzuki-reaction,[34] 
the Stille-reaction,[35] oxidative coupling of arene- and arylboronic acids,[36, 37] polymerisation 
of ethane[10, 11] and the allylic substitution reaction.[9] Furthermore its broad applicability has 
been demonstrated by investigating different transition metal catalysed processes such as C-H 
activation reactions with iridium(III)[38, 39] and platinum(II),[40] catalytic hydrogenation 
reactions with rhodium[41, 42] and ruthenium complexes,[43, 44] olefin metathesis,[45, 46] catalytic 
oxidative epoxidation,[47, 48] aldehyde olefination with high-valent rhenium compounds,[49] 
Ziegler-Natta polymerisation using an alkylzirconocene catalyst[50, 51] and the cobalt-mediated 
Pauson-Khand reaction.[52]  
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The variety of transition metal complexes and reaction types analysed by ESI MS 
demonstrates the enormous potential of this fast analytical method. The fact that also 
catalysed reactions can be successfully studied highlights that even low-concentration species 
can be selectively monitored by this technique. As CHEN has studied many transition metal 
catalysed processes with ESI MS and developed more sophisticated instruments, he can 
certainly be regarded as the pioneer in this area of research.[30]  
1.1.4 ESI MS as Tool for Detection of Reaction Intermediates in Organocatalysis  
The first study of an organocatalytic reaction by ESI MS was reported by EBERLIN and 
co-workers.[53] The 1,4-diazabicyclo[2.2.2]octane (DABCO) catalysed Baylis-Hillman 
reaction was investigated to detect and structurally characterise the reaction intermediates. 
Although neutral species were expected from the proposed catalytic cycle (Scheme 1.1), these 
species were assumed to be in equilibrium with their protonated forms in methanolic solution. 
The reaction was monitored by directly pumping the reaction mixture into the ESI MS source. 
Reaction intermediates were observed with collision-induced dissociation (CID) 
measurements, which provided strong evidence for the proposed mechanism.[54, 55] 
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Scheme 1.1: Catalytic cycle for the Baylis-Hillman reaction using methyl acrylate and aldehyde 1 
with DABCO and observed intermediates by ESI MS. 
METZGER and co-workers recently reported an ESI MS study on the proline-catalysed aldol 
reaction. They characterised all proposed reaction intermediates and also followed the 
reaction progress over time.[56] A more sophisticated application of the technique is their 
recently developed “dual ESI MS”.[57] By spraying the substrate and reagent solution 
independently in the reaction chamber, dual ESI MS allows observation of reaction 
intermediates after a few milliseconds. Using this technique, METZGER and co-workers were 
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able to clarify whether the organocatalysed α-halogenation of aldehydes proceeded via 
N-chlorination or direct C-chlorination of the enamine intermediate (Scheme 1.2). After 
reaction time of milliseconds, fragment ions resulting from CID measurements were 
unambiguously identified for intermediate 2, providing evidence for the mechanism to 
proceed via N-chlorination.  
ESI MS has also led to the confirmation of the mechanism in the conjugate umpolung 
reaction.[58]  
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Scheme 1.2: Proposed mechanism of the L-prolineamide-catalysed α-chlorination of butanal. By 
performing CID experiments intermediate 2 was identified to be relevant in the catalytic cycle. 
Intermediates in organocatalysis are generally charged (for example iminium ions) or are 
easily transformed into charged species by protic solvents (such as methanol or water), which 
makes them amenable to ESI MS detection. In this growing area of research useful methods 
are needed to aid reaction development and mechanistic understanding. As ESI MS is a very 
fast and practical technique with instruments available at most research institutes, it can be a 
very important tool for the investigation of organocatalytic reactions.  
1.1.5 ESI MS Screening  
HINDERLING and CHEN demonstrated an elegant application of ESI MS for the rapid screening 
of homogeneous polymerisation catalysts.[10] ESI MS analysis of a mixture of eight 
simultaneously synthesised Brookhart-type palladium(II)-olefin polymerisation catalysts and 
ethylene showed a complex mass spectrum. Multiple, overlapping series of oligo- and 
polymeric ions corresponded to each catalyst with between zero and one hundred ethylene 
units added. As the most effective catalyst carries the longest polymer chain, ions of the 
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highest molecular masses were selected and subjected to CID measurments. They underwent 
β-hydride elimination of the hydrocarbon chain producing ions corresponding to the most 
effective catalyst.  
Based on that work, MARKERT and PFALTZ developed a screening method for the intrinsic 
enantioselectivity of chiral catalysts.[9] By examining charged catalyst-reactant complexes by 
ESI MS they were able to rapidly identify highly selective ligands in the palladium-catalysed 
kinetic resolution of allylic esters. The first step in the catalytic cycle for the kinetic resolution 
reaction gives palladium-allyl complexes 3 and 4. As nucleophilic attack of these species is 
rate limiting, the cationic intermediates 3 and 4 exist in sufficient concentration to be detected 
by ESI MS (Scheme 1.3). 
Ar Ph
O
O
R
(S)
ArPh
O
O
R
(R)
3
4
-RCO2-
[PdL2]
-RCO2-
PhAr
PdL2
ArPh
PdL2
Nu-
[PdL2]
Nu-
PhAr
ArPh
Nu
Nu
 
Scheme 1.3: Kinetic resolution of allylic esters. 
Intermediates 3 and 4 are enantiomers and therefore cannot be distinguished by mass 
spectrometry. By introducing mass labels at the para aryl-position, which is sufficiently far 
removed from the reactive centre, the molecules become distinguishable by mass 
spectrometry (Figure 1.3). If an equimolar mixture of these “quasienantiomers” was treated 
with an achiral palladium catalyst, the catalytic intermediates 5 and 6 were detected with a 
50:50 ratio as expected (Figure 1.3, catalyst 7). If an equimolar mixture of quasienantiomers 
was subjected to a chiral catalyst, a higher reactivity for one of the quasienantiomers would be 
expected. This was the case when performing the experiment with the palladium-catalyst 
derived from ligand 8 (Figure 1.3). Using these screening conditions the most selective ligand 
to date was identified, illustrating the potential of this method. 
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Figure 1.3: ESI MS screening of palladium-catalysts for the kinetic resolution.  
MARKERT and PFALTZ also demonstrated that reliable selectivity data from catalyst mixtures 
can be obtained by analysing the corresponding reactant-catalyst complexes.[9] If the catalysts 
have different molecular weights, the resulting intermediates can be easily distinguished by 
mass spectrometry. 
1.2 Mass Labels and Quasienantiomers in Mass Spectrometry 
Enantio- or diastereomeric compounds cannot be distinguished by mass spectrometry as they 
have the same mass. By introducing mass labels, HOREAU and NOUAILLE elegantly solved this 
problem.[59]  
They were interested in the determination of the absolute configuration of secondary alcohols 
by mass spectrometry. An equimolar mixture of enantiomeric anhydrides 9 and 10 was used 
to acylate an enantiomerically pure secondary alcohol of unknown configuration 
(Scheme 1.4). The anhydrides 9 and 10 differed in configuration and mass. Kinetic resolution 
gave diastereoisomeric esters 11 and 12 (11’ and 12’ respectively) which had a mass 
difference of ∆ m/z = 1 and were therefore distinguishable by mass spectrometry. After 
subjecting this mixture to electron impact ionisation mass spectrometry (EI MS), the relative 
mass peak intensities of fragments A and B were compared. Based on the identification of the 
more abundant fragment, the absolute configuration of the secondary alcohol was assigned.  
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Scheme 1.4: Using the mass labelling strategy by Horeau the configuration of secondary alcohols 
was determined. 
Almost 10 years later SUIZDAK, FINN and co-workers reported an extension of HOREAU’s 
procedure to determine the enantiomeric excess of secondary alcohols by kinetic 
resolution.[60] Furthermore the mass labelling strategy for mass spectrometry has been used 
for the identification of enantioselective catalysts either by detection of mass-labelled 
products[61] or mass-labelled catalytic intermediates (Section 1.1.5)[9].  
The application of mass-labelled enantiomers has been discussed in a recent review by 
ZHANG and CURRAN.[62] 
1.3 The Diels-Alder Reaction 
1.3.1 General Aspects 
Since the discovery by DIELS and ALDER more than 80 years ago,[63, 64] the Diels-Alder 
reaction has established itself as a standard method for the formation of six-membered rings. 
The Nobel Prize was awarded for its discovery in 1950. Its powerful synthetic value has been 
demonstrated in the broad application for natural product synthesis, especially with regard to 
asymmetric variants.[65] 
The Diels-Alder reaction proceeds via a suprafacial [π4s+π2s] cycloaddition of a diene and a 
dienophile (Figure 1.4). The driving force of this reaction is the formation of two new σ-bonds 
accompanied by the loss of two π-bonds. Both experimental data and theoretical calculations 
indicate that the reaction occurs via a concerted mechanism rather than a stepwise process 
involving diradical intermediates.[66-68] 
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Figure 1.4: Overlap of the frontier orbitals leads to the formation of two new σ-bonds in the 
Diels-Alder reaction (exemplified for the reaction between butadiene as diene and ethylene as 
dienophile). The dashed lines show the orbital overlap which can occur as the reaction proceeds. 
Several factors influence the diastereoselectivity of Diels-Alder reactions: reaction of two 
cyclopentadiene molecules produces the endo adduct faster than the exo adduct, although the 
latter is thermodynamically more stable. Additional frontier orbital interactions stabilise the 
endo transition state (Figure 1.5). These secondary orbital interactions lower the energy of the 
endo transition state relative to that of the exo transition state.[69-71] The endo adduct is 
therefore preferentially obtained under kinetically controlled reaction conditions (endo rule). 
The endo rule also applies to acrylates and related dienophiles. In this case the endo 
selectivity can be further increased by Lewis acid catalysis, lower reaction temperatures and 
the application of pressure. 
H
H
HH
endo productexo product
favoreddisfavored
HOMOdiene
LUMOdienophile
secondary orbital
interactions
 
Figure 1.5: The endo product is produced faster for the Diels-Alder reaction of cyclopentadiene 
which can be explained by secondary orbital interactions (dashed lines show the additional bonding in 
the endo transition state). 
Another aspect of diastereoselectivity in Diels-Alder reactions is the correlation of the relative 
configuration of the diene and dienophile part in the product with the geometries of the diene 
and dienophile (Scheme 1.5). 
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Scheme 1.5: Diastereoselectivity in Diels-Alder reactions. 
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By examining the frontier orbital interactions, predictions regarding relative reaction rates and 
regioselectivity can be made. A dienophile with an electron withdrawing group (EWG) has a 
lower energy LUMO compared to an unsubstituted diene (Figure 1.6, a and b). Therefore the 
energy gap between the HOMO of the diene and the LUMO of the dienophile becomes 
smaller leading to rate acceleration.*[71-73] This situation is usually termed “Diels-Alder 
reaction with normal electron demand”. An electron donating group (EDG) in the dienophile 
can also lead to a rate acceleration. In this case the high-energy HOMO of the dienophile 
interacts with the LUMO of the diene. This is generally referred to as “Diels-Alder reaction 
with reverse electron demand” (Figure 1.6, c).[71]  
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Energy
Diels-Alder reaction with 
normal electron demand
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LUMO
LUMO
HOMO
HOMO
Energy
LUMO
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HOMO
HOMO
Energy
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Diels-Alder reaction with
reverse electron demand
a b c
 
Figure 1.6: Frontier orbital interactions for the Diels-Alder reaction. 
The large-large/small-small interactions between the frontier orbitals coefficients of the diene 
and dienophile determine the regioselectivity in the cycloaddition product.[71, 74]  
 
The benefit of Lewis acid catalysis, leading to increased rates, higher endo 
diastereoselectivity and improved regioselectivity, can be explained by the influence of the 
Lewis acid on the LUMO of the dienophile.[71] Using a Lewis acid catalyst (LA) the HOMO 
and the LUMO of the dienophile are lowered compared to an uncatalysed reaction 
(Figure 1.7, a reaction between acrolein and butadiene). This results in a smaller energy gap 
between the HOMO of the diene and the LUMO of the dienophile and rate acceleration is 
                                                 
*
 A smaller value for ELUMO-EHOMO leads to an increase in rate as the overall energy ∆E is lowered according to 
the equation for estimating the chemical reactivity by KLOPMAN[72] and SALEM.[73] 
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observed. Lewis acid coordination also leads to a greater polarisation of the C=C double bond 
resulting in a higher regioselectivity (Figure 1.7, b). Finally, a larger LUMO coefficient on 
the carbonyl carbon enables better secondary orbital interactions increasing the endo 
selectivity (Figure 1.7, c). 
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Figure 1.7: Lewis acid catalysis: (a) rate acceleration (b) regioselectivity (c) endo selectivity. 
1.3.2 Lewis Acid Catalysis in Asymmetric Diels-Alder Reactions 
Asymmetric variants of the Diels-Alder reaction were extensively developed starting in the 
1980’s.[75-77] Lewis acid catalysts have been shown to induce high enantio- and 
diastereoselectivities.[75] By forcing the reactants through a transition state that is distinctly 
lower than the competing diastereomeric transition states, a high level of stereoselectivity can 
be reached. A highly organised transition state is crucial and can be controlled by the 
following factors: a) one-point versus two-point binding in the catalyst-dienophile complex, 
b) metal ion coordination geometry and c) s-cis versus s-trans dienophile conformation.  
Among the first highly enantioselective catalysts for the Diels-Alder reaction were 
aluminium- and boron-Lewis acid complexes 13 and 14 (Scheme 1.6 and 1.7). COREY 
introduced the C2-symmetric aluminium-stilbenediamine system 13, which gave high 
enantiomeric excess for the reaction of cyclopentadiene with crotonyl imide (Scheme 1.6).[78] 
Although a two-point binding mode is generally expected for these dienophiles, X-ray 
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structures of the dimeric catalyst and 1H NMR studies indicated a one-point binding model 
through the s-trans dienophile conformation.[79] The bistriflamide ligand can be recovered 
almost quantitatively.  
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Scheme 1.6: Aluminium-stilbenediamine catalyst 13 for the enantioselective Diels-Alder reaction. 
At the same time YAMAMOTO and co-workers reported the in situ formation of 
(acyloxy)borane (CAB) complex 14, which was highly selective in Diels-Alder reactions 
between cyclopentadiene and a number of aldehyde-based dienophiles.[80, 81] More recently, 
YAMAMOTO and co-workers introduced a Brønsted acid-assisted chiral Lewis acid (BLA) 
catalyst 15, which was assumed to provide additional stabilisation of the transition state 
through intramolecular hydrogen bonding.[82] This catalyst gave excellent selectivities for the 
reaction between α-substituted aldehydes and cyclopentadiene. With catalyst 15 the 
Diels-Alder reaction with acetylenic aldehydes as dienophiles was accomplished with high 
enantioselectivity.[83] COREY’s triflic acid activated chiral oxazaborolidine 16 is one of the 
more recent contributions to the field of enantioselective Diels-Alder catalysts.[84] This very 
reactive catalyst induces high enantio- and diastereoselectivities for aldehyde- and ester-based 
dienophiles. A variation of catalyst 16, the chiral oxazaborolidine-aluminium bromide 
complex 17, showed even higher reactivity and enantioselectivity.[85] The chiral 
oxazaborolidines can be easily recovered and synthesised on a large scale. 
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Scheme 1.7: Catalysts for the enantioselective Diels-Alder reaction for one-point binding substrates.* 
                                                 
*
 For catalysts 16 and 17 illustrated in Scheme 1.7 absolute configurations have been matched to the absolute 
configuration of the Diels-Alder adduct. 
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A variety of catalysts have been used in Diels-Alder reactions with 2-oxazolidinone-based 
dienophiles such as crotonyl imide (Scheme 1.8). Especially bis(oxazoline) ligands have been 
demonstrated to give high enantioselectivities in Diels-Alder reactions with these dienophiles. 
COREY reported the application of magnesium(II)- and iron(III)bis(oxazoline) complexes.[86, 
87]
 EVANS found that copper(II)bis(oxazoline) complex 18 was an even more versatile and 
effective catalyst.[88-92] Interestingly, magnesium and iron complexes gave the enantiomeric 
cycloadducts compared to those from the copper-catalysed reactions. This can be rationalised 
by the individual metal geometries for the dienophile-catalyst complexes.[91]  
The copper(II)bis(sulfinyl)imidoamidine catalyst 19 by ELLMAN and co-workers also showed 
very high diastereoselectivities and enantioselectivities for several 2-oxazolidinone-derived 
dienophiles.[93] After 6 minutes at -78 °C, the Diels-Alder adduct of acrylate imide and 
cyclopentadiene was obtained in 96% yield with an endo:exo selectivity of 99:1 and an endo 
ee of 98%. Moderate to excellent enantioselectivities have been obtained using 
titanium-TADDOL complex 20. Its application was extensively studied by NARASAKA[94, 95] 
and others.[96-98] COLLINS used chiral zirconocene complex 21 to give the cycloadduct of 
crotonyl imide and cyclopentadiene in very good enantio- and diastereoselectivity showing 
high reactivity even at -78 °C.[99-101] 
A chiral scandium(III) catalyst, prepared from (R)-BINOL, Sc(OTf)3 and an achiral tertiary 
amine, was reported by KOBAYASHI.[102] A unique coordination structure indicated that axial 
chirality of the (R)-BINOL was extended to the tertiary amine leading to the proposed 
structure of 22a. An octahedral scandium(III)-dienophile complex was assumed to be 
generated by two-point binding of the dienophile. A turnover in selectivity was observed 
when using the related ytterbium catalyst 22b: addition of an achiral dicarbonyl-compound 
resulted in inversed stereoselectivity presumably resulting from specific coordination modes 
of ytterbium(III).[103] 
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Scheme 1.8: Catalysts for the enantioselective Diels-Alder reaction for two-point binding substrates.* 
1.3.3 Organocatalysed Diels-Alder Reactions 
The interest in metal-free enantioselective organocatalysis has increased enormously in the 
last 10 years.[104] The majority of organocatalysts are amines that typically form reactive 
intermediates such as iminium ions and enamines.[105, 106] 
In 2000 the MACMILLAN group introduced a new secondary amine-based organocatalyst for a 
range of transformations which were formally the domain of Lewis acid catalysis.[107, 108] The 
formation of iminium ion intermediates led to sufficiently activated species due to 
LUMO-lowering, which resembles Lewis acid catalysis (Scheme 1.9).  
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Scheme 1.9: Iminium ion activation through LUMO-lowering. 
The first highly enantioselective Diels-Alder reaction was performed using 5 mol% of 
imidazolidinone catalyst 23·HCl (Scheme 1.10, a).[107] Steric constraints were used in the 
catalyst design to induce high stereocontrol in the iminium ion intermediate. The 
imidazolidinone-catalysed Diels-Alder reaction has been studied extensively to achieve 
                                                 
*
 For catalyst 21 illustrated in Scheme 1.8 absolute configuration has been matched to the absolute configuration 
of the Diels-Alder adduct. 
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catalyst recovery: for example immobilisation on solid support [109] and fluorous variants 
which allowed recovery by fluorous-solid phase extractions[110] were reported. 
MACMILLAN also used imidazolidinone catalyst 24·HClO4 to achieve high asymmetric 
induction in the Diels-Alder reaction between simple, acyclic enones, considered challenging 
substrates, and cyclopentadiene (Scheme 1.10, b).[111] An advantage of the imidazolidinone 
catalysts is the commercial availability. 
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Scheme 1.10: (a) The first highly enantioselective organocatalytic Diels-Alder reaction with 
α,β-unsaturated aldehydes. (b) The first enantioselective Diels-Alder reaction with simple enones. 
A number of other organocatalysts have been used successfully in Diels-Alder reactions 
(Scheme 1.11). LEMAY and OGILVIE demonstrated that cyclic hydrazide catalyst 25, readily 
synthesised from camphorsulfonic acid, catalyses the Diels-Alder reaction in water with high 
yields, moderate diastereo- and good enantioselectivities.[112] The novel binaphthyl-based 
diamine catalyst 26 showed unprecedented high exo selectivity as well as moderate to good 
enantioselectivities.[113, 114] The only example for high endo selectivities in an organocatalysed 
Diels-Alder reactions was reported by HA and co-workers, using N-alkylated bisammonium 
catalyst 27.[115] 
HAYASHI reported the application of diarylprolinol silyl ether 28 combined with an acid to 
achieve good exo selectivities and enantioselectivities (generally above 94%).[116] Even alkyl- 
and heteroaryl-substituted acroleins were successfully converted with high enantioselectivities 
to the corresponding cycloadduct. 
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Scheme 1.11: Enantioselective Diels-Alder reactions with α,β-unsaturated aldehydes.* 
ISHIHARA and NAKANO accomplished the first enantioselective organocatalysed Diels-Alder 
reaction using α-substituted acroleins as dienophiles (Scheme 1.12).[117] In contrast to 
secondary amine imidazolidinone catalysts, which were almost inactive towards these 
substrates in cyclopropanation reactions,[118] the primary amine moiety of the phenylalanine-
derived organocatalyst 29 activated α-substituted acroleins sufficiently, presumably through 
aldimine formation. 
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Scheme 1.12: The first enantioselective organocatalysed Diels-Alder reaction with α-substituted 
acroleins. 
An alternative to secondary amines are catalysts which induce asymmetric induction through 
hydrogen bonding. RAWAL and co-workers introduced the TADDOL-organocatalysed 
Diels-Alder reaction, which produced good enantioselectivities and yields with α-substituted 
acroleins. The cycloadducts were isolated as the corresponding cyclohexanone 31 
(Scheme 1.13).[119] 
                                                 
*
 For catalyst 25 illustrated in Scheme 1.11 absolute configuration has been matched to the absolute 
configuration of the Diels-Alder adducts. 
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Scheme 1.13: Hydrogen bonding-promoted organocatalytic Diels-Alder reaction. 
1.4 Concept of Retro Reactions in ESI MS Screening 
A method for the identification of enantioselective chiral catalysts for the kinetic resolution 
based on ESI MS was developed in our group (Section 1.1.5).[9] Accordingly, the chiral 
catalyst undergoes complexation with the chiral quasienantiomeric substrates. The ratio of the 
resulting mass-labelled reaction intermediates is analysed to determine the catalyst’s inherent 
enantioselectivity (Scheme 1.14, a). This screening approach is only feasible when two 
quasienantiomeric substrates carrying the stereochemical information are used. However, for 
reactions, which lead from prochiral substrates to two enantiomeric products, this method 
cannot be applied. Therefore a new screening strategy was devised: by simply screening the 
retro reaction using chiral quasienantiomeric products as substrates, the application of the 
ESI MS screening method became possible (Scheme 1.14, b). In accordance to the principle 
of microscopic reversibility the retro reaction should proceed with the same selectivity as the 
forward reaction (Scheme 1.14, c). Screening of the retro reaction offers therefore the 
possibility to indirectly determine the catalyst’s selectivity of the forward, product-forming 
reaction. 
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Scheme 1.14: General scheme describing (a) the mass spectrometric approach for a screening 
method for forward reactions using chiral mass-labelled quasienantiomeric substrates (S)-S*
-X and 
(R)-S*
-Y, (b)  for screening of retro reactions using chiral quasienantiomeric products (S)-P*-X and 
(R)-P*
-Y leading to achiral mass-labelled substrates Sachiral-X and Sachiral-Y. (c) By the principle of 
microscopic reversibility with TS3=TS3’ and TS4=TS4’ selectivities obtained for the retro reaction 
should be applicable to the forward reaction.  
1.5 Objectives 
The aim of this thesis was the development of an ESI MS based screening method for 
enantioselective Diels-Alder catalysts. The highly enantioselective and well established 
bis(oxazoline)copper(II)-catalysed Diels-Alder reaction was chosen for the development of 
this screening method. 
The catalysts’ enantioselectivity was investigated by screening the retro reaction, because the 
chiral Diels-Alder products carry the stereochemical information necessary for the chiral 
catalyst to discriminate between the enantiomers. Mass-labelled enantiomeric Diels-Alder 
adducts A and B (“quasienantiomers”) were used as substrates to give the charged catalytic 
intermediates C and D, which should be detectable and distinguishable by ESI MS 
(Scheme 1.15). The mass peak ratio of C and D should directly reflect the intrinsic 
enantioselectivity of the chiral catalyst. In accordance to the principle of microscopic 
reversibility the screening results obtained for the retro reaction should be readily applicable 
to the forward reaction.  
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Scheme 1.15: General concept for screening chiral Diels-Alder catalysts. X and Y represent the mass 
labels. 
Extension of this concept to organocatalysed retro-Diels-Alder reactions was anticipated. 
When using secondary amine organocatalysts the catalytic intermediates correspond to 
charged iminium ions and should be readily detectable by ESI MS (Scheme 1.16).  
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Scheme 1.16: General concept for screening chiral Diels-Alder organocatalysts. X and Y represent 
the mass labels. 
Simultaneous screening of several catalysts in the same reaction mixture could significantly 
accelerate the screening process. For this reason a screening protocol for organocatalyst 
mixtures was developed. 
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2 ESI MS Screening of Chiral Copper(II)-Catalysts 
2.1 Introduction 
We were interested in developing an ESI MS screening method for the identification of highly 
selective chiral catalyst in the retro-Diels-Alder reaction (Scheme 2.1). By the principle of 
microscopic reversibility the information gained in the retro reaction should be directly 
applicable to the corresponding forward reaction. The Diels-Alder reaction is a powerful 
transformation for the construction of complex molecules with up to four stereocenters. 
Identification of highly enantioselective catalysts will further increase its value for synthetic 
applications.[76, 77]  
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Scheme 2.1: Retro-Diels-Alder reaction using quasienantiomeric Diels-Alder adducts. R1 and R2 
represent the mass labels. 
The endo Diels-Alder adducts A and B have different mass labels represented by R1 and R2 
(Scheme 2.1). The mass-labelled endo Diels-Alder adducts A and B undergo complexation 
with the chiral catalyst L*M. The resulting charged adduct-catalyst complexes can be detected 
by ESI MS along with dienophile-catalyst complexes of interest C and D, which are 
generated by loss of cyclopentadiene. The different masses of C and D enable the complexes 
to be distinguished by mass spectrometry. The ratio of C and D reflects the ability of the 
chiral catalyst to enantiodiscriminate and gives a direct measure of the enantiomeric ratio. As 
the dienophiles are achiral, they cannot be distinguished by a chiral catalyst. It is therefore 
necessary to examine the retro-Diels-Alder reaction instead of the forward Diels-Alder 
reaction, because the Diels-Alder adducts A and B contain the stereochemical information.  
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2.2 Synthesis of Quasienantiomeric Diels-Alder Adducts and Chiral 
Ligands 
The synthetic requirements for the quasienantiomeric Diels-Alder adducts were: both 
quasienantiomers should be enantiomerically pure and either the endo or the exo 
diastereoisomer must be used. In that way equal conditions regarding each quasienantiomer 
are ensured leading to reliable screening results. 
These requirements were fulfilled by using bis(oxazoline)(box)copper(II) complexes for the 
synthesis of the quasienantiomers. These complexes achieve very high asymmetric induction 
in the Diels-Alder reaction and offer a broad substrate scope both for the dienes and 
dienophiles.[88, 91, 92, 120, 121] C2-symmetric bis(oxazoline) ligands 32 have been developed 
independently by several research groups (Figure 2.1).[87, 122-124] Since their first successful 
applications in asymmetric copper-catalysed cyclopropanations,[122-124] aziridination[123] and 
Diels-Alder reactions[87] bis(oxazolines) have been employed in an impressive number of 
metal-catalysed transformations.[92, 125] 
Prominent ligands used in the copper(II)-catalysed enantioselective Diels-Alder reaction apart 
from bis(oxazolines) 32[91] are phosphinooxazolines 33[126] and bis(imines) 34[89] (Figure 2.1).  
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Figure 2.1: Prominent ligands applied in the copper(II)-catalysed enantioselective Diels-Alder 
reaction. 
EVANS and co-workers screened several bis(oxazoline) ligands for the copper(II)-catalysed 
Diels-Alder reaction of acrylate imide 35 and cyclopentadiene (Scheme 2.2). The best ligand 
in terms of diastereoselectivity and enantioselectivity turned out to be the t-Bu-box ligand 32b 
(endo:exo 98:2, endo ee >98%), followed by the i-Pr-box 32a, α-Naphthyl-box 32d and the 
Ph-box 32c.[91]  
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Scheme 2.2: Enantioselective Diels-Alder reaction with acrylate imide 35 and cyclopentadiene. 
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The scope of the enantioselective Diels-Alder reaction was tested by using different dienes 
and dienophiles. Alkyl-substituted dienes, such as cyclohexadiene or 1-phenylbutadiene, and 
heteroatom-substituted dienes were also shown to undergo the Diels-Alder reaction with high 
enantioselectivities.[121]  
The cycloaddition of 1-acetoxybutadiene with acrylate imide 35 as dienophile constitutes the 
first step of the synthesis of ent-∆1-tetrahydrocannabinol, demonstrating the synthetic value of 
bis(oxazoline)copper(II) systems for highly enantioselective synthesis (Scheme 2.3).[121]  
O
N O
O
2 mol% [Cu((S,S)-t-Bu-box)](SbF6)2
35
CH2Cl2, - 20 °C, 18 h
OAc5 eq.
N O
O O
OAc
H
37
4 steps
H
O
OH
C5H11
H
ent-∆1-tetrahydrocannabinol
trans:cis 73:27,
98% ee, 57% yield
 
Scheme 2.3: Enantioselective Diels-Alder reaction with heteroatom-substituted dienes. 
Although furan is generally considered a poor diene in Diels-Alder reactions[127, 128] EVANS 
and co-workers successfully catalysed the Diels-Alder reaction of acrylate imide 35 and furan 
using [Cu((S,S)-t-Bu-box)](SbF6)2 with excellent enantioselectivity (Scheme 2.4). 
Cycloadduct 38 was converted to ent-shikimic acid in four steps and a 37% overall yield from 
acrylate imide 35.[129]  
O
N O
O
35
O
O
N
O
O
38
HO 5 mol% [Cu((S,S)-t-Bu-box)](SbF6)2
CH2Cl2, - 78 °C, 42 h
endo:exo 80:20,
97% endo ee, 97% conv.
O
OHHO
HO
OH
4 steps
ent-shikimic acid
 
Scheme 2.4: Using furan as diene in the enantioselective Diels-Alder reaction. 
To further enhance the substrate scope 2-oxazolidinone and 2-thiazolidinone-derived 
dienophiles were used in the Diels-Alder reaction.[91] Very high diastereoselectivities and 
enantioselectivities were obtained for these substrates (Scheme 2.5).  
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O
N O
O
H
O N O
O
10 mol% [Cu((S,S)-t-Bu-box)](SbF6)2
O
N S
S
H
O N S
S
10 mol% [Cu((S,S)-t-Bu-box)](OTf)2
CH2Cl2, r.t., 24 h
CH2Cl2, -35 °C, 72 h
40
42
39
41
endo:exo 81:19, 
96% endo ee, 96% yield
endo:exo 92:8, 
97% endo ee, 86% yield
 
Scheme 2.5: Enantioselective Diels-Alder reaction with ß-substituted dienophiles.[91] 
HELMCHEN and co-workers reported the application of phosphinooxazoline ligands 33 in the 
copper(II)-catalysed enantioselective Diels-Alder reaction.[126] Originally these 
non-symmetrical P,N-ligands were developed for the enantioselective palladium-catalysed 
allylic substitution reaction,[130, 131] but they were also applied in other metal-catalysed 
transformations such as palladium-catalysed Heck-reactions,[132] silver-catalysed 1,3-dipolar 
cycloaddition[133] and iridium-catalysed asymmetric hydrogenation.[134, 135] Enantioselectivity 
in the copper(II)-catalysed Diels-Alder reaction depends strongly on the steric requirements of 
the P-aryl groups. Increasing the steric demands from phenyl- to α-Naphthyl-phosphine led to 
an increase in observed enantiomeric excess.[126] Generally enantioselectivities were lower (up 
to 97% endo ee) than those obtained with bis(oxazoline)copper(II) complexes.[91]  
Bis(imine) ligands 34, initially derived from salen (N,N’-bis(salicylideneaminoethane)), have 
been successfully used for the enantioselective copper(II)-catalysed Diels-Alder reaction of 
ß-substituted dienophiles and cyclopentadiene.[89] JACOBSEN showed their first application in 
the highly enantioselective copper(I)-catalysed asymmetric aziridination of alkenes.[136] 
Bis(imines) represent a very attractive ligand class, because they are easily prepared from 
commercially available starting material and can be readily tuned for specific electronic and 
steric demands.[137, 138] EVANS and co-workers found that in the copper(II)-catalysed 
Diels-Alder reaction bis(imine) ligands 34 gave significantly lower diastereo- and 
enantioselectivities for the 2-oxazolidinone-derived dienophiles and cyclopentadiene (up to 
94% endo ee) than the bis(oxazoline)copper(II) complexes.[89] In the case of the 
sulphur-derived dienophiles the diastereoselectivities were similar to those obtained for the 
bis(oxazoline)copper(II) complexes, but enantioselectivities were significantly lower.[89] 
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2.2.1 Bis(oxazoline) Ligand Synthesis 
All chiral bis(oxazoline) ligands were synthesised according to a procedure previously 
reported by EVANS and co-workers.[139] Using this method four bis(oxazolines) were obtained 
in three steps in moderate to excellent yields (Scheme 2.6).  
H2N
R
OH Cl Cl
OO
43a  R = i-Pr        
43b  R = t-Bu        
43d  R = β-Np
44 (81%)
HO OH
OO
Oxalyl chloride, 
Dimethylformamide,
CH2Cl2, r.t., 17 h
Et3N
CH2Cl2, r.t., 35 min NH
N
H
OO
45a  R = i-Pr     (77%)        
45b  R = t-Bu    (93%)        
45d  R = β-Np   (99%)
R
OH
R
HO
N N
OO
R R
Tosyl chloride, Et3N, 
DMAP,
CH2Cl2, r.t., 27 h
32a R = i-Pr     (93%)          
32b R = t-Bu    (73%)         
32d R = β-Np   (58%)
 
Scheme 2.6: Synthesis of bis(oxazoline) ligands 32a, 32b and 32d. 
Amino alcohols 43a and 43b were commercially available. Amino alcohol 43d was prepared 
by asymmetric aminohydroxylation (Scheme 2.7). By the method of SHARPLESS benzyl 
N-chlorocarbamate BnOCONCl was generated in situ from freshly prepared t-BuOCl 46 and 
benzyl carbamate. Benzyl N-chlorocarbamate and 2-vinylnaphthalene 47 then underwent an 
osmium-catalysed asymmetric aminohydroxylation to give protected amino alcohol 48.[140] 
Cleavage of the protecting group using standard conditions gave the enantiopure amino 
alcohol 43d in excellent yields.[141] 
NHZ NH2
OH OH
NaOH, t-BuOCl 46, Benzyl carbamate,
4 mol% K2OsO2(OH)4, (DHQ)2PHAL
n-PrOH/H2O, 0 °C, 3 h
H2, Pd/C
EtOH, r.t.,
3.5 h
Cl2,NaOH, 
H2O
43d (97%)48 (26%)47
Z =
O
Ot-BuOH
 
Scheme 2.7: Synthesis of amino alcohol 43d, precursor for the (S,S)-β-Np-box ligand 32d. 
ESI MS control experiments required (R,R)-t-Bu-box ligand (R)-32b. (R)-t-Leucine 49 was 
converted to (R)-t-leucinol (R)-43b, acetylated and ring-closed to give (R,R)-t-Bu-box ligand 
(R)-32b in excellent yield (Scheme 2.8).  
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H2N
OH Cl Cl
OO
(R)-43b 44 (81%)
HO OH
OO
Oxalyl chloride, 
Dimethylformamide,
CH2Cl2, r.t., 17 h
Et3N
CH2Cl2, r.t., 35 min NH
N
H
OO
(R)-45b (82%)
OHHO
N N
OO
Tosyl chloride, Et3N, 
DMAP,
CH2Cl2, r.t., 27 h
(R)-32b (91%)
H2N
OH
NaBH4, I2,
THF, reflux, 19 h
O
49
 
Scheme 2.8: Synthesis of (R,R)-t-Bu-box ligand (R)-32b. 
Achiral bis(oxazoline) ligand 50 was synthesised by a one step synthesis using a procedure 
reported by LEE et al. (Scheme 2.9).[142]  
N N
OO
50 (64%)
H2N
OH CNNC
ZnCl2
PhCl, 135 °C, 30 h
 
Scheme 2.9: Synthesis of achiral bis(oxazoline) ligand 50. 
2.2.2 Bis(imine) Ligand Synthesis 
Two general methods for the preparation of bis(imine) ligands have been reported. [89, 137, 138] 
Bis(imines) 34a-g were synthesised by condensation of the corresponding aromatic aldehyde 
and (1S,2S)-(+)-diaminocyclohexane or (1R,2R)-(+)-1,2-diphenylethaneamine (Table 2.1). 
Table 2.1: Synthesis of several bis(imine) ligands. 
Entry Ligand Conditions Yield (%) 
1 
 
N N
34a
 
MeOH, 30 min 41 
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Entry Ligand Conditions Yield (%) 
2 N N
34b
F F
 
MeOH, 30 min 19 
3 
34c
N N
NC CN
 
MeOH, 30 min 37 
4 N N
34d
Cl
Cl
Cl
Cl
 
MeOH, 10 min 100 
5 N N
34e
 
EtOH, 60 min 16 
6 N N
34f
 
EtOH, 60 min 81 
7 F N N
34g
F
 
EtOH, 60 min 64 
2.2.3 Synthesis of Dienophiles 
For the synthesis of the quasienantiomers aryl-substituted α,β-unsaturated dienophiles were 
used to introduce the mass label. Mass labels in the aryl para-position were assumed to be 
sufficiently removed from the reactive site of the molecule such that they would not influence 
the selectivity or reactivity of the retro-Diels-Alder reaction.[9] 
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The synthesis of the 2-oxazolidinone- and 2-thiazolidinethione-derived dienophiles was 
accomplished in three steps: a Heck reaction, followed by saponification and introduction of 
the 2-oxazolidinone or the 2-thiazolidinethione moiety (Scheme 2.10). 
R1
X
R1 = Et, n-Pr, i-Pr, n-Bu
X = I, Br
O
O R2 NaOAc, Pd(PPh3)4
Dimethylacetamide,
140 °C, 15 h R1
O
O R
1
51 R1 = Et, R2 = Et          (61%)
52 R1 = n-Pr, R2 = n-Bu   (49%)
53 R1 = i-Pr, R2 = n-Bu    (24%)
54 R1 = n-Bu, R2 = n-Bu  (62%)
NaOH (aq),
EtOH, reflux, 4 h
R
O
OH
55 R = Me       
56 R = Et        (99%)
57 R = n-Pr     (96%)
58 R = i-Pr      (89%)
59 R = n-Bu    (97%)
R
O
N O
O
R
O
N S
S
i. Oxalyl chloride, Dimethylformamide,
   CH2Cl2, r.t., 3 h
i. Oxalyl chloride, Dimethylformamide,
   CH2Cl2, r.t., 3 h
60 R = Me  (76%)
61 R = Et    (72%)
41 R = H        (39%)
63 R = Me      (70%)
64 R = Et       (68%)
65 R = n-Pr    (51%)
66 R = i-Pr     (64%)
67 R = n-Bu   (70%)
ii. 2-Oxazolidinone, n-BuLi,
   THF, -78 °C, 45 min         0 °C, 15 min
ii. 2-Thiazolidinethione, Et3N,
   CH2Cl2, -78 °C, 30 min         0 °C, 30 min
R2 = Et, n-Bu
 
Scheme 2.10: Dienophile synthesis. 
The acrylates 51-54 were synthesised according to the procedure of SCHULTZ with moderate 
yields.[143] Saponification was accomplished in near quantitative yield by heating acrylates 
51-54 at reflux for 4 hours with aqueous sodium hydroxide solution in ethanol. By the method 
of EVANS, carboxylic acids 55-59 were converted to the 2-oxazolidinone-derived dienophiles 
60 and 61 by addition of oxalyl chloride and 2-oxazolidinone.[144] After purification, the 
colourless crystalline products displayed excellent shelf life for at least 3 years at room 
temperature. 2-Thiazolidinethione-derived dienophiles 41 and 63-67 were prepared as 
described for the 2-oxazolidinone-derived dienophiles but Et3N and 2-thiazolidinethione were 
used in place of n-BuLi and 2-oxazolidinone. 
By a modified procedure of HO and MATHRE acrylate imide 35 was synthesised from in situ 
prepared anhydride 68 and 2-oxazolidinone (Scheme 2.11).[145] 
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O
N O
OO
OH
O
Cl
Et3N, EtOAc
0 °C, 40 min        
        r.t., 30 min
O
O
O 2-Oxazolidinone, LiCl
35 (63%)
THF, r.t., 4 h
68
 
Scheme 2.11: Acrylate imide 35 synthesis. 
Fumarate-derived dienophile 70 was prepared using a one pot procedure from fumaric acid 
monoethyl ester 69 (Scheme 2.12).[91] 
O
N O
O
O
EtO
O
OH
O
EtO
i. Oxalyl chloride, Dimethylformamide,
   CH2Cl2, r.t., 3 h
ii. 2-Oxazolidinone, n-BuLi,
   THF, -78 °C, 45 min         0 °C, 15 min
70 (55%)69
 
Scheme 2.12: Synthesis of fumarate-derived dienophile 70. 
2.2.4 Synthesis of Diels-Alder Adducts 
For ESI MS screening experiments enantiopure as well as racemic Diels-Alder adducts were 
needed. These were synthesised in two ways: asymmetric Diels-Alder adducts were obtained 
by using either [Cu(t-Bu-box)](OTf)2 or [Cu(t-Bu-box)](SbF6)2,[91] diethylaluminium chloride 
was used for obtaining racemic Diels-Alder adducts.[144] 
The cycloaddition of 2-oxazolidinone-derived dienophiles 60 and 61 or 2-thiazolidinone-
derived dienophiles 41 and 63-67 and cyclopentadiene using diethylaluminium chloride gave 
racemic Diels-Alder adducts rac-71-76 with very high diastereoselectivities and excellent 
conversions (Table 2.2). The diastereoselectivities of the sulphur-derived dienophiles were 
generally lower than for the 2-oxazolidinone-derived dienophiles (Table 2.2, entry 1 and 4). 
Diastereoisomers were separated by flash column chromatography.  
Table 2.2: Synthesis of racemic Diels-Alder adducts. 
R
O
N X
X
N
O
X
X
Et2AlCl
CH2Cl2, -78 °C         -20 °C, 3 h
R
 
Entry DA Adduct Endo:Exoa Conversion (%)a (Yield (%)b) 
1 rac-71 R = H, X = O  96:4 100 (84) 
2 rac-72 R = Me, X = O  97:3 100 (79) 
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Entry DA Adduct Endo:Exoa Conversion (%)a (Yield (%)b) 
3 rac-73 R = Et, X = O  96:4 85 (58) 
4 rac-74 R = H, X = S  92:8 100 (63) 
5 rac-75 R = Me, X = S  93:7 96 (75) 
6 rac-76 R = Et, X = S  91:9 100 (74) 
a Determined by 1H NMR of the crude product; b Pure endo Diels-Alder adduct was obtained. 
Enantioenriched Diels-Alder adducts (S)-77 and (S)-78 were synthesised from 
2-oxazolidinone-derived dienophiles 60 or 61 and cyclopentadiene using 20 mol% of 
[Cu((S,S)-t-Bu-box)](OTf)2 (Table 2.3).[91] Traces of water were found to severely diminish 
the catalyst activity. The colour of the catalyst mixture gave reliable evidence of the presence 
of a catalyst-water adduct: a blue reaction mixture indicated a catalyst-water adduct, a green 
reaction mixture indicated the absence of water.  
Table 2.3: Synthesis of 2-oxazolidinone-derived Diels-Alder adducts (S)-77 and (S)-78. 
R
O
N O
O
H
O N O
O
R
20 mol% [Cu((S,S)-t-Bu-box)](SbF6)2
CH2Cl2, -78 °C        r.t., 24 h
60 R = Me 
61 R = Et
 
Entry DA Adduct Endo:Exoa Endo ee (%)b 
(Exo ee (%)) 
Conversion (%)a 
(Yield (%)c) 
1 (S)-77 75:25 95 (86) 100 (59) 
2 (S)-78 67:33 89 56 (40) 
a Determined by 1H NMR of the crude product; b Determined by chiral HPLC; c Pure endo Diels-Alder adduct 
was obtained. 
[Cu((S,S)-t-Bu-box)](OTf)2 was used for the synthesis of sulphur-containing Diels-Alder 
adducts (S)-79-83 and their enantiomeric analogues (R)-84-88 were synthesised using the 
[Cu((R,R)-t-Bu-box)](OTf)2 catalyst (Table 2.4).[121] Conversions were in all cases near 
quantitative. Independent of the aryl-substituent diastereoselectivities and enantioselectivities 
were similar for all products. The fact that the Diels-Alder adducts were obtained as yellow 
needles (except for (S)-79 and (R)-84) greatly facilitated their handling.  
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Table 2.4: Synthesis of 2-thiazolidinethione-derived Diels-Alder adducts. 
R
O
N S
S
H
O N S
S
R
20 mol% [Cu((S,S)-t-Bu-box)](OTf)2
CH2Cl2, -78 °C         -35 °C, 72 h
63 R = Me      
64 R = Et       
65 R = n-Pr      
66 R = i-Pr       
67 R = n-Bu
(S)-79 R = Me 
(S)-80 R = Et 
(S)-81 R = n-Pr   
(S)-82 R = i-Pr     
(S)-83 R = n-Bu
20 mol% [Cu((R,R)-t-Bu-box)](OTf)2
CH2Cl2, -78 °C         -35 °C, 72 h
(R)-84 R = Me 
(R)-85 R = Et      
(R)-86 R = n-Pr  
(R)-87 R = i-Pr   
(R)-88 R = n-Bu
NO
SS
R
 
Entry DA Adduct Endo:Exoa Endo ee 
(%)b 
Endo ee (%) after 
Recrystallisation 
Conversion (%)a 
(Yield (%)c) 
1 (S)-79  97:3 95 - 99 (79) 
2 (R)-84  97:3 94 - >99 (87) 
3 (S)-80  97:3 93 >99 >99 (87) 
4 (R)-85  97:3 94 99 >99 (74) 
5 (S)-81  97:3 94 99 100 (67) 
6 (R)-86  97:3 94 >99 99 (71) 
7 (S)-82  97:3 93 >99 100 (79) 
8 (R)-87 97:3 94 >99 100 (87) 
9 (S)-83  96:4 93 >99 100 (74) 
10 (R)-88  97:3 93 99 100 (66) 
a Determined by 1H NMR of the crude product; b Determined by chiral HPLC; c Pure endo Diels-Alder adduct 
was obtained. 
X-ray analysis of (R)-86 confirmed the assumed configuration (Figure 2.2).  
 
Figure 2.2: Crystal structure of Diels-Alder adduct (R)-86. 
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Furan-derived Diels-Alder adduct 38 was synthesised according to the procedure by 
EVANS.[121] It was not possible to obtain the enantiopure product when using acrylate imide 
35, furan and 5 mol% of catalyst. Even after recrystallisation the endo Diels-Alder adduct was 
only obtained with an enantiomeric excess of 77% (Table 2.5). The combination of higher 
temperatures and longer reaction times resulted in a reversed endo:exo ratio with the exo 
diastereoisomer predominantly formed (Table 2.5, entry 1 and 3). Shortening of the reaction 
times (Table 2.5, entry 2) and lowering the temperatures (Table 2.5, entry 4) resulted in the 
endo diastereoisomer becoming more favoured. EVANS reported that at higher temperatures 
the cycloaddition reaction presumably was in a rapid equilibrium favouring the formation of 
the racemic exo Diels-Alder products.[129]  
Table 2.5: Asymmetric Diels-Alder reaction with furan as diene. 
O
N O
O
35
O 5 mol% [Cu((S,S)-t-Bu-box)](SbF6)2
O
O
N
O
O
38
CH2Cl2
 
Entry Conditions Endo:Exoa Conversion (%)a 
1 RT, 22 h 22:78 17 
2 -20 °C, 2.5 h 65:35 (endo ee 77%)b 86 
3 -20 °C, 24 h 45:55 83 
4 -78 °C, 42 h 82:18 9 
a Determined by 1H NMR of the crude product; b Determined by chiral HPLC. 
2.3 Development of Screening Method 
To examine catalyst-reactant complexes the most important prerequisite is their detection by 
ESI MS. Therefore complexes must be charged or converted into charged species and they 
must have a sufficiently long lifetime to be detected by ESI MS. To evaluate which model 
system fulfilled the criteria, preliminary studies examining the reaction intermediates for the 
forward Diels-Alder reaction were conducted. 
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2.3.1 2-Oxazolidinone-Derived Quasienantiomers 
To test if 2-oxazolidinone-derived species were suitable for ESI MS screening, an equimolar 
mixture of either dienophile 60 or 61 and [Cu((S,S)-t-Bu-box)](OTf)2 in dichloromethane was 
stirred at room temperature (Scheme 2.13). Aliquots of the reaction mixtures were taken at 
intervals (15 minutes to 24 hours) and analysed by ESI MS. Under these conditions no 
dienophile-catalyst complexes were detected (Figure 2.3). The only mass peaks detected at 
m/z 295, 313 and 651 were related to the t-Bu-box ligand 32b. These findings were confirmed 
by examination of the catalyst solution showing the same mass peaks. 
O
N
O
Cu
O
R
N N
OO
2 x OTf
2 +
O
N
O
O
R
N N
OO
32b
Cu(OTf)2 ,
CH2Cl2
60 R = Me 
61 R = Et
89 R = Me 
90 R = Et
 
Scheme 2.13: Anticipated formation of dienophile-catalyst complex 89 or 90. 
250 350 450 550 650 750m/z
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Irel
[L + H]+
[L + H3O]+
[2xL + Cu]+295
313
651
L = N N
OO
32b
 
Figure 2.3: ESI MS spectrum of dienophile 60 and [Cu((S,S)-t-Bu-box)](OTf)2. 
Neither variation of the solvent (acetone, acetonitrile, methanol or methanol-water) and 
temperature (-78 °C to 40 °C) nor the use of a different fumarate-derived dienophile 69 
resulted in detectable dienophile-catalyst complexes 89, 90 or 91 (Scheme 2.14). 
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O
N
O
Cu
O
EtO
O
N N
OO
2 x OTf
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O
N
O
O
69
O
N N
OO
32b
Cu(OTf)2 ,
CH2Cl2
EtO
91
 
Scheme 2.14: Anticipated formation of dienophile-catalyst complex 91. 
Mass peak m/z 651, corresponding to the singly charged {Cu[(S,S)-t-Bu-box]2} complex, was 
observed in all spectra implying that the dienophile-catalyst complex was presumably not 
stable under ESI MS conditions. We thought that this problem arose because the non-covalent 
interactions of the dienophile and the copper(II)-catalyst were not sufficiently strong for the 
complex to survive the ESI MS nebulisation process. 
2.3.2 2-Thiazolidinethione-Derived Quasienantiomers 
As 2-oxazolidinone-derived dienophiles were unsuitable for detection by ESI MS, dienophiles 
with stronger binding affinity to copper(II) had to be found. EVANS and co-workers reported 
that 2-thiazolidinethione-derived dienophiles showed enhanced reactivity in the asymmetric 
Diels-Alder reaction relative to their 2-oxazolidinone-derived counterparts.[91] To qualify 
these observations they performed a direct competition experiment between the 
2-oxazolidinone- and the 2-thiazolidinone-derived dienophile showing that 93 and 41 were 
more reactive than their corresponding 2-oxazolidinone analogues 92 and 39 (Scheme 2.15). 
These findings can be rationalised by an inherent increase in dienophilicity and/or a greater 
affinity of 2-thiazolidinonethione-derived dienophiles for the catalyst relative to their 
2-oxazolidinone counterparts.[91] Assuming the latter to be true, the dienophile-catalyst 
complexes should be more stable and therefore amenable to detection by ESI MS.  
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R
O
N O
O H
O N O
O
R
, [Cu((S,S)-t-Bu-box)](OTf)2
R
O
N S
S
H
O N S
S
RR = Me 95 (S)
                          = ~ 20
R = Me 94 (O)
R = Ph 42 (S)
                          = ~ 30
R = Ph 40 (O)
92 R = Me   
39 R = Ph
93 R = Me   
41 R = Ph
94 R = Me   
40 R = Ph
95 R = Me   
42 R = Ph
 
Scheme 2.15: Direct competition experiment between 2-oxazolidinone- and 2-thiazolidinone-derived 
dienophiles.[91] 
Using 2-thiazolidinethione-derived dienophile 63 and cyclopentadiene with 10 mol% of 
[Cu((S,S)-t-Bu-box)](OTf)2 the Diels-Alder reaction was performed (Scheme 2.16). After 
stirring for 18 hours at room temperature an aliquot of the reaction mixture was analysed by 
ESI MS. The spectrum showed the desired dienophile-catalyst complex 96 at m/z 620 and the 
Diels-Alder adduct-catalyst complex 97 at m/z 686, as well as the already familiar mass peaks 
at m/z 295, 313, 357, 375 and 651 (Figure 2.4). The corresponding Et-dienophile-catalyst 
complexes 98 (m/z 634) and the Diels-Alder adduct-catalyst complex 99 (m/z 700) were 
detected in a separate experiment (Figure 2.5). 
Copper-containing complexes were easily identified by their characteristic isotope pattern. 
Interestingly only copper(I)-complexes were observed although Cu(II)(OTf)2 was used to 
generate the catalyst. Similar observations have been reported previously[146-148] and explained 
by electrochemical reactions occurring at the capillary which can affect the oxidation state of 
the metal species. Electrochemical processes during the electrospray process are therefore 
responsible for Cu2+ appearing as Cu1+ in the mass spectrum.  
10 mol% [Cu((S,S)-t-Bu-box)](OTf)2
O
N S
S
H
O N S
S
Me
Me
CH2Cl2, r.t., 18 h
63 79
 
Scheme 2.16: The Diels-Alder reaction using dienophile 63. 
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Figure 2.4: ESI MS spectrum of the Diels-Alder reaction using dienophile 63. 
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Figure 2.5: ESI MS spectrum of the Diels-Alder reaction using dienophile 64. 
To evaluate if the mass-labelled substrates can be detected together in the same reaction 
mixture by ESI MS, the Diels-Alder reaction was performed using an equimolar mixture of 
dienophiles 63 and 64 with [Cu((S,S)-t-Bu-box)](OTf)2 (Scheme 2.17). The reaction mixture 
was stirred for 18 hours at room temperature. An aliquot of the reaction mixture was analysed 
by ESI MS showing the dienophile-catalyst complexes 96 and 98 along with the Diels-Alder 
adduct-catalyst complexes 97 and 99 (Figure 2.6). The mass peak intensities of dienophile 
complexes 96 and 98 gave a 50:50 ratio representing the initial ratio. The observed ratio for 
the Diels-Alder adduct complexes was 53:47 suggesting a slightly higher reactivity of the Me-
labelled dienophile 63. The results showed that it was possible to detect reaction intermediates 
of the Diels-Alder reaction with a mass difference of ∆ m/z = 14 conveniently by ESI MS. 
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Scheme 2.17: Competition experiment between Me- and Et-labelled dienophile 63 and 64. 
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Figure 2.6: ESI MS spectrum of the retro-Diels-Alder reaction depicted in Scheme 2.17.  
2.3.3 Evaluation of Retro-Diels-Alder Reaction Conditions 
Having found substrates suitable for monitoring reaction intermediates in the forward 
Diels-Alder reaction, conditions for the retro reaction were investigated. Preliminary studies 
used one equivalent of [Cu((S,S)-t-Bu-box)](OTf)2 as this led to higher conversion and better 
detection of intermediates. Elevated temperatures were necessary for the reaction to proceed, 
but care was taken to prevent the uncatalysed retro-Diels-Alder reaction (see Section 2.6).  
Retro-Diels-Alder reactions were performed using racemic Diels-Alder adduct rac-74 and 
[Cu((S,S)-t-Bu-box)](OTf)2. After stirring for the indicated times and temperatures, aliquots 
of the reaction mixture were analysed by ESI MS (Table 2.6). Reaction temperatures at 80 °C 
or 100 °C gave sufficient conversion to the dienophiles. Reaction times were even shortened 
to one hour. Microwave irradiation was also used, but gave poor results (Table 2.6, entry 7). 
1H NMR of the reaction mixtures confirmed the conversion observed by ESI MS. 
Chapter 2 
 
40
Table 2.6: Screening reaction conditions for the retro-Diels-Alder reaction. 
O
N
S
S
H
O
N
S
S
1 eq. [Cu((S,S)-t-Bu-box)](OTf)2
rac-74
41
H
O
Cu S
N
SN
N
*
+
O
N S
S
N
Cu
N
+*
100 101
 
Entry Conditions Heating 
Source 
DA Adduct rac-72 : 
Dienophile 62a 
DA Adduct Complex 100 :  
Dienophile Complex 101b 
1 48 h, r.t. oil bath 98:2 97:3 
2 18 h, 40 °C oil bath 97:3 94:6 
3 18 h, 50 °C oil bath 94:6 90:10 
4 1 h, 60 °C oil bath 95:5 95:5 
5 2 h, 80 °C oil bath 86:14 82:18 
6c 2 h, 100 °C oil bath 75:25 81:19 
7 1.5 h, 70 °C microwave 97:3 96:4 
a Ratio determined by 1H NMR; b Ratio determined by ESI MS; c 1:1 mixture of rac-75 and rac-76 as starting 
material. 
2.3.4 Retro-Diels-Alder Reaction under Non-Catalytic Conditions 
Having found conditions for the retro-Diels-Alder reaction experiments were conducted with 
mass-labelled racemic Diels-Alder adducts rac-75 and rac-76 to test if the relevant 
intermediates could be detected (Scheme 2.18). The Diels-Alder adducts were structurally 
identical except for the mass label in aryl para-position. Therefore they should show the same 
reactivity towards the catalyst resulting in the same mass peak intensities for Me- and 
Et-labelled substrates. The dienophile-catalyst complexes 96 and 98 along with the 
Diels-Alder adduct complexes 97 and 99 were detected by ESI MS (Figure 2.7). The ratio for 
the dienophile complexes showed a 51:49 ratio which was very close to the expected 50:50 
ratio. The slight deviation can be attributed either to weighing errors or to a higher reactivity 
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of the Me-labelled substrate. Investigations concerning this point will be discussed later (see 
Secion 2.3.5). 
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Scheme 2.18: The retro-Diels-Alder reaction using rac-75 and rac-76. 
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Figure 2.7: ESI MS spectrum for the reaction depicted in Scheme 2.18.  
If the racemic Diels-Alder adducts were substituted by an equimolar mixture of mass-labelled 
quasienantiomers (S)-79 and (R)-85 (Scheme 2.19), mass peak intensities for the dienophile 
complexes 96 and 98 should reflect the catalyst’s enantioselectivity. As seen in Figure 2.8, 
quasienantiomer (S)-79 was converted faster to the corresponding dienophile 63 by the chiral 
catalyst than quasienantiomer (R)-85. By analysing the mass peak intensities of the 
dienophile-catalyst complexes 96 and 98 a ratio of 73:27 was observed. 
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Scheme 2.19: The retro-Diels-Alder reaction using quasienantiomers (S)-79 and (R)-85. 
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Figure 2.8: ESI MS spectrum of the retro-Diels-Alder reaction depicted in Scheme 2.19. 
For verification of the results by ESI MS the retro-Diels-Alder reaction was conducted with 
the (R,R)-catalyst. The inversely labelled quasienantiomers (R)-84 and (S)-80 were also 
reacted with both [Cu((S,S)-t-Bu-box)](OTf)2 and [Cu((R,R)-t-Bu-box)](OTf)2. If the method 
using these quasienantiomers was valid, reaction of both quasiracemates with the 
(S,S)-catalyst should lead to exact the inverse dienophile complex ratios (for example 70:30 
vs. 30:70). If the reaction was conducted using the same quasiracemate with either the (S,S)-
catalyst or the (R,R)-catalyst again exact inverse dienophile complex ratios should be 
detected. 
The general trend showed that the (S,S)-catalyst was always more reactive towards the 
(S)-Diels-Alder adducts to undergo the retro-Diels-Alder reaction and to subsequently give 
the corresponding dienophiles (Table 2.7, entry 1 and 3, Figure 2.9). Vice versa the 
(R,R)-catalyst preferentially converted the (R)-Diels-Alder adducts to the corresponding 
dienophiles (Table 2.7, entry 2 and 4, Figure 2.9). Interestingly, using the same quasiracemate 
with either the (S,S)- or the (R,R)-catalyst led to the expected inverse ratio, but different 
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values (Table 2.7, entry 1/2 or 3/4; see also Section 2.3.5). For the Diels-Alder adduct 
complexes roughly the initial 50:50 ratio with slightly more of the less favoured Diels-Alder 
adduct was observed. This finding might be an indication for the conversion of the reaction. A 
substantial amount of the faster reacting Diels-Alder adduct had already been converted to the 
dienophile, therefore more of the less reactive Diels-Alder adduct remained in the reaction 
mixture. 
Table 2.7: Control experiments using Me- and Et-labelled quasienantiomers in the retro-Diels-Alder 
reaction. 
H
O N S
S
Et
H
O N S
S
Me
1 eq. [Cu(t-Bu-box)](OTf)2
CH2Cl2, 100 °C, 2 h
NO
SS
Et
NO
SS
Me
(S)-79
(S)-80
(R)-85
(R)-84
R
O
N S
S
N
Cu
N
+*
96 R = Me and 98 R = Et
 
Entry Quasienantiomers Cat. Dienophile Complex 
96 : 98a 
DA Adduct Complex 
Me : Eta 
1 (S)-79/(R)-85 S,S 73:27 44:56 
2 (S)-79/(R)-85 R,R 38:62 50:50 
3 (R)-84/(S)-80 S,S 37:63 52:48 
4 (R)-84/(S)-80 R,R 74:26 43:57 
a Ratio determined by ESI MS. 
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Figure 2.9: ESI MS spectra of the control experiments using Me- and Et-labelled quasienantiomers. 
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2.3.5 Retro-Diels-Alder Reaction under Catalytic Conditions 
To test if this method also enabled us to monitor reaction intermediates under catalytic 
conditions the retro-Diels-Alder reaction was performed with 20 mol% of catalyst. High 
catalyst loading of 20 mol% was necessary to obtain good ESI MS detection and intensity of 
the mass peaks. In addition a protocol for analysing the dienophile ratio directly from the 
reaction mixture by HPLC was developed, so the ESI MS results were confirmed by a second 
analytical method. 
For verification of the method control experiments using both quasiracemates (S)-79 and 
(R)-85 or (R)-84 and (S)-80 with both catalysts, [Cu((S,S)-t-Bu-box)](OTf)2 or 
[Cu((R,R)-t-Bu-box)](OTf)2, were conducted. Using either (S)-79 and (R)-85 or (R)-84 and 
(S)-80 as quasienantiomers with the (S,S)-catalyst should led to the exact inverse ratio for the 
dienophile complexes. The same results are expected when using the same quasiracemate 
with either the (S,S)- or the (R,R)-catalyst. For comparison the results using stoichiometric 
amounts of catalyst were included in Table 2.8 (see Section 2.3.4, Table 2.7). 
It became immediately evident that the expected inverse ratios using the same catalyst but 
opposite quasiracemates were not obtained (Table 2.8, entry 2/6 or 4/8). The same was 
observed for using the same quasiracemate, but opposite catalysts (Table 2.8, entry 2/4 or 
6/8). As two experiments showed the expected enantioselectivities (Table 2.8, entry 2 and 8), 
the outcome of the reactions can only be explained by a higher reactivity of the chiral catalyst 
for the Me-Diels-Alder adduct independent of its configuration. This effect was smaller using 
stoichiometric amounts of catalyst and became more pronounced under catalytic conditions 
(Table 2.8). HPLC analysis of the reaction mixtures supported the ESI MS results.  
Table 2.8: Results of the retro-Diels-Alder reaction under non-catalytic and catalytic conditions. 
H
O N S
S
Et
H
O N S
S
Me
[Cu(t-Bu-box)](OTf)2
CH2Cl2, 100 °C, 2 h
NO
SS
Et
NO
SS
Me
(S)-79
(S)-80
(R)-85
(R)-84
R
O
N S
S
N
Cu
N
+
*
96 R = Me and 98 R = Et
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Entry Cat. Catalyst 
Loading 
Quasi- 
enantiomers 
Dienophile 
Complex 
96 : 98a 
Dienophile 
63 : 64b 
DA Adduct 
Complexes 
Me : Eta 
1 S,S 1.0 eq. (S)-79/(R)-85 73:27 - 44:56 
2 S,S 0.2 eq. (S)-79/(R)-85 68:32 66:34 50:50 
3 R,R 1.0 eq. (S)-79/(R)-85 38:62 23:77 52:48 
4 R,R 0.2 eq. (S)-79/(R)-85 50:50 43:57 50:50 
5 S,S 1.0 eq. (R)-84/(S)-80 37:63 21:79 52:48 
6c S,S 0.2 eq. (R)-84/(S)-80 49:51 37:63 51:49 
7 R,R 1.0 eq. (R)-84/(S)-80 74:26 65:35 43:57 
8c R,R 0.2 eq. (R)-84/(S)-80 71:29 61:39 50:50 
a Dienophile and Diels-Alder adduct complex ratio determined by ESI MS; b Dienophile ratio determined by 
HPLC; c Reaction time 1 hour. 
To further investigate the catalyst’s selectivity direct competition experiments between 
equimolar mixtures of either (S)-79 and (S)-80 or (R)-84 and (R)-85 were conducted 
(Table 2.9). Taking Me- and Et-Diels-Alder adducts of the same configuration eliminated any 
stereochemical influence. If the catalyst was unaffected by the mass labels, a 50:50 mixture of 
dienophile complexes 96 and 98 would be expected.  
Table 2.9: Direct competition experiment between Me- and Et-labelled Diels-Alder adducts. 
R
O
N S
S
N
Cu
N
+*
R
O
N S
S
N
Cu
N
+*
NO
SS
Me
H
O N S
S
Et
H
O N S
S
Me
1 eq. / 0.2 eq. [Cu((S,S)-t-Bu-box)](OTf)2
CH2Cl2, 100 °C, 2 h
1 eq. / 0.2 eq. [Cu((R,R)-t-Bu-box)](OTf)2
CH2Cl2, 100 °C, 2 h
NO
SS
Et
(S)-79 (S)-80
(R)-84 (R)-80
96 R = Me and 98 R = Et
96 R = Me and 98 R = Et
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Entry Cat. Catalyst Loading 
Quasi-
enantiomers 
Dienophile Complex 
96 : 98a 
DA Adduct Complexes 
Me : Eta 
1 S,S 1.0 eq. (S)-79/(S)-80 54:46 50:50 
2 R,R 1.0 eq. (R)-84/(R)-85  56:44 51:49 
3 S,S 0.2 eq. (S)-79/(S)-80 64:36 50:50 
4c R,R 0.2 eq. (R)-84/(R)-85 65:35 50:50 
a Dienophile and Diels-Alder adduct complex ratio determined by ESI MS. 
The direct competition experiments confirmed that the catalyst is more reactive towards the 
Me-substituted substrates (Table 2.9). It also showed clearly that the effect was more 
pronounced under catalytic conditions. This was confirmed in another experiment by varying 
the amount of [Cu((S,S)-t-Bu-box)](OTf)2 in the retro-Diels-Alder reaction of (R)-84 and 
(S)-80 (Table 2.10). The ratios were monitored by ESI MS and HPLC. Using 
1 - 0.6 equivalents of (S,S)-catalyst the expected dienophile ratio was observed. When the 
catalyst loading was below 0.6 equivalents the catalyst gradually distinguished less between 
the quasienantiomers. The initial complexation with the Diels-Alder adducts was not affected 
by the mass labels, generally a 50:50 ratio was observed, indicating that a difference in 
activation energy for the Me- and Et-substituted substrates undergoing the retro reaction must 
play a role.  
Table 2.10: Varying the amount of catalyst in the retro-Diels-Alder reaction. 
NO
SS
Me
H
O N S
S
Et
X eq. [Cu((S,S)-t-Bu-box)](OTf)2
CH2Cl2, 100 °C, 2 h
(S)-80(R)-84
R
O
N S
S
N
Cu
N
+*
96 R = Me and 98 R = Et
 
Entry Eq. Catalyst Dienophile Complex 96 : 98a Dienophile 63 : 64b 
1 1.0 37:63 21:79 
2 0.8 36:64 27:73 
3 0.6 33:67 25:75 
4 0.4 42:58 26:74 
5 0.2 49:51 37:63 
a Dienophile and Diels-Alder adduct complex ratio determined by ESI MS; b Dienophile ratio determined by 
HPLC. 
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To explain the catalyst’s preference for Me-labelled substrates steric and electronic factors 
were considered. As the mass labels were well removed from the reactive site, electronic 
factors must be responsible for the difference. Hammett substitution constants, σ, calculated 
from ionisation constants of benzoic acids,[149] quantify the effects that electron-donating or 
electron-withdrawing groups have on the transition state or intermediates during the course of 
a reaction.[150] Steric interactions are excluded by considering meta- and para-substituents 
only. Hammett constants can be further refined by factoring the electronic effect into a 
resonance component R and non-resonance “field” component F, leading to the following 
equation  
σ = fF + rR + h 
where f, r and h are entirely independent of the substituent.[151, 152] F and R are also known as 
Swain-Lupton constants.[150] As these constants can be useful tools to derive quantitative 
structure-activity relationships (QSAR)[153] they were used to explain electronic influences in 
the mass-labelled retro-Diels-Alder substrates. Comparing the Hammett substitution constants 
σP for methyl- and ethyl-substituents the electronic difference is very small, but significant 
(Table 2.11). The more refined resonance constants R show a larger difference (Table 2.11, 
-0.18 vs. -0.15) implying that the methyl substituent is slightly more electron-donating than 
the ethyl substituent.[152] Although the differences for R are small and values fluctuate 
depending on the parameters used,[150, 154] a preference for the more electron rich substrate by 
the catalyst is a possible explanation for the higher reactivity of the Me-labelled substrate. 
Why this preference is more pronounced under catalytic conditions remains unclear. 
Table 2.11: Hammett substitution constants and modified Swain-Lupton constants.[150]  
Entry Substituent σP F R 
1 Me -0.17 0.01 -0.18 
2 Et -0.15 0.00 -0.15 
3 n-Pr -0.15 0.04 -0.19 
4 i-Pr -0.13 0.01 -0.14 
5 n-Bu -0.16 -0.01 -0.15 
 
To find suitable quasienantiomers in which the mass labels would not influence the reactivity 
of the catalyst several substituted Diels-Alder adducts were synthesised (Figure 2.10). They 
were tested in a direct competition experiment using 20 mol% of catalyst and Diels-Alder 
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adducts with the same configuration but different substituents (Table 2.12). If the catalyst was 
not influenced by the mass labels 50:50 dienophile complex ratios were expected. We found 
that Et- and n-Bu-substituted Diels-Alder adducts did not influence the catalyst reactivity 
therefore being suitable quasienantiomers. In other tested pairs such as Et/i-Pr and n-Pr/n-Bu 
the mass label had an influence on the catalyst’s reactivity (Table 2.12, entry 3/4 and 5/6). A 
further advantage of the Et- and n-Bu quasienantiomers was that the reaction mixture could be 
directly analysed by HPLC to determine the Et- to n-Bu-dienophile ratio.  
Steric effects did not influence the catalyst’s reactivity because the results were independent 
of the substituent size (Table 2.12, compare entry 1 and 3). The results are consistent with the 
σP and R values listed in Table 2.11 with very similar σP and R values for ethyl- and 
n-butyl-substituents. 
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Figure 2.10: Several differently substituted Diels-Alder adducts. 
Table 2.12: Direct competition experiment between several Diels-Alder adducts. 
R
O
N S
S
N
Cu
N
+*
R
O
N S
S
N
Cu
N
+*
R = R1 and R2
NO
SS
R1
H
O N S
S
R2
H
O N S
S
R1
(S)-DA adduct
(R)-DA adduct
(S)-DA adduct
(R)-DA adduct
20 mol% [Cu((S,S)-t-Bu-box)](OTf)2
CH2Cl2, 100 °C, 1 h
20 mol% [Cu((R,R)-t-Bu-box)](OTf)2
CH2Cl2, 100 °C, 1 h
NO
SS
R2
R = R1 and R2
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Entry Cat. Quasienantiomers  
(R1 : R2) 
Dienophile Complex 
R1 : R2 a 
DA Adduct Complex 
R1 : R2 a 
1 S,S (S)-79/(S)-80 64:36 50:50 
2 R,R (R)-84/(R)-85 65:35 50:50 
3 S,S (S)-80/(S)-81 47:53 50:50 
4 R,R (R)-85/(R)-86 47:53 50:50 
5 S,S (S)-82/(S)-83 54:46 50:50 
6 R,R (R)-87/(R)-88 54:46 50:50 
7 S,S (S)-80/(S)-83 50:50 49:51 
8 R,R (R)-85/(R)-88 51:49 49:51 
a Dienophile and Diels-Alder adduct complex ratios determined by ESI MS. 
2.3.6 Direct Analysis of Catalytic Intermediates in the Retro-Diels-Alder 
Reaction: General Screening Protocol  
The general screening protocol for the retro-Diels-Alder reaction used an equimolar mixture 
of Et- and n-Bu-Diels-Alder adducts and 20 mol% of copper(II)-catalyst in dichloromethane. 
For ESI MS analysis aliquots of the reaction mixture were taken, diluted to 10-5 M and 
analysed by ESI MS. The ratios for the dienophile and Diels-Alder adduct complexes were 
determined by integration of the mass peaks (see Section 5.5.1 for details). For verification 
HPLC analysis of the dienophiles 64 and 67 in the reaction mixture was performed.  
Application of the general screening protocol was demonstrated by conducting the 
retro-Diels-Alder reaction with (S)-80 and (R)-88 using [Cu((S)-t-Bu-box)](OTf)2 
(Scheme 2.20). The ESI MS spectrum in Figure 2.11 showed a ratio of 68:32 for the Et- to 
n-Bu-dienophile complexes 98 and 102. For the Et- to n-Bu-Diels-Alder adduct complexes 99 
and 103 a ratio of 49:51 was obtained.  
This experiment demonstrated that it is possible to directly monitor reaction intermediates of 
the retro-Diels-Alder reaction under catalytic conditions. Analysis of the dienophile complex 
mass peaks gives a direct measure of the catalysts’ enantioslectivity.  
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Scheme 2.20: The retro-Diels-Alder reaction using (S)-80 and (R)-88 as quasienantiomers. 
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Figure 2.11: ESI MS spectrum for the retro-Diels-Alder reaction depicted in Scheme 2.20.  
2.3.7 Furan-Based Quasienantiomers 
In principle the driving force for the retro-Diels-Alder reaction with furan-containing 
Diels-Alder adducts should be greater than that for cyclopentadiene-derived adducts.[129] 
Unfortunately the synthesis of the 2-thiazolidinethione-derived Diels-Alder adduct 
incorporating furan was not successful. Also the retro-Diels-Alder reaction of 38 already took 
place at low temperatures without addition of catalyst: after storing Diels-Alder adduct 38 for 
5 days at 4 °C in deuterated dichloromethane, 20% of dienophile 35 was observed by 
1H NMR (Scheme 2.21). For this reason and synthetic difficulties screening of furan-derived 
quasienantiomers was not explored further. 
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Scheme 2.21: Retro-Diels-Alder reaction with furan-derived Diels-Alder adduct 38. 
2.4 Control Experiments 
2.4.1 Reversed Ligand Configuration and Inversely Labelled Quasienantiomers 
To test the validity of our method control experiments using both quasiracemates, (S)-80 and 
(R)-88 or (R)-85 and (S)-83, with both catalysts, [Cu((S,S)-t-Bu-box)](OTf)2 and 
[Cu((R,R)-t-Bu-box)](OTf)2, were conducted. As described earlier, retro-Diels-Alder reaction 
with each of the quasiracemates with the (S,S)-catalyst should produce the exact inverse 
dienophile-catalyst complex ratio (for example 70:30 vs. 30:70). The same is expected for the 
control experiments using the (R,R)-catalyst.  
Reaction of each quasiracemate with the (S,S)-catalyst produced the expected inverse ratios 
for the dienophile-catalyst complexes 98 and 102 (Table 2.13, entry 1 and 2, Figure 2.12). 
The same was detected when the ligand configuration was inverted (Table 2.13, entry 1/3 and 
entry 2/4, Figure 2.13). The mass peak at m/z 651 representing the [Cu(t-Bu-box)2]+ complex 
was present in all spectra. The HPLC results for the dienophiles 64 and 67 correlated perfectly 
with the results obtained by ESI MS (Table 2.13). The results of the control experiments were 
in excellent agreement and this method was therefore applied to screen for highly 
enantioselective catalysts for the retro-Diels-Alder reaction. 
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Table 2.13: Control experiments with both quasiracemates. 
H
O N S
S
n-Bu
H
O N S
S
Et
[Cu(t-Bu-box)](OTf)2
CH2Cl2, 100 °C, 1 h
NO
SS
n-Bu
NO
SS
Et
(S)-80
(S)-83
(R)-88
(R)-85
R
O
N S
S
N
Cu
N
+*
98 R = Et and 102 R = n-Bu
 
Entry Cat. Quasi- 
enantiomers 
Dienophile Complex 
 98 : 102a 
Dienophile 
64 : 67b 
DA Adduct Complex  
Et : n-Bua 
1 S,S (S)-80/(R)-88 68:32 69:31 49:51 
2 S,S (R)-85/(S)-83 32:68 29:71 49:51 
3 R,R (S)-80/(R)-88 31:69 32:68 50:50 
4 R,R (R)-85/(S)-83 69:31 69:31 48:52 
a Dienophile and Diels-Alder adduct complex ratio determined by ESI MS; b Dienophile ratio determined by 
HPLC. 
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Figure 2.12: ESI MS spectra for control experiments with (a) (S)-80 and (R)-88 and (b) (R)-85 and 
(S)-83 with [Cu((S,S)-t-Bu-box)](OTf)2.  
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Figure 2.13: ESI MS spectra for control experiments with (S)-80 and (R)-88 using 
(a) [Cu((S,S)-t-Bu-box)](OTf)2 and (b) [Cu((R,R)-t-Bu-box)](OTf)2. 
2.4.2 Comparison with the Results from the Preparative Forward Diels-Alder 
Reaction 
In accordance to the principle of microscopic reversibility we expected the results obtained by 
ESI MS to be in good agreement with the preparative forward Diels-Alder reaction. 
n-Bu-dienophile 67 and cyclopentadiene were subjected to Diels-Alder reaction using 
20 mol% of [Cu((S,S)-t-Bu-box)](OTf)2 (Scheme 2.22). Only the concentration of the starting 
material was changed compared to that of the retro reaction (0.01 M vs. 0.02 M) due to 
practical considerations. HPLC analysis was not possible when the reaction mixture was too 
dilute, because conversion was too small. An enantiomeric ratio of 64:36 was observed which 
correlated very well with the ESI MS results (ESI MS ratio 68:32).  
H
O N S
S
n-Bu
O
N S
S
n-Bu
20 mol% [Cu((S,S)-t-Bu-box)](OTf)2
CH2Cl2, 100 °C, 1 h
endo:exo 86:14,
endo ee 28%,
conversion 31%
67 (S)-83
 
Scheme 2.22: The preparative forward Diels-Alder reaction. 
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2.5 Ligand Screening 
2.5.1 ESI MS Screening Using Bis(oxazoline) Ligands 
Having established a reliable ESI MS screening method a series of copper(II)-catalysts were 
tested for their ability to enantiodiscriminate (Table 2.14). The choice of ligands was inspired 
by the work of EVANS, who tested several bis(oxazoline)copper(II)-catalysts for the 
Diels-Alder reaction with acrylate imide 35 and cyclopentadiene (see Section 2.2).[91]  
The highest enantioselectivities in the retro-Diels-Alder reaction using (S)-80 and (R)-88 as 
quasienantiomers were observed for the β-Naphthyl-box-derived catalyst, followed by the 
Ph-box-, t-Bu-box-, i-Pr-box- and finally the Bn-box-derived catalysts (Table 2.14). The 
results were confirmed by direct analysis of the reaction mixture by HPLC (Table 2.14) and 
by performing the preparative forward reactions (discussed in the next section). Additional 
peaks in the mass spectra resulted from the protonated ligand and adducts of the protonated 
ligand with water. Singly charged copper-box complexes were also observed along with the 
corresponding copper-box water adducts.  
Table 2.14: Screening results using five different bis(oxazoline) ligands. 
98 R = Et and 102 R = n-Bu
R
O
N S
S
N
Cu
N
+*
H
O N S
S
Et
CH2Cl2, 100 °C, 1 h
N N
OO
R R
NO
SS
n-Bu
22 mol%
20 mol% Cu(OTf)2
(S)-80 (R)-88
 
Entry R Dienophile Complex 98 : 102a Dienophile 67 : 64b 
1 β-Np (32d) 
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Entry R Dienophile Complex 98 : 102a Dienophile 67 : 64b 
2 Ph (32c) 
 
 
3 t-Bu (32b) 
 
 
4 i-Pr (32a) 
 
 
5 Bn (32e) 
 
 
a Dienophile and Diels-Alder adduct complex ratio determined by ESI MS; b Dienophile ratio determined by 
HPLC; c The additional middle peak represents the ligand. 
Our results indicated an unexpected order of relative catalyst enantiodiscrimination, 
β-Np>Ph>t-Bu>i-Pr>Bn, which deviated from EVANS’ previous observations 
t-Bu>i-Pr>α-Np>Ph.[91] This could be due to different dienophiles and different reaction 
conditions (discussed in the next section). 
The reproducibility of our results was confirmed by repetition of the experiments giving 
nearly identical results (Table 2.15).  
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Table 2.15: Reproduction of the screening results of Table 2.14. 
Entry R Dienophile Complex  
98 : 102a 
Dienophile 
64 : 67b 
DA Adduct Complex  
Et : n-Bua 
1 β-Np (32d) 86:14 90:10 39:61 
2 Ph (32c) 83:17 84:16 47:53 
3 t-Bu (32b) 64:36 66:34 50:50 
4 i-Pr (32a) 65:35 60:40 50:50 
a Dienophile and Diels-Alder adduct complex ratio determined by ESI MS; b Dienophile ratio determined by 
HPLC. 
2.5.2 Comparison with the Results from the Preparative Forward Diels-Alder 
Reaction 
The copper(II)-catalysed Diels-Alder reaction of dienophile 64 and dienophile 67 using 
bis(oxazoline) ligands 32a-e proceeded with similar selectivities and trend as the retro 
reaction (Table 2.16). The β-Naphthyl-substituted catalyst gave the highest enantiomeric 
excess, the Bn-substituted catalyst the lowest. The mass labels only had a minor influence on 
the endo enantiomeric excess, generally it was 2% lower for dienophile 64. The 
diastereoselectivity for all catalysts was found to be good to excellent, especially considering 
the high temperature. Conversions were only moderate, possibly due to dimerisation of 
cyclopentadiene and decomposition of starting material. A very good correlation of ESI MS 
and the forward reaction was found (Figure 2.14). 
Table 2.16: Results for the forward Diels-Alder reaction at 100 °C.  
H
O N S
S
R1
O
N S
S
R1
64 R1 = Et  
67 R1 = n-Bu
CH2Cl2, 100 °C, 1 h
N N
OO
R2 R2
22 mol%
20 mol% Cu(OTf)2
(S)-80 R1 = Et  
(S)-83 R1 = n-Bu
 
Entry Dienophile R1 R2 Endo:Exoa Endo ee (%)b Conv. (%)a 
1 n-Bu (Et) β-Np (32d) 99:1 (93:7) 76 (74) 40 (49) 
2 n-Bu (Et) Ph (32c) 96:4 (84:16) 72 (70) 76 (23) 
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Entry Dienophile R1 R2 Endo:Exoa Endo ee (%)b Conv. (%)a 
3 n-Bu (Et) t-Bu (32b) 86:14 (95:5) 28 (n.d.) 31 (51) 
4 n-Bu (Et) i-Pr (32a) 85:15 (86:14) 12 (10) 72 (29) 
5 n-Bu  Bn (32e) 85:15 4 11 
a Determined by 1H NMR of the crude product; b Determined by chiral HPLC. 
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Figure 2.14: Comparison between ESI MS results and forward reactions. 
Due to the unexpected order of relative catalyst enantiodiscrimination, 
β-Np>Ph>t-Bu>i-Pr>Bn, which deviated from EVANS’ previous findings, 
t-Bu>i-Pr>α-Np>Ph, and due to the fact that EVANS’ reactions were performed at lower 
temperatures,[91] Diels-Alder reactions were conducted under similar conditions to those 
described by Evans (Table 2.17, entry 1-5). The β-Naphthyl-box-derived catalyst again gave 
the best enantiomeric excess (97%) for the β-substituted dienophile 67 at -35 °C. Interestingly 
the order of the catalyst enantiodiscrimination changed to β-Np>t-Bu>Ph>i-Pr>Bn, the 
t-Bu-box-derived catalyst showing higher selectivities than the Ph-substituted catalyst 
(Table 2.17, entry 2 and 3). At room temperature the order was the same as that at 100 °C 
(Table 2.17, entry 6-10). At both temperatures diastereoselectivities were good to excellent. 
At -35 °C conversions fluctuated strongly, indicating that the most selective ligands also gave 
the most active catalysts (Table 2.17, entry 1 and 3). At room temperature conversions were 
good. 
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Table 2.17: The forward Diels-Alder reaction usingt different reaction conditions. 
H
O N S
S
n-Bu
O
N S
S
n-Bu
CH2Cl2
N N
OO
R R
22 mol%
20 mol% Cu(OTf)2
67 (S)-83
 
Entry R Conditions Endo:Exoa Endo ee (%)b Conv. (%)a 
1 β-Np (32d) -35 °C, 48 h >99:1 97 100 
2 Ph (32c) -35 °C, 48 h >99:1 89 19 
3 t-Bu (32b) -35 °C, 48 h >99:1 95 100 
4 i-Pr (32a) -35 °C, 48 h >99:1 23 6 
5 Bn (32e) -35 °C, 48 h n.d. 17 <1 
6 β-Np (32d) r.t., 20 h 99:1 92 93 
7 Ph (32c) r.t., 20 h 98:2 80 100 
8 t-Bu (32b) r.t., 20 h 88:12 74 65 
9 i-Pr (32a) r.t., 20 h 93:7 15 100 
10 Bn (32e) r.t., 20 h 95:5 14 68 
a Determined by 1H NMR of the crude product; b Determined by chiral HPLC. 
The enantiomeric excess for all preparative reactions is summarised in Figure 2.15 in 
comparison with the ESI MS results. It is evident that under all conditions the 
β-Naphthyl-substituted catalyst gave the highest enantiomeric excess declining in the 
following order Ph>t-Bu>i-Pr>Bn with one exception at -35 °C where the t-Bu-derived 
catalyst performed better than the Ph-derived catalyst. The trend predicted by ESI MS was 
confirmed by the forward preparative reactions. 
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Figure 2.15: Summary of the forward Diels-Alder results in comparison with ESI MS results. 
As the β-Naphthyl-substituted catalyst showed excellent enantioselectivities the Diels-Alder 
reaction was performed with lower catalyst loading (Table 2.18). The reactions were carried 
out at -35 °C and stirred for 48 hours in dichloromethane. The enantiomeric excess was very 
high up to 1 mol% catalyst loading and only the endo diastereoisomer was observed by 
1H NMR (Table 2.18). However, conversions decreased with lower catalyst loading. When 
using the unsubstituted dienophile 41 with 10 mol% of catalyst the enantiomeric excess 
(97%) and diastereoselectivity (endo:exo >99:1) were very high, but conversion was low 
(22%). The enantioselectivity was equal to that reported by EVANS using the t-Bu-box catalyst 
and unsubstituted dienophile 41 (endo ee 97%, endo:exo 92:8, 86% yield).[91] The low 
conversion compared to EVANS results can presumably be attributed to the lower dienophile 
concentration in our case (0.1 M vs. 1.0 M).  
Table 2.18: Different catalyst loadings for the Diels-Alder reaction with [Cu((S,S)-β-Np-box)](OTf)2. 
H
O N S
S
Et
O
N S
S
Et
64 (S)-80
CH2Cl2
[Cu((S,S)-β-Np-box)](OTf)2
 
Entry Cat. Loading (mol%) Endo:Exoa Endo ee (%)b Conv. (%)a 
1 20 >99:1 97 >99 
2 10 >99:1 97 40 
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Entry Cat. Loading (mol%) Endo:Exoa Endo ee (%)b Conv. (%)a 
3 5 >99:1 96 55 
4 1 >99:1 96 8 
5 0.5 n.d. 89 <1 
a Determined by 1H NMR of the crude product; b Determined by chiral HPLC. 
In summary, the β-Naphthyl-box catalyst gave equal results to the t-Bu-box catalyst with 
unsubstituted dienophile 41 but enhanced enantioselectivity for the substituted Et- and 
n-Bu-dienophiles 64 and 67. However, the t-Bu-box-derived catalyst is more readily 
synthesised from commercially available starting material in contrast to the β-Naphthyl-box 
catalyst and will therefore remain the ligand of choice for this transformation.  
2.5.3 ESI MS Screening Using Phosphinooxazoline Ligands 
To demonstrate the versatility of this screening method we tested several 
phosphinooxazolines as a different ligand class.  
The general procedure for the retro-Diels-Alder reaction was applied (Section 2.3.6) using 
quasienantiomers (S)-80 and (R)-88. Phosphinooxazoline ligands 33a-h, readily available in 
our group, showed very low enantioselectivity (Table 2.19). Phenyl-substituted ligand 33b 
showed a preference for the opposite enantiomer than its o-tolyl-substituted analogue 33c 
(Table 2.19, entry 1 and 3). The C5-substituted ligands 33f and 33g with o-tolyl groups at the 
P-atom exhibited a similar selectivity than their phenyl-substituted counterparts 33a and 33b 
(Table 2.19, entry 6/7 and entry 1/2) indicating that the influence of the C5 aryl-substitution 
overruled the influence of the P-aryl groups. Diels-Alder adduct complex ratios were usually 
around 50:50 as observed in the screening with bis(oxazoline) ligands (Section 2.5.1). 
Except for entries 2, 3 and 4 in Table 2.19 ESI MS results correlated well with HPLC 
analytics of the reaction mixtures.  
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Table 2.19: Screening of phosphinooxazoline ligands in the retro-Diels-Alder reaction. 
H
O N S
S
Et
20 mol% [Cu(phosphinooxazoline)](OTf)2
CH2Cl2, 100 °C, 1 hNO
SS
n-Bu
(S)-80 (R)-88
R
O
N S
S
P
Cu
N
+*
104 R = Et and 105 R = n-Bu
 
Entry Ligand Dienophile Complex 
 104 : 105a 
Dienophile 
64 : 67b 
DA Adduct Complex 
Et : n-Bua 
1 N
O
P
33a
Ph2
 
55:45 52:48 50:50 
2 N
O
P
33b
Ph2
 
60:40 68:32 52:48 
3 N
O
P
33c
o-Tol2
 
40:60 33:67 53:47 
4 N
O
P
33d
o-Tol2
 
51:49 42:58 51:49 
5 N
O
P
33e
(o-CF3Ph)2
 
53:47 50:50 51:49 
6 N
O
P
33f
Ph
Pho-Tol2
 
55:45 55:45 57:43 
7 N
O
P
33g
o-Tol
o-Tolo-Tol2
 
57:43 53:47 53:47 
8 N
O
P
33h
Ph
o-Tol2
 
49:51 48:52 53:47 
a Dienophile and Diels-Alder adduct complex ratio determined by ESI MS; b Dienophile ratio determined by 
HPLC. 
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To verify the ESI MS results preparative forward Diels-Alder reactions were performed 
according to the same conditions as described in Section 2.4.2. With a few exceptions 
(Table 2.20, entry 4 and 5) the enantiomeric excess obtained by ESI MS was higher than that 
observed for the preparative reaction. This is presumably due to monitoring the intrinsic 
enantioselectivity of the catalysts by ESI MS, which is not disturbed by uncatalysed side 
reactions or catalytically active impurities. As observed by ESI MS the preparative results 
confirmed 33b and 33c as most selective phosphinooxazoline ligands. However, a clear trend 
cannot be reproduced by the preparative reaction. Comparison of both data sets made clear 
that phosphinooxazolinecopper(II)-catalysts are not very enantioselective in the Diels-Alder 
reaction. Diastereoselectivities were moderate when compared to the those obtained with 
bis(oxazoline) ligands[91] and conversions were low.  
Table 2.20: Preparative Diels-Alder reaction using phosphinooxazolinecopper(II)-catalysts. 
H
O N S
S
n-Bu
O
N S
S
n-Bu
CH2Cl2, 100 °C, 1 h
20 mol%  [Cu((S)-phosphino-
oxazoline)](OTf)2
67 83
 
Entry Cat. Endo:Exoa Endo ee (%)b ESI MS “ee” (%)c Conv. (%)a 
1 33a 85:15 rac. 10 (S) 28 
2 33b 80:20 8 (S) 20 (S) 12 
3 33c n.d. 8 (R) 20 (R) <1 
4 33d 84:16 6 (S) 2 (S) 25 
5 33e 72:28 6 (S) 6 (S) 13 
6 33f 80:20 rac. 10 (S) 21 
7 33g n.d. 4 (S) 14 (S) 13 
a Determined by 1H NMR of the crude product; b Determined by chiral HPLC; c Et-dienophile-n-Bu-dienophile 
complex. 
2.5.4 ESI MS Screening Using Bis(imine) Ligands 
The screening of bis(imine) ligands in the copper(II)-catalysed retro-Diels-Alder reaction was 
motivated by their facile and diverse synthesis which readily allowed building a library. 
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Several bis(imine) ligands were synthesised from either (1S,2S)-(+)-1,2-diaminocyclohexane 
or (1R,2R)-(+)-1,2-diphenylethaneamine (Figure 2.16).  
F
N N
34a
N N
34d
Cl
Cl
N N
34b
F N N
34c
NC
N N
34f
N N
34g
N N
34e
Cl
Cl
F
F
CN
 
Figure 2.16: Bis(imine) ligands used in the copper(II)-catalysed retro-Diels-Alder reaction. 
Only for ligands 34d and 34e dienophile-catalyst complexes were observed in the retro-Diels-
Alder reaction using (S)-80 and (R)-88 as quasienantiomers (Table 2.21). Ligand 34d 
produced a high enantiomeric ratio which was expected from previous results by EVANS.[89] 
The isotope pattern was complicated by the presence of chloride in the complex. The 
α-Naphthyl-substituted ligand 34e showed almost no enantioselectivity. The results correlated 
with the HPLC analytics of the reaction mixture. 
Table 2.21: Screening of bis(imine)copper(II)-catalysed retro-Diels-Alder reaction. 
H
O N S
S
Et
20 mol% [Cu(bis(imine))](OTf)2
CH2Cl2, 100 °C, 1 hNO
SS
n-Bu
(S)-80 (R)-88
R
O
N S
S
N
Cu
N
+*
106 R = Et and 107 R = n-Bu
 
Entry Ligand Dienophile Complex 
106 : 107a 
Dienophile 
64 : 67b 
1 N NCl
Cl
34d
Cl
Cl
 
 
74:26 
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Entry Ligand Dienophile Complex 
106 : 107a 
Dienophile 
64 : 67b 
2 N N
34e
 
 
47:53 
a Determined by ESI MS; b Determined by HPLC. 
Results from the preparative forward Diels-Alder reaction further confirmed the 
2,6-dichlorosubstituted ligand 34d as highly diastereoselective and enantioselective 
(Table 2.22). Ligand 34e showed excellent diastereoselectivities but, as expected from the 
ESI MS screenings, hardly any enantioselectivity. For both ligands diastereoselectivities and 
conversion increased with lower reaction temperatures.  
Unfortunately synthesis of several ligands in one pot and subsequent screening of this mixture 
in the copper(II)-catalysed retro-Diels-Alder reaction could not be accomplished because for 
some bis(imine) ligands no catalytic intermediates were detected by ESI MS. 
Table 2.22: Bis(imine)copper(II)-catalysed forward Diels-Alder reaction. 
O
N S
S
n-Bu
20 mol% [Cu(bis(imine))](OTf)2 H
O N S
S
n-Bu
CH2Cl2
67 (S)-83
 
Entry Ligand Conditions Endo:Exoa Endo ee 
(%)b 
Conv. 
(%)a 
1 100 °C, 1 h 87:13 28 55 
2 r.t., 20 h 89:11 73 97 
3 
 
N N
34d
Cl
Cl
Cl
Cl
 
-20 °C, 48 h 99:1 87 95 
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Entry Ligand Conditions Endo:Exoa Endo ee 
(%)b 
Conv. 
(%)a 
4 100 °C, 1 h 84:16 -2 36 
5 r.t., 20 h 95:5 4 51 
6 
 
N N
34e
 
-20 °C, 48 h >99:1 14 78 
a Determined by 1H NMR of the crude product; b Determined by chiral HPLC. 
2.6 Studies on the Retro-Diels-Alder Reaction 
2.6.1 Influence of Temperature and Reaction Time on the Retro-Diels-Alder 
Reaction 
Elevated temperature was crucial to achieve retro reaction but could also lead to non-catalytic 
decomposition of the Diels-Alder adducts. If the uncatalysed retro reaction occurs to any 
extent the observed ratio of dienophile complexes does not correspond to the intrinsic 
enantioselectivity of the catalyst. To investigate this we subjected the retro-Diels-Alder 
reaction to different temperatures and analysed the reaction mixtures by ESI MS. A decline of 
dienophile complex ratios towards a 50:50 ratio would indicate occurrence of an uncatalysed 
retro reaction. Although Me- and Et-substituted Diels-Alder adducts were used in these 
experiments, the conclusions should be applicable to the reactions with Et- and 
n-Bu-quasienantiomers. 
The experiments were performed using the general screening procedure at different 
temperatures. At 160 °C the dienophile complex ratio remained constant for 2 minutes 
(Table 2.23, entry 1-3). After 10 minutes ESI MS analysis revealed a nearly racemic mixture 
(adjusting for the catalyst’s preference for the Me-Diels-Alder adduct) indicating that the 
uncatalysed retro reaction was dominating (Table 2.23, entry 4). A similar result was 
observed at 200 °C (Table 2.23, entry 5-7). 
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Table 2.23: Influence of reaction conditions on the retro-Diels-Alder reaction. 
96 R = Me and 98 R = Et
H
O N S
S
Me
20 mol% [Cu((S,S)-t-Bu-box)](OTf)2
NO
SS
Et
CH2Cl2
(S)-79 (R)-85
R
O
N S
S
N
Cu
N
+*
 
Entry Conditions Dienophile Complex 96 : 98a Dienophile 63 : 64b 
1 160 °C, 30 s 72:28 - 
2 160 °C, 2 min 73:27 - 
3 160 °C, 10 min 57:43 52:48 
4 160 °C, 1 h 52:48 51:49 
5 200 °C, 10 s 69:31 - 
6 200 °C, 40 s 70:30 - 
7 200 °C, 5 min 54:46 50:50 
a Dienophile and Diels-Alder adduct complex ratio determined by ESI MS; b Dienophile ratio determined by 
HPLC. 
To confirm that the uncatalysed retro reaction was the reason for the decline in selectivity the 
retro-Diels-Alder reaction was carried out in the absence of catalyst. If the uncatalysed retro 
reaction took place, dienophile would be observed. After terminating the reaction after the 
indicated times, possibly present dienophiles underwent complexation with a copper(II)-
catalyst. The complexation reactions were performed to render dienophiles present in solution 
amenable to ESI MS detection. 
As seen in Table 2.24 the uncatalysed retro-Diels-Alder reaction only occurred above 110 °C. 
Stirring for 1 minute at 160 °C gave a relatively small amount of dienophile, which seemed to 
contradict earlier observations (compare Table 2.23, entry 1 and 2). No influence of the 
uncatalysed retro reaction had been detected after 1 minute at 160 °C. The proportion of 
uncatalysed retro reaction was probably small compared to the catalysed process therefore the 
dienophile complex ratio had not been yet affected. The findings in Table 2.24 proved that the 
retro-Diels-Alder reaction does not occur below 110 °C and therefore selectivities of reactions 
carried out below that temperature should not be affected. 
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Table 2.24: Uncatalysed retro-Diels-Alder reaction at elevated temperatures. 
96 R = Me and 98 R = Et
R
O
N S
S
N
Cu
N
+*
H
O N S
S
Me
∆
NO
SS
Et
CH2Cl2
(S)-79 (R)-85
 
Entry Conditions Amount of Dienophile Complexes 96 and 98a,b 
1 80 °C, 15 min - 
2 80 °C, 2 h - 
3 100 °C, 15 min - 
4 100 °C, 2 h - 
5 110 °C, 15 min - 
6 110 °C, 2 h - 
7 120 °C, 15 min - 
8 120 °C, 2 h 4%c 
9 160 °C, 1 min 10%c 
10 160 °C, 2 h 37%c 
a Amount of dienophiles compared to the amount of DA adducts determined by ESI MS; b Achiral 
[Cu(dimethyl-box)](OTf)2 or chiral [Cu((S,S)-t-Bu-box)](OTf)2 was added after the reaction and stirred for 
20 minutes at room temperature; c Conversion calculated from the integration of both Diels-Alder adduct 
complex mass peaks versus the integration of both dienophile complex mass peaks.  
2.6.2 Reversibility of the Retro-Diels-Alder Reaction under Standard Reaction 
Conditions 
For evaluation concerning the reversibility of the retro-Diels-Alder reaction and thus possible 
inaccuracies for selectivity measurements, an equimolar mixture of Me-Diels-Alder adduct 
rac-75 and Et-dienophile 64 was added to [Cu((S,S)-t-Bu-box)](OTf)2 (Scheme 2.23). If the 
retro-Diels-Alder reaction was reversible under the applied conditions, the product of the 
Diels-Alder reaction between the Et-dienophile 64 and the liberated cyclopentadiene should 
be detected by ESI MS. Of course the generated Me-dienophile 63 can also undergo the 
Diels-Alder reaction with cyclopentadiene, but it cannot be detected separately, because 
Me-Diels-Alder adduct rac-75 is already present.  
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After stirring for 30 minutes at room temperature ESI MS analysis showed the expected 
complexes for the Me-Diels-Alder adduct 97 and the Et-dienophile 98 (Figure 2.17, a). After 
subjecting the reaction mixture to standard retro-Diels-Alder reaction conditions the reaction 
mixture was again analysed by ESI MS (Figure 2.17, b). If the reaction was reversible under 
the applied conditions, formation of the Et-Diels-Alder adduct (S)-80 was expected. Analysis 
of the ESI MS spectrum showed the Me-Diels-Alder adduct complex 97, the Me-dienophile 
complex 96 (product of the retro-Diels-Alder reaction) and the Et-dienophile complex 98. The 
absence of the Et-Diels-Alder adduct complex 99 in the ESI MS spectrum indicated that the 
reaction was not reversible under these conditions. Either the concentration of the liberated 
diene was too small to sufficiently undergo the Diels-Alder reaction or the liberated 
cyclopentadiene dimerised immediately under the applied conditions. Even if the reaction was 
reversible the amount was negligible and would not affect the dienophile ratios. 
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Scheme 2.23: Investigating the reversibility of the retro-Diels-Alder reaction.  
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Figure 2.17: ESI MS spectra for the reaction depicted in Scheme 2.23 (a) before and (b) after 
subjecting to standard reaction conditions. 
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2.7 Conclusion and Outlook 
The objectives of this work were to develop a screening method for the identification of chiral 
catalysts in the retro-Diels-Alder reaction based on electrospray ionisation mass spectrometry 
(ESI MS). We have shown that it is possible to selectively monitor the relevant 
catalyst-reactant intermediates by ESI MS and use the results to identify highly 
enantioselective catalysts. Sufficiently strong binding between the substrates and the metal 
catalyst is necessary to allow detection. It was crucial to evaluate the influence of the mass 
labels that distinguish the complexes by ESI MS.  
By using mass-labelled quasienantiomers this method was shown to give a direct measure of 
the intrinsic enantioselectivity of a chiral catalyst. As the intrinsic selectivity is measured, 
unselective background reactions, catalytically active impurities and ligand dissociation do 
not alter the results in contrast to product analysis. A general screening protocol was 
developed allowing rapid screening limited only by the reaction time. Several control 
experiments confirmed the validity of this screening technique. 
The applicability of this method was demonstrated with five bis(oxazoline) ligands in 
copper(II)-catalysed retro-Diels-Alder reactions. This led to the identification of highly 
selective ligands. A separate analytical method (HPLC) confirmed the selectivities obtained 
by ESI MS. Preparative forward Diels-Alder reactions further confirmed the results in 
accordance to the principle of microscopic reversibility. The versatility of this method was 
shown by screening different ligand classes such as phosphinooxazolines and bis(imines).  
After successful establishment of an ESI MS screening method for catalyst-reactant 
complexes of organometallic species this concept was extended to organocatalytic reactions. 
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3 ESI MS Screening of Organocatalysed Retro-Diels-Alder 
Reactions 
3.1 Introduction 
Our ESI MS screening method was originally developed for the copper(II)-catalysed 
retro-Diels-Alder reaction and was later extended to metal-free organocatalytic reactions. 
The first highly enantioselective organocatalytic Diels-Alder reaction was reported by 
MACMILLAN and co-workers in 2000.[107] α,β-Unsaturated aldehyde 108 and chiral 
imidazolidinone catalyst 23·HCl formed iminium ion species 109, which was sufficiently 
activated due to LUMO-lowering to undergo cycloaddition. Accordingly, Diels-Alder 
reaction with cyclopentadiene involved the intermediacy of iminium ion species 110. 
Hydrolysis produced Diels-Alder adduct 111 and the regenerated imidazolidinone catalyst 
23·HCl (Scheme 3.1). Iminium ion intermediates, which are the relevant reaction 
intermediates in this catalytic cycle, are easily detectable by ESI MS.[57]  
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R O
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Scheme 3.1: Organocatalysed Diels-Alder reaction with an α,β-unsaturated aldehyde 118 and 
cyclopentadiene. 
In order to identify highly enantioselective organocatalysts for the retro-Diels-Alder reaction, 
we envisioned a general screening protocol for secondary amine organocatalysts, including 
imidazolidinone-derived catalyst 23·HCl. As demonstrated for the copper(II)-catalysed 
retro-Diels-Alder reaction the screening was conducted by monitoring catalytic intermediates 
by ESI MS. Therefore endo Diels-Alder adducts E and F, representing the mass-labelled 
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quasienantiomers, underwent iminium ion formation with a chiral organocatalyst 
(Scheme 3.2). The resulting charged Diels-Alder adduct iminium ion species can be detected 
by ESI MS along with the dienophile iminium ions of interest G and H. The different masses 
of G and H enable the iminium ions to be distinguished by mass spectrometry. The ratio of G 
and H reflects the catalyst ability for enantiodiscrimination and gives a direct measure of the 
enantiomeric ratio. By the principle of microscopic reversibility the information obtained for 
the retro-Diels-Alder reaction should be directly applicable to the corresponding forward-
Diels-Alder reaction. 
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Scheme 3.2: Iminium ion intermediates for the retro-Diels-Alder reaction with secondary amine 
organocatalysts. R1 and R2 represent the mass labels. 
3.2 Synthesis of Quasienantiomeric Diels-Alder Adducts 
The quasienantiomers should be: a) enantiopure or highly enantioenriched (both to the same 
degree) and b) consisting of the same, single diastereoisomer. The mass labels must also be 
sufficiently removed from the reaction centre such that they do not influence the catalyst 
reactivity. The quasienantiomers were structurally related to those used for the screening of 
copper(II)-catalysed retro-Diels-Alder reactions.  
Diels-Alder adducts for the organocatalysed retro-Diels-Alder reaction were obtained by 
reduction of the previously used Diels-Alder adducts (S)-80, (S)-81 and (S)-83 and (R)-85-88. 
The enantio- and diastereopure endo Diels-Alder adducts (S)-112, (S)-113 and (S)-114 and 
(R)-115-118 were readily obtained following a reduction procedure by IZAWA and 
MUKAIYAMA (Schemes 3.3 and 3.4).[155, 156] Good to excellent yields were obtained when the 
reaction was performed in 0.2 mmol scale or less.  
O
H
(S)
N
S
S
R1
(S)-80 R1 = Et       
(S)-81 R1 = n-Pr   
(S)-83 R1 = n-Bu
[(i-Bu)2]AlH
Toluene, -78 °C, 20 min         
-45 °C, 3 h O
H
(S)
R1
(S)-112 R1 = Et      (80%) 
(S)-113 R1 = n-Pr   (81%) 
(S)-114 R1 = n-Bu  (>99%)
Scheme 3.3: Synthesis of (S)-Diels-Alder adducts for the organocatalytic retro-Diels-Alder reaction.  
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(R)-86 R2 = n-Pr    
(R)-87 R2 = i-Pr   
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H
(R)
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(R)-116 R2 = n-Pr   (88%)
(R)-117 R2 = i-Pr    (68%)
(R)-118 R2 = n-Bu  (69%)
[(i-Bu)2]AlH
Toluene, -78 °C, 20 min         
-45 °C, 3 h
Scheme 3.4: Synthesis of (R)-Diels-Alder adducts for the organocatalytic retro-Diels-Alder reaction.  
An alternative route to obtain mass-labelled Diels-Alder adducts was the direct synthesis from 
the aldehydes 119 and 120 and cyclopentadiene with imidazolidinone catalyst 23·HCl 
(Scheme 3.5). This strategy was abandoned because the diastereoisomers of adducts 116 and 
118 could not be separated. Initially the organocatalysed Diels-Alder reaction gave the 
dimethyl diacetal which was hydrolysed to give the corresponding aldehyde. 
23·HCl
O
N
H
NO
MeOH:H2O, r.t., 24 h
i.  10 mol%
ii. CHCl3:H2O: TFA  2:1:1
    r.t., 2 h
119 R = n-Pr  
120 R = n-Bu
R
O
116 R = n-Pr endo:exo 1:1.3, 82% yield
118 R = n-Bu endo:exo 1:1.3, 75% yield
R
Ph
 
Scheme 3.5: Diels-Alder reactions using aldehydes 119 and 120 as starting material. 
3.3 Development of Screening Method 
3.3.1 Preliminary Experiments 
To develop the screening conditions, the Diels-Alder reaction of cinnamaldehyde and 
cyclopentadiene using imidazolidinone catalyst 23·HCl was investigated. Both enantiomers of 
imidazolidinone catalyst 23·HCl were commercially available or were synthesised in a one 
pot procedure from (S)- or (R)-phenylalanine methyl ester 121·HCl (Scheme 3.6).[107]  
121·HCl
Ph
NH
O
OMe Ph
NH2
O
NHMe N
H
NO
ii. HCl in Et2O
23·HCl
overall yield 27%122
i. MeNH2,
   EtOH, r.t., 18 h
ii. aq. sat. NaHCO3
i. Acetone, p-TSA,
  MeOH, reflux, 18 h
Ph
 
Scheme 3.6: Synthesis of imidazolidinone catalyst 23·HCl.[107] 
The forward-Diels-Alder reaction was conducted as depicted in Scheme 3.7. Analysis by 
ESI MS showed the best iminium ion detection when the reaction mixture was diluted in 
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either methanol or acetonitrile. After 10 minutes of stirring at room temperature, the iminium 
ion species 124 at m/z 333 was observed (Figure 3.1, a). The most prominent mass peak at 
m/z 241 represented catalyst 23 plus sodium cation. The mass peak at m/z 219 was identified 
as the protonated catalyst 23. After 6 hours a new peak at m/z 267 was detected which was 
assigned to the dimethyl diacetal sodium adduct (Figure 3.1, b). Iminium ion intermediate 125 
at m/z 399 was not observed under these conditions. For confirmation dimethyl diacetal 
adduct 126 was dissolved in methanol and analysed by ESI MS showing an intense peak at 
m/z 267.  
O
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MeOH:H2O, r.t. Ph
OMe
OMe
N
NO
Ph
H
Ph
124
M+ = 333
Ph
N
NO
Ph
125
M+ = 399
123 126
 
Scheme 3.7: The iminium ion intermediates in the organocatalysed Diels-Alder reaction with 
imidazolidinone 23·HCl as catalyst. 
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Figure 3.1: ESI MS spectra of the Diels-Alder reaction with catalyst 23·HCl (a) after 10 min and (b) 
after 6 hours. 
Retro-Diels-Alder reaction was not achieved by heating Diels-Alder adduct 127 in methanol 
at 100 °C for 24 hours. As retro-Diels-Alder reactions had worked well in dichloromethane 
for the copper(II)-catalysed reactions, organocatalytic retro-Diels-Alder reactions were 
performed using 20 mol% imidazolidinone catalyst in that solvent at 100 °C (Scheme 3.8). 
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After 2 hours iminium ion species 124 and 125 along with catalyst-derived mass peaks 
(m/z 219 and 241) were observed in the ESI MS spectrum (Figure 3.2). Because no methanol 
was present the dimethyl diacetal adduct 126 was not detected. Addition of water to the 
reaction mixture resulted in low peak intensities of the iminium ion intermediates. 
Retro-Diels-Alder reaction also proceeded at room temperature. These conditions were milder 
and closely resembled those for the originally developed Diels-Alder reaction by 
MACMILLAN and co-workers (room temperature, 8 hours).[107] 
O
CH2Cl2, 100°C, 2 h
O
123127
20 mol% 23·HCl
 
Scheme 3.8: The organocatalysed retro-Diels-Alder reaction in dichloromethane. 
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Figure 3.2: ESI MS spectrum of the retro-Diels-Alder reaction as depicted in Scheme 3.8. 
3.3.2 Evaluation of Appropriate Quasienantiomers 
To determine suitable quasienantiomers, combinations of differently substituted Diels-Alder 
adducts were tested in a direct competition experiment (Table 3.1). Equimolar mixtures of 
(R)-Diels-Alder adducts, for example (R)-115 and (R)-116, underwent the retro-Diels-Alder 
reaction with imidazolidinone catalyst 23·HCl. Taking only the (R)-Diels-Alder adducts 
eliminated the stereochemical influence and the reaction could be analysed with regard to the 
mass labels. If the catalyst was unaffected by the mass substituents, a 50:50 ratio for the 
dienophile iminium ions A and B was expected. Out of all tested combinations (R)-116 and 
(R)-118 showed the least difference towards the catalyst (Table 3.1, entry 5) and were 
therefore chosen to be used as quasienantiomers in the following screening reactions. A near 
50:50 ratio of the Diels-Alder adduct iminium ions indicated also no influence of the mass 
Chapter 3 
 
78
labels for the initial iminium ion formation. The results are not entirely consistent with the 
Hammett substitution constants σP and R values (see Section 2.3.5, Table 2.11). Although 
Hammett substitution constants σP give similar values for substituents in entry 1, 3 and 5 
(Table 3.1), the more refined R values are electronically more similar for substituents in entry 
2, 3 and 4 than in entry 1 and 5. 
Table 3.1: Direct competition experiment for determination of suitable quasienantiomers. 
20 mol% 23·HClH H
OO
N
N
O
Ph
R1 R2
CH2Cl2, r.t., 24 h
R2
50   :    50
B
(R)-115 R1 = Et    
(R)-116 R1 = n-Pr   
(R)-117 R1 = i-Pr
(R)-116 R2 = n-Pr    
(R)-117 R2 = i-Pr   
(R)-118 R2 = n-Bu
N
N
O
Ph
R1
A
 
Entry Quasienantiomers 
R1 : R2 
Dienophile  
Iminium Ions A : Ba 
DA Adduct  
Iminium Ions R1 : R2 a 
1 (R)-115/(R)-116 43:57 n.d. 
2 (R)-115/(R)-117 63:37 59:41 
3 (R)-115/(R)-118 47:53 n.d. 
4 (R)-117/(R)-118 36:64 40:60 
5 (R)-116/(R)-118 48:52 51:49 
a Ratio determined by ESI MS. 
3.3.3 Direct Monitoring of Iminium Ion Intermediates in the retro-Diels-Alder 
Reaction using Imidazolidinone and Proline-Based Catalysts: General 
Screening Protocol 
The retro-Diels-Alder reaction was conducted under inert atmosphere and anhydrous solvents 
to ensure reproducible reaction conditions. Typical conditions were 20 mol% of 
organocatalyst and performing the reactions at room temperature. An aliquot of the reaction 
mixture was diluted in acetonitrile and injected directly into the mass spectrometer. The ratios 
for the dienophile iminium ions were determined by integration (see Section 5.5.1 for details). 
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It was important to keep the same mass range (∆ m/z = 300) throughout all experiments for 
comparable data.  
Using quasienantiomers (S)-114 and (R)-116 a 88:12 ratio of dienophile iminium ions A and 
B was observed (Scheme 3.9). As expected the (S)-catalyst was more reactive towards the 
(R)-Diels-Alder adduct which is in agreement with the results reported in the literature.[107]  
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Ph
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Scheme 3.9: The organocatalysed retro-Diels-Alder reaction. 
3.4 Control Experiments 
3.4.1 Reversed Ligand Configuration and Inversely Labelled Quasienantiomers  
Control experiments were performed to prove the validity of this method. Four experiments 
involving both quasiracemates, (S)-114 and (R)-116 and (R)-118 and (S)-113, with either the 
(S)- or the (R)-imidazolidinone catalyst 23·HCl or (R)-23·HCl were conducted. If the method 
is valid reaction of the same quasiracemate either with the (S)- or the (R)-catalyst should give 
exactly the inverse ratios for the dienophiles (for example 88:12 vs. 12:88). Comparing the 
results of both quasiracemates with the same catalyst should also show the exact inverted 
ratio. If the dienophile ratios do not match, this implies that the mass labels of the 
quasienantiomers affect the stereoselectivity of the catalyst.  
All experiments showed the expected matching ratios validating our method (Table 3.2, 
Figure 3.3). Diels-Alder adduct iminium ion ratios were very similar to those obtained for the 
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dienophile adducts (except for entry 4) suggesting that iminium ion formation was already 
determined by the configuration of the Diels-Alder adducts.  
Table 3.2: Control experiments with both quasiracemates and inversely configurated catalysts. 
20 mol% 23·HCl/(R)-23·HClH H
OO
R1 R2
CH2Cl2, r.t., 24 h
N
N
O
Ph
n-Pr
N
N
O
Ph
n-Bu B
A
(R)-116 R2 = n-Pr 
(R)-118 R2 = n-Bu
(S)-113 R1 = n-Pr  
(S)-114 R1 = n-Bu
 
Entry Cat. Quasienantiomers 
R1 : R2 
Dienophile  
Iminium Ions A : Ba 
DA Adduct  
Iminium Ions R1 : R2 a 
1 S (S)-113/(R)-118 12:88 10:90 
2 S (R)-116/(S)-114 88:12 92:8 
3 R (S)-113/(R)-118 88:12 86:14 
4 R (R)-116/(S)-114 15:85 30:70 
a Dienophile and Diels-Alder adduct iminium ion ratios determined by ESI MS. 
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(R)-cat.
(R)-116/(S)-114
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(S)-113/(R)-118
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A
B
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B
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Figure 3.3: ESI MS spectra of the control experiments. 
3.4.2 Comparison with Preparative Experiments 
In accordance to the principle of microscopic reversibility we expected the stereoselectivity of 
the forward-Diels-Alder reaction to be in good agreement with that of the retro-Diels-Alder 
reaction. At similar conditions as the retro reaction, the obtained enantiomeric excess for the 
Diels-Alder reaction was in excellent agreement with the ESI MS results (Table 3.3, entry 1, 
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75% ee; compare Table 3.2, ESI MS 76% ee). The Diels-Alder adduct 127 was converted to 
the dimethyl diacetal 126[157] for additional GC analysis confirming the results for the 
Diels-Alder adduct 127. Conversions in dichloromethane were low whereas good to excellent 
conversions were obtained in methanol:water as solvent. Presumably catalyst regeneration in 
anhydrous dichloromethane was not possible resulting in low conversion. Concentration of 
the dienophile was lower in dichloromethane because retro-Diels-Alder reaction conditions 
were simulated. This also could have had an effect on conversion. A remarkably high 
enantiomeric excess was observed when stirring the reaction for 10 minutes at 50 °C. 
Table 3.3: Preparative Diels-Alder reactions with cinnamaldehyde 123 and cyclopentadiene. 
O O
123 127
OMe
126
OMeNH4Cl
MeOH, reflux, 1.5 h
OMe
126
OMe
20 mol% 23·HCl
 
Entry Conditions Conv. (%)a Endo:Exoa Endo ee (%)b Exo ee (%)b 
1c CH2Cl2, r.t., 24 h 5 1 : 3.2 75 (74)d 84 (83) d 
2e, f, g MeOH:H2O 95:5, r.t., 24 h 99 1 : 1.4 90 92 
3c CH2Cl2, 50 °C, 10 min 6 1 : 1.5 82 86 
a Determined by 1H NMR of the crude product; b Determined by chiral GC; c 0.1 M; d The corresponding 
dimethyl diacetal 126 was analysed; e 1.0 M; f The dimethyl diacetal 126 was treated with CHCl3:TFA:water 
2:1:1 for 2 hours at r.t. to give the aldehyde; g 5 mol% of catalyst was used. 
3.5 ESI MS Screening of Imidazolidinone and Proline-based 
Organocatalysts 
3.5.1 ESI MS Screening Results 
Applying the general screening protocol, a series of readily available organocatalyst were 
screened in the retro-Diels-Alder reaction (Table 3.4).  
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Table 3.4: Screening results for a series of organocatalysts. 
H H
OO
n-Bu n-Pr
CH2Cl2, r.t., 24 h
N
n-Pr
N
n-Bu
20 mol% organocatalyst
(R)-116(S)-114
A
B
 
88 : 12
m/z
54 : 46
m/z
41 : 59
m/zm/z
83 :  17
N
H
N
O
23·HCl 128·HCl
N
H
N
S
N
H
N
O
129·HCl
N
H
N
O
130·TFA
 
78 : 2284 : 16
m/z m/z
73 : 27
m/z
40 :  60
m/z
N
H
OH
131
N
H
O Si
132
N
H
O Si
133
N
H
O Si
134
 
57 : 43
m/z
67 : 33
m/z
45 : 55
m/zm/z
59 : 41
136
N
H OH
O
N
H OMe
O
137·HCl 138
N
H
N
N
H
O
F3C
CF3
F3C
CF3
Si
135
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The highest enantioselectivity was observed for the imidazolidinone catalyst 23·HCl.[107] The 
sulphur-substituted catalyst 128·HCl showed good enantioselectivity. Synthesis of 128·HCl 
was achieved using Lawessons’ reagent to introduce the sulphur (Scheme 3.10). The crude 
product was converted to the free secondary amine 139 for purification by column 
chromatography. Addition of HCl to a solution of 139 gave the secondary amine salt 
128·HCl. The preparative forward-Diels-Alder reaction in methanol:water using 20 mol% of 
128·HCl proceeded with 92% conversion, an endo:exo selectivity of  1:1.5, an endo 
enantiomeric excess of 86% and an exo enantiomeric excess of 85%. As the results were 
comparable to those of imidazolidinone catalyst 23·HCl (compare Table 3.3, entry 2) 
exchange of oxygen by sulphur had only a minimal influence on the enantioselectivity.  
N
H
N
O
Ph
Lawessons' reagent
N
H
N
S
Ph HCl in Et2O
N
H
N
S
Ph
128·HCl 
62% yield
toluene, reflux, 30 min
workup: NaHCO3 (aq.)
23·HCl 139
 
Scheme 3.10: Synthesis of sulphur-containing catalyst 128·HCl. 
Diarylprolinol silyl-derived catalysts 132-135[158, 159] showed promising enantioselectivities. 
However, the forward-Diels-Alder reactions with cinnamaldehyde and cyclopentadiene using 
20 mol% of the corresponding diarylprolinol silyl ether gave less than 1% conversion to the 
Diels-Alder adduct in all cases (Scheme 3.11). Instead formation of the ene-products 140a 
and 140b was observed in some cases (catalyst 132 7% conversion, catalyst 133 and 134 5%, 
catalyst 135 no conversion). An enantioselective ene-reaction using the same starting material 
and the same catalysts in methanol was reported by HAYASHI and co-workers previously.[160] 
Higher yields (83-91%) than in dichloromethane were obtained presumably because 
hydrolysis and regeneration of the catalyst were facilitated in methanol. They reported that 
using 134·HCl in methanol:water gave the Diels-Alder adduct 127 in 12% yield without ene 
product formation. These results suggested that the course of the reaction can change 
dramatically under acid conditions. In a recent publication, HAYASHI and co-workers reported 
that in the presence of an acid catalyst the Diels-Alder reaction becomes the major pathway 
affording the exo isomer with high diastereo- and excellent enantioselectivities.[116]  
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Scheme 3.11: Diarylprolinol silyl ethers 132-135 as catalysts for the reaction between 
cinnamaldehyde 123 and cyclopentadiene. 
To summarise diarylprolinol silyl-derived catalysts 132-135 showed promising 
enantioselectivities in ESI MS, but almost no reactivity when applied in the Diels-Alder 
reaction. As catalyst reactivity is an important aspect, we investigated if relative reactivity can 
be correctly predicted by ESI MS. From the ESI MS spectra the catalyst’s reactivity was 
deduced by comparing the mass peak intensities of the dienophile iminium ions to those of 
the Diels-Alder adducts. Three catalysts showing high (catalyst 136), medium (catalyst 
23·HCl) and low (catalyst 132) dienophile to adduct iminium ion ratios in the retro-Diels-
Alder reaction were compared to the forward reaction with cinnamaldehyde and 
cyclopentadiene. The Diels-Alder reaction was conducted in methanol:water with 5 mol% 
catalyst loading at room temperature and terminated after 6 hours. The most reactive catalyst 
turned out to be imidazolidinone catalyst 23·HCl, followed by proline 136 and diarylprolinol 
silyl ether 132 (Table 3.5). These were different from the ESI MS results, for which proline 
136 seemed to be the most efficient catalyst. However, a correlation for the measured 
reactivities of the retro reaction by ESI MS and the preparative forward reaction cannot be 
expected because different solvents (dichloromethane/ methanol) were used. 
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Table 3.5: Comparison of the reactivity in the retro-Diels-Alder reaction by ESI MS and in the 
preparative forward-Diels-Alder reaction. 
Entry Cat. Dienophile vs. DA Adduct  
Iminium Ions (ESI-MS)a 
Conv. DA Reaction (%)b 
1 136 97:3 11 
2 23·HCl 67:33 77 
3 132 6:94 3 
a Ratio determined by ESI MS by comparing the amount of dienophile iminium ions to DA adduct iminium 
ions; b Conversion determined by 1H NMR. 
With this ESI MS screening method iminium ion intermediates of organocatalysts can be 
monitored to give information about the catalysts’ enantioselectivity. In principle, the method 
is broadly applicable as long as charged iminium ion intermediates are formed. In some cases 
organocatalysts form iminium ions, but give zwitterionic species during the electron 
ionisation process which cannot be detected by ESI MS.  
3.5.2 Control Experiments with Inversely Labelled Quasienantiomers 
The screening results were confirmed by conducting control experiments with the inversely 
labelled quasienantiomers. When those were used, exact inversion of the dienophile iminium 
ion ratios was expected. Comparison of both data sets showed that the dienophile ratios 
matched perfectly in most cases (Table 3.6).  
Table 3.6: Confirmation of screening results with opposite quasienantiomers. 
20 mol% organocatalyst
H H
OO
n-Bu n-Pr
(S)-114
H H
OO
n-Pr n-Bu
(S)-113
CH2Cl2, r.t., 24 h
N
n-Pr
N
n-Bu
A
B
(R)-116
(R)-118
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Entry Cat. (R)-116/(S)-114 
Dienophile  
Iminium Ion 
A : B 
DA Adduct  
Iminium Ion 
n-Pr : n-Bu 
(S)-113/(R)-118 
Dienophile 
Iminium Ion 
A : B 
DA Adduct  
Iminium Ion 
n-Pr : n-Bu 
1 23·HCl 88:12 92:8 12:88 10:90 
2 128·HCl 83:17 46:54 19:81 28:72 
3 129·HCl 54:46 22:78 43:57 74:26 
4 130·TFA 41:59 30:70 60:40 65:35 
5 131 40:60 27:73 60:40 78:22 
6 132 84:16 70:30 20:80 29:71 
7 133 78:22 63:37 23:77 33:67 
8 134 73:27 55:45 19:81 28:72 
9 135 67:33 21:79 28:72 76:24 
10 136 57:43 63:37 43:57 27:73 
11 137·HCl 59:41 63:37 40:60 22:78 
12 138 45:55 44:56 55:45 51:49 
3.6 ESI MS Screening of Peptide-Catalysts 
Small oligopeptides present an interesting class of potential catalysts since they are not as 
complex as enzymes and antibodies, but offer many sites for functional and structural 
modifications.[106, 161] Using peptides in metal-free asymmetric catalysis is a newly developing 
field,[162-171] we therefore became interested in screening enantioselective peptides for the 
retro-Diels-Alder reaction in collaboration with the group of H. WENNEMERS. Peptides 
contain secondary amines which can undergo iminium ion formation with aldehydes 
rendering them amenable to screening conditions similar to those applied for the 
imidazolidinone and proline-based organocatalysts. 
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3.6.1 General Screening Protocol 
To ensure reproducible results, the retro-Diels-Alder reaction was conducted under inert 
atmosphere and with anhydrous solvents. Endo n-Pr- and n-Bu-labelled quasienantiomers 
with 20 mol% of peptide-catalyst in methanol were used. These are typical conditions for 
organocatalysis. Peptides were used as TFA salts. An aliquot of the reaction mixture was 
diluted in methanol and injected directly in the mass spectrometer. The ratios for the 
dienophile iminium ions were determined by integration. A representative reaction using 
quasienantiomers (S)-113 and (R)-128 is shown in Scheme 3.12. The dienophile iminium ion 
ratio was 70:30, which confirmed that the retro-Diels-Alder reaction was actually catalysed 
by the peptide.  
H
H
O
O
n-Pr
n-Bu MeOH, r.t., 24 h
N
n-Pr
N
n-Bu
20 mol%
N
H
O
N
O
NH
O
O OH
NH2
(S)-113
(R)-118
A B141·TFA
 
Scheme 3.12: The peptide-catalysed retro-Diels-Alder reaction. 
3.6.2 Comparison with the Forward-Diels-Alder Reaction 
For confirmation of the results by ESI MS and to investigate the activity of the 
peptide-catalyst, the Diels-Alder reaction was conducted in methanol under similar conditions 
to that of the retro-Diels-Alder reaction (Table 3.7). Additionally, the reaction was conducted 
in dimethylformamide and dichloromethane to evaluate the potential of the peptide-catalysts. 
When methanol was used as solvent, dimethyl diacetal 126 was obtained and hydrolysed to 
give 127.  
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The endo enantiomeric excess obtained for the forward reactions in methanol and 
methanol:water was very similar (Table 3.7, entry 1 and 2) and correlated excellently with the 
results obtained by ESI MS (Scheme 3.12, ESI MS 40% ee). Addition of water led to better 
conversion presumably because regeneration of the catalyst was facilitated by hydrolysis 
(Table 3.7, entry 1).[107] The reaction in dimethylformamide (not dried) gave lower endo 
enantiomeric excess and moderate conversion. Very low conversion was observed for the 
reaction in dichloromethane with 5 % of water probably due to the low solubility of the 
peptide salt in that solvent. As enantioselectivities were promising, a screening consisting of 
several peptide-catalysts was conducted. 
Table 3.7: The preparative Diels-Alder reaction with tripeptide PPD-NH2 141·TFA.a 
PPD-NH2 141·TFA
O
O
123 127
r.t., 24 h
20 mol%
N
H
O
N
O
NH
O
O OH
NH2
126
OMe
OMe
 
Entry Solvent Endo:Exob Endo ee (%)c Exo ee (%)c Conv. (%)b 
1d MeOH:H2O 95:5 1:2.3 41 39 83 
2e MeOH 1:2.2 (1:2.2)d 41 (40)d 32 (30)d 27 
3 Dimethylformamide 1:2.2 35 30 56 
4 CH2Cl2:H2O 95:5 1:2.3 n.d. n.d. 4 
a All reactions were 1.0 M regarding dienophile 123; b Determined by 1H NMR of the crude product; 
c Determined by chiral GC; d The dimethyl diacetal 126 was analysed; e The dimethyl diacetal 126 was treated 
with CHCl3:TFA:water 2:1:1 for 2 hours at r.t. to give 127. 
3.6.3 ESI MS Screening Results 
Applying the general screening protocol several small oligopeptide were subjected to 
screening (Table 3.8). Common mass peaks in all spectra next to the iminium ion 
intermediates of interest were the protonated peptide, the sodium adduct along with 
[(peptide)2H]+ complex and its corresponding sodium adduct. 
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Table 3.8: ESI MS screening results of a series of peptides. 
H H
OO
n-Pr n-Bu
MeOH, r.t., 24 h
20 mol% peptide·TFA
(S)-113
N
n-Pr
N
n-Bu
A
B
(R)-118
 
67 : 33 68 : 32 64 : 36 52 : 48 70 : 30
N
H
O
N
O
NH
O
OH
O NH2
PPN-OH 142·TFA
N
H
O
N
O
NH
O
NH2
O NH2
PPN-NH2 143·TFA
N
H
O
N
O
NH
O OH
PPhomoN-NH2 144·TFA
O
NH2
N
H
O
N
O
NH
O
NH2
O NH2
pPN-NH2 145·TFA
N
H
O
N
O
NH
O
NH2
O OH
PPD-NH2 141·TFA
m/z m/z m/z m/z m/z
 
m/z
55 : 45
m/z
51 : 49
m/z
68 : 32
m/z
62 : 38 57 : 43
m/z
N
H
O
N
O
NH
O
OMe
O OH
PPD-OMe 146·TFA
N
H
O
N
O
NH
O
NH2
pPD-NH2 147·TFA
HO O
N
H
O
N
O
NH
PPE-NH2 148·TFA
OH
O
O
NH2
N
H
O
N
O
NH
O
OH
OH
PPS-OH 149·TFA
N
H
O
N
O
NH
O
OH
PPT-OH 150·TFA
OH
 
44 : 56
m/z m/z
58 : 42
m/z
60 : 40
m/z
70 : 30
m/z
38 : 62
N
H
O
N
O
NH
O
OH
PPF-OH 151·TFA
N
H
O
N
O
NH
O
OH
PPH-OH 152·TFA
NH
N
N
H
O
N
O
NH
O
N
HO O
O
NH2
PPDP-NH2 153·TFA
N
H
O
N
O
NH
O
N
HO O
O
NH2
PPDp-NH2 154·TFA
N
H
O
N
O
NH
O
N
HO O
pPDP-NH2155·TFA
O
NH2
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m/z
66 : 34 38 : 62a
m/z m/z
39 : 61a
m/z
39 : 61a
m/z
38 : 62a
N
H
O
HN
O
NH
O
NH2
O
HO
Pad-NH2 158·TFA
N
H
O
HN
O
NH
O
NH2
PAF-NH2 159·TFA
N
H
O
HN
O
NH
O
NH2
OH
PAY-NH2 160·TFA
N
H
O
N
O
NH
O
N
H
HO O
O
NH2
PPDd-NH2 156·TFA
O
H2N
HN
O
NH
O
N
H
O
NH2
PAD-NH2 157·TFA
OH
O
 
m/z
41 : 59a
m/z
38 : 62a
m/z
41 : 59a
m/z
39 : 61a
m/z
47 : 53a
N
H
O
HN
O
NH
O
NH2
HN
PAW-NH2 162·TFA
N
H
O
HN
O
NH
O
NH2
NHN
PAH-NH2 161·TFA
N
H
O
HN
O
NH
O
NH2
PAibF-NH2 163·TFA
N
H
O
HN
O
NH
O
NH2
OH
PAibY-NH2 164·TFA
N
H
O
HN
O
NH
O
NH2
NHN
PAibH-NH2 165·TFA
 
m/z
39 : 61a
m/z
48 : 52a
HO
NH2
O
H
N
O
HN OH
O
H2N
O
HO
TyD-NH2 168·TFA
m/z
40 : 60
m/z
44 : 56
m/z
48 : 52a
HN
O
NH
O
N
H O
H2N
OH
PGY-NH2 166·TFA
N
H
O
NH
HO
O
NH
O
H2N
O
HO
pYD-NH2 167·TFA
HO
NH2
O
N
O NH
O
H2N
TpE-NH2 169·TFA
O
HO
N
H
O
NH
PD-NH2 170·TFA
O
NH2
O
HO
 
a Inversely labelled quasienantiomers were used. 
PPD-NH2 141·TFA gave the highest enantiomeric excess of 40%. Peptides containing the 
proline-proline motif generally gave enantiomeric excesses between 24-40% and the 
proline-alanine motif produced 25% enantiomeric excess. All peptide-catalysts favoured the 
(S)-enantiomer with one exception (PPF-OH 151·TFA). The stereochemistry of the first 
amino acid determined the overall stereoselectivity of the peptide-catalysts 
ESI MS Screening of Organocatalysed Retro-Diels-Alder Reactions 
 
91 
(PPDP-NH2 153·TFA and pPDP-NH2 155·TFA) and remained quantitatively unchanged by 
the second, third or fourth amino acid (PAD-NH2 157·TFA and Pad-NH2 158·TFA). Peptides 
starting with a non-cyclic amino acid such as threonine showed low enantioselectivities 
(TyD-NH2 168·TFA). 
Peptides as catalysts showed an improvement in enantioselectivity compared to proline 
(Section 3.5.1, ratio 57:43). Modification of the amino acid chain did not significantly 
influence stereoselectivity. In all cases, MACMILLAN’s imidazolidinone catalyst 23·HCl was 
found to give better enantioselectivities than the tested peptides.[107]  
3.6.4 Control Experiments with Inversely Labelled Quasienantiomers 
The screening results were confirmed by conducting a screening with the inversely labelled 
quasienantiomers (R)-114 and (S)-116, for which we expected to observe inverted ratios 
compared to those with (S)-113 and (R)-118. As seen in Table 3.9 dienophile ratios for both 
quasiracemates correlated well, demonstrating once more the applicability of this ESI MS 
screening method. The Diels-Alder adduct iminium ions either showed a near 50:50 mixture 
or more of the non-favoured Diels-Alder adduct, which might reflect the distribution of the 
remaining Diels-Alder adducts in solution.  
Table 3.9: Confirmation of screening results with inversely labelled quasienantiomers. 
n-Pr
20 mol% peptide·TFA
H H
OO
n-Bu n-Pr
(R)-116(S)-114
H H
OO
n-Bu
(R)-118(S)-113
MeOH, r.t., 24 h
N
n-Pr
N
n-Bu
A
B
 
Entry Cat. (S)-113/(R)-118 
Dienophile 
 Iminium Ions 
A : B 
DA Adduct  
Iminium Ions 
n-Pr : n-Bu 
(R)-116/(S)-114 
Dienophile  
Iminium Ions  
A : B 
DA Adduct  
Iminium Ions  
n-Pr : n-Bu 
1 141·TFA 70:30 57:43 36:64 62:38 
2 142·TFA 67:33 40:60 32:68 54:46 
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Entry Cat. (S)-113/(R)-118 
Dienophile 
 Iminium Ions 
A : B 
DA Adduct  
Iminium Ions 
n-Pr : n-Bu 
(R)-116/(S)-114 
Dienophile  
Iminium Ions  
A : B 
DA Adduct  
Iminium Ions  
n-Pr : n-Bu 
3 147·TFA 45:55 27:73 55:45 25:75 
4 150·TFA 57:43 38:62 36:64 58:42 
5 151·TFA 44:56 45:55 54:46 69:31 
6 152·TFA 58:42 44:56 40:60 57:43 
7 153·TFA 60:40 57:43 36:64 61:39 
8 155·TFA 38:62 19:81 61:39 - 
9 156·TFA 66:34 48:52 36:64 - 
10 168·TFA 40:60 51:49 54:46 54:46 
11 169·TFA 44:56 47:53 56:44 50:50 
3.7 Conclusion and Outlook 
Our ESI MS screening method was extended to organocatalytic retro-Diels-Alder reactions. 
After testing the influence of the mass labels and establishing a reliable screening protocol, 
we successfully demonstrated that monitoring of iminium ion species in the retro-Diels-Alder 
reaction is a valuable tool to gain information about the catalysts’ enantioselectivity. The 
application of this method in a screening with imidazolidinone and proline-based ligands 
confirmed that MACMILLAN’s imidazolidinone 23·HCl was a highly enantioselective catalyst 
for the retro-Diels-Alder reaction. Control experiments and the results of preparative 
forward-Diels-Alder reactions validated our method.  
The versatility of this method was demonstrated by conducting a screening of 30 peptides to 
evaluate their potential as enantioselective catalyst in the retro-Diels-Alder reaction. It was 
found that peptides can function as catalysts in the retro-Diels-Alder reaction with moderate 
enantioselectivities.  
So far it was not possible to determine a catalyst’s activity by this ESI MS screening method. 
An extension of this method including this aspect would greatly increase the usefulness of this 
technique. Also diastereoselectivity still remains a problem in organocatalysed Diels-Alder 
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reactions. An additional screening set-up concerning this issue would therefore be desirable. 
By using a mixture of mass-labelled enantiopure endo and exo Diels-Alder adducts this could 
be accomplished. 
This screening method, enabling the rapid identification of highly selective organocatalysts, is 
not limited to the Diels-Alder reaction. This methodology should be readily applicable to 
other organocatalysed transformations. Work on extending this concept to Michael reactions 
is currently carried out in our group. 
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4 ESI MS Screening of Organocatalyst Mixtures 
4.1 Objectives 
After establishing a reliable protocol for the screening of single organocatalysts, we wanted to 
test if this method was amenable to screening mixtures of organocatalysts in a one pot 
procedure for the retro-Diels-Alder reaction.  
Previously HINDERLING and CHEN demonstrated that olefin polymerisation reactions, 
catalysed simultaneously by eight different palladium-catalysts, can be analysed by ESI MS 
to identify the most active catalyst.[10] ELLMAN and co-workers used multi-substrate screening 
to discover new substrates for C-H activation reactions. Subsequent selective product 
labelling allowed analysis by ESI MS.[172] MARKERT and PFALTZ showed that it was possible 
to obtain reliable selectivity data from catalyst mixtures by ESI MS screening of 
quasienantiomers. By detection of the catalytic intermediates by ESI MS the intrinsic 
enantioselectivity of each individual catalyst was determined for the palladium-catalysed 
allylic substitution reaction.[9] This was the first and to date only example of multi-catalyst 
screening by ESI MS to evaluate enantioselectivity. There was no restriction to the number of 
catalysts screened in one mixture as long as the mass peaks did not overlap. Using the 
quasienantiomer strategy, catalysts did not need further labelling as the intermediates were 
easily distinguished by their inherent mass differences.  
Multi-catalyst screenings greatly accelerate the trial and error process for (organo)catalyst 
development making it interesting for high-throughput applications. With conventional 
product analysis it is not possible to screen for enantioselectivity in multi-catalyst mixtures. 
This encouraged us to pursue the development of an ESI MS screening method to 
simultaneously screen several organocatalysts in one reaction mixture. 
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4.2 Development of a Screening Method for Mixtures of Imidazolidinone 
and Proline-Based Organocatalysts 
4.2.1 Preliminary Studies 
In order to successfully screen mixtures of organocatalysts, the masses of the tested catalysts 
must be theoretically different by at least ∆ m/z = 1 to avoid mass peak overlap. The catalysts 
should also show similar mass peak intensities for the reactive intermediates, otherwise the 
least-intense mass peaks become too small. The mass range should be held constant (for 
example ∆ m/z 500) for comparable results. 
Preliminary experiments were conducted using imidazolidinone catalyst 23·HCl, which 
showed excellent enantioselectivities in the screening of single catalysts (Section 3.5.1, 
ratio 12:88), and imidazolidinone catalyst 130·TFA, which showed moderate enantio- and 
opposite stereoselectivity (Section 3.5.1, ratio 60:40). To demonstrate the compatibility with a 
different catalyst type proline 136 (Section 3.5.1, ratio 43:57) was used as well. Mass peak 
intensities for all three ligands were good to excellent making them amenable to testing.  
The starting point was to use two catalysts in one reaction mixture with either (S)-113 and 
(R)-118 or (S)-114 and (R)-116 as quasienantiomers (Scheme 4.1). Standard reaction 
conditions developed for single catalyst screening were applied (Section 3.3.3). 
H H
OO
R1 R2
CH2Cl2, r.t., 24 h
N
n-Pr
N
n-Bu
A
B
(S)-113 R1 = n-Pr and (R)-118 R2 = n-Bu or
(S)-114 R1 = n-Bu and (R)-116 R2 = n-Pr
10 mol% each
organocatalyst
 
Scheme 4.1: Multi-catalyst screening in one reaction mixture for the retro-Diels-Alder reaction. 
Using proline 136 and imidazolidinone 130·TFA in the retro-Diels-Alder reaction, ESI MS 
spectra showed the expected ratios (Figure 4.1, a). It is remarkable that catalysts with 
opposite stereoselectivity can be successfully tested in one reaction mixture. When screening 
proline 136 and imidazolidinone 23·HCl the correct ratio was detected for proline 136, but for 
23·HCl lower enantioselectivity than for the single screening was observed (Figure 4.1, b). 
The outcome for testing imidazolidinones 23·HCl and 130·TFA was similar: the expected 
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ratio was detected for 130·TFA whereas the ratio for 23·HCl was lower than anticipated 
(Figure 4.1, c). 
280 320m/z
A
A
B
B
38 : 62
(41:59)
60 : 40
(57:43)
280 375m/z
A
44 : 56
(43:57)
A
B
B
24 : 76
(12:88)
m/z325 375
A
B
B
A
28 : 72
(12:88)
58 : 42
(59:41)
a b c
N
H OH
O
136
N
H
N
O
130·TFA
N
H OH
O
136
N
H
N
O
23·HCl
N
H
N
O
130·TFA
N
H
N
O
23·HCl
Figure 4.1: ESI MS spectra for screening of two organocatalysts in one reaction mixture: (a) and (c) 
using (S)-114 and (R)-116 and (b) (S)-113 and (R)-118 as quasienantiomers. The reaction conditions 
are depicted in Scheme 4.1. The ratios of the single catalyst screening are given in brackets. 
Upon addition of proline 136 to imidazolidinones 23·HCl and 130·TFA the most selective 
imidazolidinone catalyst 23·HCl was easily identified, followed by imidazolidinone catalyst 
130·TFA and proline 136 (Figure 4.2). The ratios for the latter two were in accordance to 
those for the single catalyst screening. Although 23·HCl was clearly the most selective 
catalyst in this mixture, its ratio remained lower compared to that of the single screening 
(29:71 vs. 12:88).  
The spectrum showed hardly any contamination, which allowed correct analysis of the less-
intense mass peaks. Prominent additional mass peaks resulted from the Diels-Alder adduct 
iminium ion intermediates, the protonated catalysts and their sodium ion adducts. 
275 300 325 350 375
m/z
0
20
40
60
80
100
Irel
A
B
44 : 56
(43:57)
B
60 :40
(59:41)
A
29 :71
(12:88)
B
A
N
H OH
O
136
N
H
N
O
130·TFA
N
H
N
O
23·HCl
Figure 4.2: ESI MS screening using three organocatalysts. The reaction conditions are depicted in 
Scheme 4.1. The dashed boxes frame the mass peaks of the Diels-Alder adduct iminium ion 
intermediates for 136 and 130·TFA. The ratios of the single catalyst screening are given in brackets. 
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As acids influence diastereo- and enantioselectivity of Diels-Alder reactions,[116, 160] mixing of 
trifluoroacetate and chloride counter-ions could be responsible for the drop in 
enantioselectivity for 23·HCl.  
Several more combinations of organocatalysts were tested including diarylprolinol silyl ether 
derived catalysts 132-135, which generally gave low mass peak intensities and selectivities 
deviated from those in the single catalyst screening. Therefore mixtures containing these 
organocatalysts were not investigated further. 
4.2.2 Influence of Counter-Ions in Catalyst Mixtures 
To investigate the counter-ion influence on the retro-Diels-Alder reaction, two catalysts were 
tested in combination with chloride and trifluoroacetate. 
130·HC
130·TFA
N
H
N
O
N
H
N
O
23·HCl
23·TFA
 
Figure 4.3: Imidazolidinone catalysts 23 and 130 with chloride and trifluoroacetate as counter-ions. 
Single screening of 23·HCl and 23·TFA gave similar ratios, demonstrating that counter-ion 
influence on enantioselectivity was minimal (Figure 4.4, a and b). However, mixing catalysts 
with different counter-ions produced lower ratios than those in the single catalyst screening 
(Figure 4.4, c). Subsequent use of a mixture of catalyst 23 and 130 both with the same 
counter-ion (chloride or trifluoroacetate) resulted in the expected ratio for 130, but again in a 
lower ratio for 23. 
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Figure 4.4: ESI MS spectra for (a) single screening of 23·HCl and (b) 23·TFA and (c) screening of a 
mixture of 23·HCl and 23·TFA. Reactions were conducted at room temperature for 24 hours using 
20 mol% of catalyst for the single screening and 10 mol% of each catalyst for the mixture. 
Testing structurally closely related catalysts 23·HCl and 128·HCl in the same reaction mixture 
also gave ratios which were lower than those of the single catalyst screening (Figure 4.5, a). 
Addition of proline 136 to imidazolidinones 23·HCl and 128·HCl resulted in further lowering 
of the ratios for 23·HCl and 128·HCl. The observed ratio for the proline-derived intermediates 
was in accordance to that of the single catalyst screening (Figure 4.5, b).  
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m/z
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B
80 : 20
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A
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75 : 25
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Figure 4.5: ESI MS spectra for (a) screening catalysts 23·HCl and 128·HCl using (S)-114 and (R)-116 
as quasienantiomers and (b) screening of three organocatalysts in one reaction mixture using (S)-113 
and (R)-118 as quasienantiomers. The reaction conditions are depicted in Scheme 4.1. The ratios of 
the single catalyst screening are given in brackets. 
In general, the effect of the counter-ions was ambiguous. Nonetheless catalysts with the same 
counter-ions were used in the following experiments to exclude any possible influence of 
different counter-ions. The presence of proline 136 seemed to have a major influence on the 
reaction mixture, possibly induced by the presence of its free carboxylic acid. Therefore 
proline 136 was substituted in some cases by proline methyl ester 137·HCl. 
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4.2.3 Optimisation of the Reaction Conditions 
Several factors such as catalyst loading, temperature and reaction time were evaluated for 
catalyst mixtures as the reaction conditions applied for the single catalyst screening did not 
give optimal results. 
Screening of four different catalyst loadings (1, 5, 10 and 20 mol%) with catalyst 23·HCl, 
130·HCl and 136 showed best results when 20 mol% of each catalyst were used. Therefore 
the following experiments were conducted with that amount of each catalyst.  
Reaction temperatures were varied from -78 °C to 50 °C (Figure 4.6). Quasienantiomers 
(S)-113 and (R)-118 were used and the reaction time was 24 hours. To our surprise the best 
ratio for catalyst 23·HCl was detected at 50 °C. It was remarkable that at elevated 
temperatures the catalyst displayed a higher enantioselectivity than at lower temperatures. At 
-78 °C an inverse ratio was detected for catalyst 23·HCl, which was even more pronounced 
when shortening the reaction time to 2 hours (ratio 83:17). The selectivities of proline 136 
were independent of the reaction temperature whereas enantioselectivity for catalyst 130·HCl 
constantly declined going from -78 °C to 50 °C.  
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Figure 4.6: ESI MS spectra for temperature screening using 136, 130·HCl and 23·HCl. The reactions 
were conducted at the indicated temperatures for 24 hours using 20 mol% of each catalyst. The 
dashed boxes in the top spectrum frame the Diels-Alder adduct iminium ion intermediates of catalyst 
136 and 130·HCl. The ratios of the single catalyst screening are given in brackets.* 
The temperature screening was repeated with proline methyl ester 137·HCl to eliminate the 
effect of the carboxylic acid side chain of proline 136. The reaction time was shortened to 
8 hours as a decline of the ratio for catalyst 23·HCl was observed after that time at room 
temperature (2 h, ratio 36:64; 8 h, ratio 35:65; 130 h, ratio 46:54; 48 h, ratio 46:54).  
As observed previously, catalyst 23·HCl showed enhanced enantioselectivity at 50 °C 
(ratio 15:85) compared to that at -78 °C (ratio 47:53) (Figure 4.7). The ratio obtained at 50 °C 
corresponded to that of the single catalyst screening. For proline methyl ester 137·HCl ratios 
were largely unaffected by temperature, whereas the ratio for catalyst 130·HCl declined going 
from -78 °C to 50 °C from 59:41 to nearly racemic.  
                                                 
*
 Relative mass peak intensities are given with regard to the most-intense mass peak in the spectrum, generally 
the [23+H]+ or [23+Na]+ mass peak. 
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Figure 4.7: ESI MS spectra for the temperature screening using proline methyl ester 137·HCl, 
130·HCl and 23·HCl. The reactions were conducted at the indicated temperatures for 8 hours using 
20 mol% of each catalyst. The ratios of the single catalyst screening are given in brackets. 
Further shortening of the reaction time to 60 minutes produced perfect correlation with the 
single screening for all three catalysts. Catalyst 23·HCl performed with the expected high 
enantioselectivity. For 137·HCl and 130·HCl similar enantioselectivities with inverse 
stereoselectivity were observed (Figure 4.8). Shortening of the reaction time to 30 minutes 
gave very similar results, although the ratio of 23·HCl was slightly lower compared to that for 
60 minutes.  
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Figure 4.8: ESI MS spectra for reaction times of 30 and 60 minutes. The reactions were conducted at 
50 °C for the indicated times using 20 mol% of each catalyst. The dashed boxes frame the Diels-Alder 
adduct iminium ion intermediates for 137·HCl and 130·HCl. The ratios of the single catalyst screening 
are given in brackets. 
The screening for enantioselectivity of three organocatalysts in one reaction mixture was 
accomplished by using 20 mol% of each catalyst, shortening the reaction time from 24 hours 
to 1 hour and performing the reaction at 50 °C instead of at room temperature. During the 
course of investigation for optimal screening conditions, an increase of enantioselectivity with 
increasing temperature was observed for catalyst 23·HCl.  
Similar temperature effects such as the enhancement and/or inversion of enantiomeric excess 
with increasing temperature in asymmetric processes have been reported before (for example 
for the reduction with chiral 1,4-dihydronicotinamides,[173] the desymmetrisation with chiral 
tin-compounds,[174] the addition of diethyl zinc to aldehydes[175] and the cobalt-catalysed 
homo Diels-Alder reaction[176]). In some cases the Eyring equation*[177-179] was applied to 
                                                 
*
 Evaluation of temperature dependence for stereoselectivity in terms of differential activation enthalpy and 
entropy can be calculated from the Eyring equation[177-179] ln(kS/kR)=-(∆∆H‡S-R/RT)+(∆∆S‡S-R/R) derived from 
ln(kS/kR)=-∆∆G‡S-R/RT with ∆G‡ =∆H‡-T∆S‡, in which kS and kR are the overall rate constants leading to the two 
enantiomers and ∆∆H‡S-R=∆∆H‡S-∆∆H‡R and ∆∆S‡S-R=∆∆S‡S-∆∆S‡R represent the differential activation 
enthalpy and entropy. ∆∆G‡S-R is the difference in free activation energy for the (S)- and the (R)-enantiomers. 
∆∆H‡S-R and ∆∆S‡S-R can be calculated by plotting ln(kS/kR) values, derived from 
ln(kS/kR)=ln[(100+%ee)/(100-%ee)], as a function of the reciprocal temperature.  
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calculate the differential activation parameters ∆∆H‡S-R and ∆∆S‡S-R.[173, 174] Comparatively 
large values for ∆∆S‡S-R were obtained for these calculations, indicating that the entropy term 
contributes to the differential free activation energy ∆∆G‡S-R more than usual.[173, 174] 
Therefore the entropy term accounts for the unique temperature dependence.[173, 174] The 
relatively large ∆∆S‡S-R-values were assumed to originate from large activation volume 
variations caused for example by the broad movement sphere of an benzylic group.[173]  
This rationale can be applied to our experimental findings, where an increase in 
enantioselectivity with increasing temperature was exclusively observed for the benzyl-group 
containing imidazolidinone catalyst 23 and not for imidazolidinone catalyst 130 and proline 
136 or proline methyl ester 137·HCl, respectively. An alternative explanation for the unusual 
temperature behaviour could be that a different reaction pathway operates at lower 
temperatures.  
4.2.4 ESI MS Screening Results 
Subjecting the initially used catalyst mixture including imidazolidinone 23·HCl and 130·HCl 
and proline 136 to optimised reaction conditions (50 °C, 1 hour, 20 mol% of each catalyst) 
gave results which were in perfect agreement with previous data from single catalyst 
screening (Figure 4.9). Imidazolidinone 23·HCl was correctly identified as the most selective 
ligand in this mixture, whereas proline 136 and imidazolidinone 130·HCl showed essentially 
the same stereoselectivity values but opposite sense of chiral induction.  
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Figure 4.9: Screening of three organocatalysts in the same reaction mixture using quasienantiomers 
(S)-114 and (R)-116. The reaction was conducted at 50 °C for 1 hour using 20 mol% of each catalyst. 
The ratios of the single catalyst screening are given in brackets. 
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4.3 Screening of Peptide-Catalyst Mixtures 
4.3.1 Preliminary Studies 
Preliminary studies for screening peptide-catalyst mixtures in the retro-Diels-Alder reaction 
were conducted with two peptide-catalysts (10 mol% each) using (S)-113 and (R)-118 as 
quasienantiomers (Figure 4.10). The mass peak intensities were sufficiently intense, showing 
the dienophile and Diels-Alder adduct iminium ion intermediates as well as the protonated 
peptides. The selectivities for both peptide-catalysts were in accordance to those for the single 
screening, even when catalysts with opposite selectivities were screened (Figure 4.10, a). 
Catalysts with a mass difference of only ∆ m/z = 5 were comfortably analysed next to each 
other (Figure 4.10, c). In one case even enhanced selectivity compared to the single screening 
was observed for both catalysts (Figure 4.10, b). Although selectivities did not match exactly 
with those of the single catalyst screening in some cases, the more selective catalyst was 
always clearly identified (Figure 4.10, for example in d, catalyst PPDp-NH2 154·TFA). 
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Figure 4.10: ESI MS spectra for the screenings with two peptide-catalysts in one reaction mixture 
using 10 mol% of each catalyst. The reactions were conducted at room temperature for 24 hours. The 
dashed boxes frame the Diels-Alder adduct iminium ion intermediates if present in the spectrum. The 
ratios of the single catalyst screening are given in brackets. 
4.3.2 ESI MS Screening Results 
Applying the general screening conditions (20 mol% of each catalyst, r.t., 24 h) to mixtures of 
three peptide-catalysts did not give the ratios expected from the single screening. Interestingly 
the observed ratios were generally better than in the single screening.  
Subsequently, the optimised conditions developed previously for the imidazolidinone and 
proline-based catalysts were applied (20 mol% of each catalyst, 50 °C, 1 h) using (S)-113 and 
(R)-118 as quasienantiomers. The correlation between the selectivities of the catalysts in the 
mixtures compared to those in the single catalyst screening was very good (Figure 4.11). 
Although selectivities were very similar for all peptide-catalysts, the trend for the most 
selective catalyst in a mixture was clearly identified (Figure 4.11, 
a PPDp-NH2 154·TFA>PPD-OMe 146·TFA>pPN-NH2 144·TFA). As observed before, 
peptide-catalysts with opposite stereoselectivity can be monitored in the same reaction 
mixture (Figure 4.11, b).  
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Figure 4.11: ESI MS spectra for the screening of three peptide-catalysts in the same reaction mixture 
using optimised reaction conditions. The dashed boxes frame the Diels-Alder adduct iminium ion 
intermediates if present in the spectrum. The ratios of the single catalyst screening are given in 
brackets. 
Simultaneous screening of imidazolidinone and proline-based organocatalysts with peptide-
catalysts was not possible because different retro-Diels-Alder conditions were mandatory: 
peptide-catalysed reactions were conducted in methanol whereas imidazolidinone and proline-
based organocatalysis was performed in dichloromethane.  
4.4 Conclusion and Outlook 
Based on the previously developed screening method, a procedure for screening 
simultaneously up to three organocatalysts in one reaction mixture was developed.  
This method allowed to distinguish catalytic intermediates originating from different 
organocatalysts due to their inherently different masses. Therefore mass peaks were easily 
assigned and subsequent analysis gave the intrinsic enantioselectivities of the individual 
catalysts. It was possible to observe a clear trend to identify the most selective catalyst in a 
mixture. After optimising the reaction conditions, the results of the multi-catalyst screenings 
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were in perfect agreement with those for the single screening. We also showed that the 
optimised conditions were successfully applied for the simultaneous screening of up to three 
peptide-catalysts.  
During the development of the screening conditions, an unusual temperature-
enantioselectivity relationship was discovered for imidazolidinone catalyst 23·HCl. Further 
studies will be necessary to elucidate the origin of these temperature effects.  
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5 Experimental 
5.1 Analytical Methods 
NMR-Spectroscopy: NMR spectra were measured either on a Bruker Advance 400 (400 
MHz) or a Bruker Advance DRX 500 (500 MHz) NMR spectrometer, equipped with BBO 
broadband probe heads. The chemical shift, δ value, is given in ppm. The chemical shift δ 
values were corrected to the following references: 7.26 ppm (1H NMR) and 77.0 ppm (13C 
NMR) for CHCl3, 5.32 ppm (1H NMR) and 54.0 ppm (13C NMR) for CH2Cl2, 3.35 ppm and 
4.78 ppm (1H NMR) and 49.3 ppm (13C NMR) for CH3OH, 7.16 ppm (1H NMR) and 128.06 
(13C NMR) for C6H6 and 2.50 ppm (1H NMR) and 39.5 ppm (13C NMR) for (CH3)2SO. The 
assignment of 1H- and 13C-signals was partly made by 2D-NMR, namely COSY, HMQC and 
HMBC. 13C NMR spectra were recorded 1H-decoupled. Multiplets were assigned with s 
(singlet), d (doublet), t (triplet), q (quartet), quint (quintet), sext (sextet), m (multiplet). The 
index br stands for broad. 
Mass Spectrometry (MS): Mass spectra were measured by DR. H. NADIG (Department of 
Chemistry, University of Basel) on a VG70-250 (electron ionisation (EI)) mass spectrometer 
or on MAR 312 (fast atom bombardment (FAB)) mass spectrometer. FAB was performed 
with 3-nitrobenzyl alcohol (NBA) as matrix. ESI MS spectra were measured on a Finnigan 
MAT LCQ and on a Varian 1200L Triple Quad MS/MS. The signals are given in mass-to-
charge ratio (m/z). The fragment and intensities are given in brackets. All values are rounded 
to the nearest whole number. 
Infra-red Spectroscopy (IR): Infra-red spectra were measured on a Perkin Elmer 1600 series 
FTIR spectrometer. Solid samples were measured as KBr discs, liquid samples were 
measured between NaCl plates. Absorption bands are given in wave numbers ν~  [cm-1]. The 
peak intensity is assigned with s (strong), m (medium) and w (weak). The index br stands for 
broad. 
Melting Point (m.p.): Melting points were measured on a Büchi 535 melting point apparatus. 
The values are not corrected. 
Optical Rotation ([α] 20D ): [α] 20D -Values were measured on a Perkin Elmer Polarimeter 341 in 
a cuvette (1 = 1 dm) at 20 °C. Concentration, c, is given in g/100 mL. 
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Thin Layer Chromatography (TLC): TLC plates were obtained from Macherey-Nagel 
(Polygram® SIL/UV254, 0.2 mm silica with fluorescence indicator, 40 × 80 mm; Polygram® 
ALOX N/UV254, 0.2 mm alox with fluorescence indicator, 40 × 80 mm). UV light (254 nm, 
366 nm), basic permanganate solution [3 g KMnO4, 20 g K2CO3, 5 mL 5% (w/w) aqueous 
NaOH and water (300 mL)] and cerammoniummolybdate solution [2 g Ce(SO4)2·H2O, 48 g 
(NH4)6MoO24·H2O in 1000 mL 10% aqueous (w/w) H2SO4] were used to aid visualisation. 
Gas Chromatography (GC): Gas chromatographs were measured on Carlo Erba HRGC 
Mega2 Series 800 (HRGS Mega 2). For chiral separations ß- and γ-cyclodextrine columns 
(30 m × 0.25 mm × 0.25 µm) were used. 
High Performance Liquid Chromatography (HPLC): HPLC analyses were measured on 
Shimadzu systems with SLC-10A System Controller, CTO-10AC column oven, LC10-AD 
pump system, DGU-14A degasser and SPD-M10A Diode Array- or UV-vis detector. Chiral 
columns used included Chiracel OD-H, OB-H, OJ, AS, AD-H and Chiralpak AD (4.6 × 
250 mm) as well as Chiracel OD and AD (20 × 300 mm) from Diacel Chemical Industries 
Ltd. 
Elemental Analysis (EA): Elemental analyses were measured by MR. W. KIRSCH 
(Department of Chemistry, University of Basel) on a Leco CHN-900 (C-, H-, N-detection) 
and Leco RO-478 (O-detection) analysers. The data are indicated in mass percent. 
Chemicals: Commercially available starting material were purchased from Acros, Aldrich, 
Alfa Aesar, Fluka or Lancaster and Strem Chemicals.  
5.2 Working Techniques 
Sensitive Compounds: Syntheses of air- and moisture-sensitive compounds were carried out 
under an inert atmosphere in a glove box (MBRAUN labmaster 130, N2) and using standard 
Schlenk techniques (Ar). 
Solvents: Dichloromethane, diethyl ether, pentane, tetrahydrofuran and toluene were dried 
and degassed by distillation from an adequate drying agent under a nitrogen atmosphere.[180] 
Other solvents were purchased dry from Fluka or Aldrich in septum sealed bottles and kept 
under an inert atmosphere over molecular sieves. If necessary, solvents were degassed by 
three freeze-pump-thaw cycles.  
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Column Chromatography: Silica gel was obtained from Merck (silica gel 60, 
0.040-0.063 mm) and aluminium oxide from Fluka (Buchs; basic, 0.040-0.063 mm, 
Brockmann activity I). Flash column chromatography was performed under 0.1-0.8 bar 
(N2 pressure), solvents were technical grade and were purified prior to use by distillation. 
5.3 Synthesis of Quasienantiomeric Diels-Alder Adducts and Chiral 
Ligands for the Copper(II)-Catalysed Retro-Diels-Alder Reaction 
5.3.1 Bis(oxazoline) Ligand Synthesis 
2,2-Dimethylmalonyl dichloride (44)[139] 
Cl Cl
O O
 
N,N-Dimethylformamide was added (0.33 mL) to dimethylmalonic acid (5 g, 37.8 mmol) in 
dichloromethane (57 mL). After cooling to 0 °C oxalyl chloride (9.60 mL, 114 mmol) was 
added dropwise during 30 minutes. After stirring for 17 hours at room temperature, 
evaporation of the solvent under reduced pressure gave a yellow oil with orange droplets. The 
mixture was distilled immediately under argon (180 °C, 5×10-1 mbar) to give 
2,2-dimethylmalonyl dichloride 44 (5.20 g, 81%) as a colourless transparent liquid. 
C5H6Cl2O2 (169.01): 
1H NMR (400.1 MHz, CDCl3): δ = 1.68 (s, 6 H, CH3). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 23.1 (CH3), 69.1 (C), 172.0 (C). 
IR (NaCl): ν~ = 3000w, 1794s, 1464m, 980m, 913m, 845m, 722m. 
EA calcd (%) for C5H6Cl2O2: C, 35.53; H, 3.58. Found: C, 35.65; H, 3.66.  
The spectroscopic data are in agreement with that previously reported in the literature.[139] 
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(S)-N,N’-Bis[1-(hydroxymethyl)-2-methylpropyl]-2,2-dimethyl-malonamide (45a) 
N
H
6 7 N
H
OO
8 OH
21
3
OH
4 5
 
General Method I: Triethylamine (6.87 mL, 48.5 mmol) was added dropwise to L-valinol 
(2.00 g, 19.4 mmol) in dichloromethane (23 mL) at 0 °C. Then a solution of 
2,2-dimethylmalonyl dichloride 44 (1.64 g, 9.70 mmol) in dichloromethane (8 mL) was added 
via cannula during 5 minutes. A white precipitate formed and the suspension was stirred for 
35 minutes at room temperature. Dichloromethane (60 mL) was added, dissolving most of the 
white solid. The reaction mixture was washed with 1 N HCl (15 mL) and the aqueous layer 
was extracted with dichloromethane (8 mL). The combined organic extracts were washed 
with saturated aqueous NaHCO3 (15 mL) and the aqueous layer was extracted with 
dichloromethane (8 mL). The combined organic extracts were washed with brine (15 mL) and 
the aqueous layer was extracted with dichloromethane (8 mL). The combined organic extracts 
were dried (Na2SO4) and the solvent was removed under reduced pressure to give a colourless 
solid. The crude product was recrystallised (ethyl acetate) to give diamide 45a (2.26 g, 77%) 
as colourless crystals. 
C15H30N2O4 (302.41): 
m.p. 90-91 °C (ethyl acetate). 
1H NMR 400.1 MHz, CDCl3): δ = 0.90 (d, 3J = 6.6 Hz, 6 H, CHCH3), 0.93 (d, 3J = 6.6 Hz, 6 
H, CHCH3), 1.48 (s, 6 H, CCH3), 1.77-1.83 (m, 2 H, CHCH3), 3.35 (br s, 2 H, OH), 3.50 (m, 
2 H, NHCH), 3.69-3.79 (m, 4 H, CH2), 6.50 (br d, 3J = 9.1 Hz, 2 H, NH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 18.8 (CH3, 4/5), 19.6 (CH3, 4/5), 23.7 (CH3, 8), 29.1 
(CH, 3), 50.2 (C, 7), 57.2 (CH, 2), 63.6 (CH2, 1), 174.5 (C, 6). 
IR (KBr): ν~ = 3327s, 2964s, 1644s, 1546s, 1455s, 1390m, 1287m, 1187m, 1073m, 1027s. 
MS (FAB, NBA (subtr)), m/z (%): 303 ([M+H]+, 100), 285 ([M-OH2]+, 26), 200 (18), 130 
(20), 86 (35), 69 (38). 
[α] 20D  = _31.8 (c = 1.02, MeOH). 
EA calcd (%) for C15H30N2O4: C, 59.58; H, 10.00; N, 9.26; O, 21.16. Found: C, 59.60; H, 
9.84; N, 9.28; O, 20.81.  
The spectroscopic data are in agreement with that previously reported in the literature.[181] 
 
Experimental 
 
117
(S)-N,N’-Bis[1-(hydroxymethyl)-2,2-dimethylpropyl]-2,2-dimethyl-1,3-propanediamide 
(45b)[139] 
N
H
5
6 N
H
O
7
2
1
HO
3
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OH
O
 
By general method I (S)-t-leucinol (4.68 g, 40.0 mmol), triethylamine (13.4 mL, 100 mmol) 
and 2,2-dimethylmalonyl dichloride 44 (3.38 g, 20.0 mmol) in dichloromethane (60 mL) gave 
the crude product. It was purified by recrystallisation (ethyl acetate) to give malonamide 45b 
(6.13 g, 93%) as colourless plates. 
C17H34N2O4 (330.46): 
m.p. 159-161 °C (ethyl acetate) [lit.,[139] 163.3-163.7 °C]. 
1H NMR (400.1 MHz, CDCl3): δ = 0.92 (s, 18 H, C(CH3)3), 1.50 (s, 6 H, CH3), 3.12 (br s, 2 
H, OH), 3.42-3.47 (m, 2 H, CH), 3.81-3.89 (m, 4 H, CH2), 6.45 (br d, 3J = 9.9 Hz, 2 H, NH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 23.8 (CH3, 7), 26.8 (CH3, 4), 33.4 (C, 3), 50.2 (C, 
6), 59.6 (CH, 2), 62.3 (CH2, 1), 174.7 (C, 5). 
IR (KBr): ν~ = 3333s, 2956s, 1644s, 1533s, 1472s, 1361m, 1272m, 1183m, 1044m, 889m, 
644m. 
MS (FAB, NBA (subtr)), m/z (%): 331 ([M+H]+, 100), 313 ([M-OH2]+, 22), 214 (12), 144 
(16), 100 (21), 83 (22). 
[α] 20D  = +2.00 (c = 1.00, MeOH) [lit.,[139] +2.5 (c = 0.75, MeOH)]. 
EA calcd (%) for C17H34N2O4: C, 61.79; H, 10.37; N, 8.48; O, 19.37. Found: C, 61.68; H, 
10.25; N, 8.49; O, 19.19.  
The spectroscopic data are in agreement with that previously reported in the literature.[139] 
 
t-Butyl-hypochlorite (46)[182]  
O Cl
 
A flask equipped with a gas inlet tube was charged with a solution of NaOH (16.0 g, 
0.40 mol) in water (100 mL) and placed into a water bath at 15-20 °C. After all contents were 
cooled to this temperature, t-butyl alcohol (14.8 g, 0.20 mol) in water (100 mL) was added. 
The reaction mixture was stirred rapidly while Cl2 was bubbled through at a constant rate for 
1 hour. The upper oily layer of the yellow reaction mixture was separated and washed with 
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10% (w/w) aqueous Na2CO3 (6 × 5 mL), followed by water (4 × 15 mL). After drying (CaCl2) 
and filtration t-butyl-hypochlorite 46 (14.80 g, 68%) was obtained as a yellow transparent 
liquid which was kept in the dark at -20 °C. 
C4H9ClO (108.57): 
1H NMR (400.1 MHz, CDCl3): δ = 1.17 (s, 9 H, CH3). 
IR (NaCl): ν~ = 2982s, 1462s, 1367s, 1248s, 1180s, 841s. 
Density ρ = 0.96. 
The spectroscopic data are in agreement with that previously reported in the literature.[182] 
 
(S)-(2-Hydroxy-1-naphthalen-2-yl-ethyl)-carbamic acid benzyl ester (48)[140]  
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Benzyl carbamate (469 mg, 3.10 mmol) was dissolved in n-propanol (4 mL) with gentle 
heating and ultrasound. 7 mL freshly prepared aqueous NaOH (7.5 mL, 122 mg, 3.05 mmol) 
were added and the mixture was sonicated until all solid had dissolved. Then freshly prepared 
t-butyl-hypochlorite 46 (331 mg, 3.05 mmol) was added, followed by a solution of 
hydroquinine 1,4-phthalazinediyl diether [(DHQ)2PHAL] ligand (40 mg, 0.05 mmol) in 
n-propanol (3.5 mmol). The reaction mixture was cooled to 0 °C and 2-vinylnaphthalene 47 
(154 mg, 1 mmol) in n-propanol (1 mL) was added. The reaction mixture was quickly 
warmed to room temperature to achieve complete solvation of 2-vinylnaphthalene. A solution 
of K2OsO2(OH)4 (14.7 mg, 0.04 mmol) in aqueous NaOH (0.5 mL) was added and the clear 
green reaction mixture was stirred at 0 °C for 3 hours. The grey slurry was filtered off, 
followed by a wash with cold n-propanol/water (1:1, 3 mL) giving a white solid. The crude 
product was purified by flash column chromatography (SiO2, 1 × 4 cm, ethyl acetate/hexanes 
1:1) to remove the undesired regioisomer, and recrystallisation (ethyl acetate) to give 
protected amino alcohol 48 (83 mg, 26%) as colourless prisms. 
C20H19NO3 (321.37): 
m.p. 138-139 °C (ethyl acetate) [lit.,[140] 133-134 °C]. 
Rf = 0.57 (ethyl acetate/hexanes 1:1). 
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1H NMR (500.1 MHz, CDCl3): δ = 0.83 (d, 3J = 9.0 Hz, 1 H, OH), 3.93 (s, 2 H, CH2OH), 
5.00-5.15 (m, 3 H, CH2O, CH), 5.68 (s, 1 H, NH), 7.36-7.50 (m, 8 H, Har), 7.79-7.84 (m, 4 H, 
Har). 
13C{1H} NMR (125.8 MHz, CDCl3): δ = 57.3 (CH, 11), 66.5 (CH2, 12), 67.2 (CH2, 14), 124.6 
(CarH), 125.6 (CarH), 126.3 (CarH), 125.5 (CarH), 127.8 (CarH), 128.0 (CarH), 128.4 (CarH), 
128.7 (CarH), 128.9 (CarH), 133.1 (Car), 133.4 (Car), 136.4 (Car), 136.6 (Car), 156.7 (C, 13). 
IR (KBr): ν~ = 3316s, 1683s, 1545s, 1454m, 1332m, 1261s, 1060s. 
MS (FAB, NBA (subtr)), m/z (%): 322 ([M+H]+, 30), 290 ([M-CH3O]+, 18), 243 (6), 171 
(13), 91 ([C7H7]+, 100). 
[α] 20D  = +54.0 (c = 0.32, EtOH, 99% ee) [lit.,[140] +50.9 (c = 0.32, EtOH)]. 
EA calcd (%) for C20H19NO3: C, 74.75; H, 5.96; N, 4.36. Found: C,74.73; H, 5.99; N, 4.41. 
HPLC: Chiralcel AD, i-propanol/heptane (30:70), 0.70 mL/min, 20 °C, 220 nm, tR = 9.5 min 
(major), tR = 11.5 min (minor). 
 
(S)-2-Amino-2-naphthalen-2-yl-ethanol (43d)[141]  
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Protected amino alcohol 48 (321 mg, 1 mmol) was dissolved in EtOH (13 mL) aided by 
ultrasound, then 10% Pd/C (109 mg) was added. The reaction mixture was stirred for 
3.5 hours under a hydrogen-atmosphere until the completion of the reaction (checked by 
TLC). The catalyst was removed by filtration over celite and the solvent was removed under 
reduced pressure to give amino alcohol 43d (181 mg, 97%) as an amorphous grey solid. 
C12H13NO (187.23): 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.87 (s, 3 H, OH, NH2), 3.56 (dd, 2J = 10.8 Hz, 3J = 8.1 
Hz, 1 H, CHH), 3.77 (dd, 2J = 10.6 Hz, 3J = 4.6 Hz, 1 H, CHH), 4.19 (dd, 3J = 8.1 Hz, 3J = 4.6 
Hz, 1 H, CH), 7.44-7.50 (m, 3 H, Har), 7.80-7.84 (m, 4 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 57.8 (CH, 2), 68.3 (CH2, 1), 125.3 (CarH), 125.3 
(CarH), 126.1 (CarH), 126.5 (CarH), 127.9 (CarH), 128.1 (CarH), 128.4 (CarH), 131.4 (Car), 
133.2 (Car), 133.8 (Car). 
IR (KBr): ν~ = 3194bs, 2897bs, 1573s, 1504m, 1462m, 1362s, 1281s, 1061s, 953s, 900s, 
823s, 747bs. 
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[α] 20D  = +32.0° (c = 0.20, EtOH) [lit.,[141] +33.9 (c = 1.39, CHCl3)]. 
MS (FAB, NBA (subtr)), m/z (%): 341 (13), 216 (41), 188 ([M+H]+, 100), 171 ([M-NH2]+, 
87), 156 ([M-CH2OH]+, 88), 77 (18). 
The spectroscopic data are in agreement with that previously reported in the literature.[141] 
 
(S)-N,N’-Bis[2-hydroxy-1-naphthalen-2-yl-ethyl]-2,2-dimethyl-malonamide (45d) 
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Triethylamine (0.40 mL, 2.79 mmol) was added dropwise to amino alcohol 43d (209 mg, 
1.11 mmol) in dichloromethane (1.5 mL) at 0 °C Then a solution of 2,2-dimethylmalonyl 
dichloride 44 (94.0 mg, 0.558 mmol) in dichloromethane (0.5 mL) was added during 
3 minutes. A white precipitate formed and the suspension was stirred for 20 minutes at 0 °C, 
followed by 70 min at room temperature. Dichloromethane (3 mL) was added to dissolve the 
white solid, the reaction mixture was washed with 1 N HCl (1 mL) and the aqueous layer was 
extracted with dichloromethane (1 mL). The combined organic extracts were dried (Na2SO4) 
and concentrated under reduced pressure to give malonamide 45d (281 mg, >99%) as a 
colourless amorphous solid. 
C29H30N2O4 (470.56): 
m.p. 64-65 °C (dichloromethane) [lit.,[141] 169-170 °C]. 
Rf = 0.67 (ethyl acetate/MeOH 19 : 1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.55 (s, 6 H, CH3), 3.90 (dd, 2J = 11.4 Hz, 3J = 6.6 Hz, 2 
H, CHH), 3.99 (dd, 2J = 11.4 Hz, 3J = 4.0 Hz, 2 H, CHH), 5.25 (dt, 3J = 7.0 Hz, 3J = 4.0 Hz, 2 
H, CH), 2.29-7.81 (m, 14 H, Har). 
13C{1H} NMR (100.6 MHz, MeOH-D4): δ = 24.6 (CH3, 5), 51.9 (C, 4), 57.6 (CH, 2), 66.2 
(CH2, 1), 126.2 (CarH), 126.9 (CarH), 127.1 (CarH), 127.4 (CarH), 128.9 (CarH), 129.2 (CarH), 
129.5 (CarH), 134.5 (Car, 7), 135.1 (Car, 12), 138.6 (Car, 6), 176.2 (C, 3). 
IR (KBr): ν~ = 2976s, 1786s, 1690s, 1515s, 1466s, 1391s, 1334s, 1277s, 1225s, 1039s, 802m, 
761m, 702s, 528s. 
[α] 20D  = +79 (c = 0.18, EtOH) [lit.,[141] +85 (c = 0.20, EtOH)].  
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The spectroscopic data are in agreement with that previously reported in the literature.[141] 
 
(R)-t-Leucinol ((R)-43b)[139] 
H2N 3 4
OH
2
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(R)-t-Leucine 49 (500 mg, 3.81 mmol) was added in one portion to a stirred solution of 
NaBH4 (346 mg, 9.16 mmol) in THF (10 mL). After cooling to 0 °C a solution of I2 (967 mg, 
3.81 mmol) in THF (8 mL) was added dropwise during 30 minutes. After warming the 
reaction mixture to room temperature, the reaction was heated at reflux for 19 hours. After 
cooling to room temperature the reaction mixture turned into a white suspension. MeOH 
(3 mL) was added carefully until all solid had dissolved. Vigorous gas evolution was 
observed during the addition. After removal of the solvent under reduced pressure, the white 
paste was stirred for 5 hours at room temperature with 20% (w/w) aqueous KOH (10 mL). 
The slightly green solution was extracted with dichloromethane (3 × 10 mL, 1 × 5 mL). Brine 
was added after the first extraction to reduce the emulsion in the aqueous layer. The combined 
organic extracts were dried (Na2SO4) and concentrated under reduced pressure to give a 
yellow transparent oil, which solidified upon cooling to 4 °C. The product (R)-43b was used 
without purification in the next step. 
C6H15NO (117.19): 
1H NMR (400.1 MHz, CDCl3): δ = 0.90 (s, 9 H, CH3), 2.49 (dd, 3J = 10.1 Hz, 2J = 3.8 Hz, 1 
H, CH2), 3.19 (t, 3J = 10.1 Hz, 1 H, CH), 3.70 (dd, 3J = 10.1 Hz, 2J = 3.8 Hz, 1 H, CH2). 
The spectroscopic data are in agreement with that previously reported in the literature.[139] 
 
(R)-N,N’-Bis[1-(hydroxymethyl)-2,2-dimethylpropyl]-2,2-dimethyl-1,3-propanediamide 
((R)-45b)  
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By general method I (R)-t-leucinol (100 mg, 0.85 mmol), triethylamine (0.30 mL, 
0.43 mmol) and 2,2-dimethylmalonyl dichloride 44 (72.0 mg, 0.427 mmol) in 
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dichloromethane (16 mL) gave the crude product. It was purified by recrystallisation 
(ethyl acetate) to give diamide (R)-45b (116 mg, 82%) as colourless plates.  
C17H34N2O4 (330.46): 
m.p. 158-159 °C (ethyl acetate). 
1H NMR (400.1 MHz, CDCl3): δ = 0.93 (s, 18 H, CH3), 1.52 (s, 6 H, CH3), 2.45 (br s, 2 H, 
OH), 3.45-3.48 (m, 2 H, CH), 3.84-3.90 (m, 4 H, CH2), 6.40 (br d, 3J = 9.1 Hz, 2 H, NH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 23.7 (CH3, 7), 26.8 (CH3, 4), 33.4 (C, 3), 50.2 (C, 
6), 59.6 (CH2, 1), 62.6 (CH, 2), 174.7 (C, 5). 
IR (KBr): ν~ = 3335s, 2966s, 2361s, 1648s, 1541s, 1473s, 1395m, 1368m, 1268m, 1184m, 
1051m. 
MS (FAB, NBA (subtr)), m/z (%): 331 ([M+H]+, 100), 313 ([M-OH2]+, 28), 214 (15), 187 (9), 
144 (21), 100 (23), 83 (27), 57 (36), 41 (33).  
[α] 20D  = _2.6 (c = 0.47, MeOH). 
EA calcd (%) for C17H34N2O4: C, 61.79; H, 10.37; N, 8.48; O, 19.37. Found: C, 61.67; H, 
10.18; N, 8.48; O, 19.43.  
The spectroscopic data are in agreement with that of the enantiomer previously reported in the 
literature.[139] 
 
2,2-Bis{2-[4(S)-i-propyll-1,3-oxazolinyl]}propane (32a) 
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General Method II: According to a procedure by EVANS,[139] triethylamine (4.01 mL, 
29.1 mmol) was added to a solution of malonamide 44 (2.00 g, 6.61 mmol) and 
4-(dimethylamino)pyridine (81.0 mg, 0.61 mmol) in dichloromethane (26 mL). The flask was 
placed in a room temperature water bath and a solution of p-toluenesulfonyl chloride (2.53 g, 
13.22 mmol) in dichloromethane (6 mL) was added during 10 minutes, followed by a rinse 
with dichloromethane (2 mL). After stirring for 27 hours at room temperature, the solution 
was diluted with dichloromethane (20 mL) and washed with saturated aqueous NH4Cl 
(30 mL). To dissolve the solid formed in the aqueous layer water (15 mL) was added. The 
aqueous layer was extracted with dichloromethane (3 × 25 mL). The combined organic 
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extracts were washed with saturated aqueous NaHCO3 (25 mL) and the aqueous layer was 
extracted with dichloromethane (3 × 25 mL). The combined organic extracts were dried 
(Na2SO4) and concentrated under reduced pressure. The resulting white-yellow solid was 
triturated with hot pentane (1 × 20 mL, 1 × 6 mL, 1 × 4 mL), followed by gravity filtration 
through a hot frit. After removal of the solvent, the colourless solid was recrystallised 
(pentane) to give ligand 32a (1.64, 93%) as a colourless transparent oil. 
C15H26N2O2 (266.38): 
1H NMR (400.1 MHz, CD2Cl2): δ = 0.83 (d, 3J = 6.8 Hz, 6 H, CHCH3), 0.90 (d, 3J = 6.8 Hz, 
6 H, CHCH3), 1.44 (s, 6 H, CH3), 1.66-1.77 (m, 2 H, CHCH3), 3.85-3.97 (m, 4 H, CH2), 4.16-
4.21 (m, 2 H, NCH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 17.6 (CH3, 1/2), 18.3 (CH3, 1/2), 24.3 (CH3, 8), 32.5 
(CH, 3), 38.6 (C, 7), 70.2 (CH2, 5), 71.8 (CH, 4), 168.5 (C, 6). 
IR (NaCl): ν~ = 2960s, 1662s, 1467s, 1353m, 1248m, 1144s, 1112s, 980s, 925m. 
MS (FAB, NBA (subtr)), m/z (%): 267 ([M+H]+, 100), 181 (15), 155 (13), 69 (21), 41 (22). 
[α] 20D  = _125.6 (c = 1.09, CH2Cl2). 
EA calcd (%) for C15H26N2O2: C, 67.63; H, 9.84; N, 10.52; O, 12.01. Found: C, 66.87; H, 
9.72; N, 10.43; O, 13.01.  
The spectroscopic data are in agreement with that previously reported in the literature.[183]  
 
2,2-Bis{2-[4(S)-t-butyl-1,3-oxazolinyl]}propane (32b)[139] 
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By general method II malonamide 45b (3.00 g, 9.08 mmol), 4-(dimethylamino)pyridine 
(111 mg, 0.91 mmol), triethylamine (5.57 mL, 40.0 mmol) in dichloromethane (36 mL) and a 
solution of p-toluenesulfonyl chloride (3.47 g, 18.2 mmol) in dichloromethane (8 mL) gave 
ligand 32b (1.96 g, 73%) as colourless plates.  
C17H30N2O2 (294.43): 
m.p. 86-87 °C (pentane) [lit.,[139] 88.9-89.8 °C]. 
1H NMR (400.1 MHz, CDCl3): δ = 0.86 (s, 18 H, CH3), 1.50 (s, 6 H, CH3), 3.84 (dd, 3J = 
10.0 Hz, 3J = 7.0 Hz, 2 H, CH), 4.05-4.16 (m, 4 H, CH2). 
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13C{1H} NMR (100.6 MHz, CDCl3): δ = 24.4 (CH3, 7), 25.6 (CH3, 1), 33.9 (C, 2), 38.6 (C, 
6), 69.0 (CH2, 4), 75.3 (CH, 5), 168.6 (C, 5). 
IR (KBr): ν~ = 2956s, 2870m, 1660s, 1478s, 1360s, 1259s, 1146s, 1123s, 978s, 925s. 
MS (FAB, NBA (subtr)), m/z (%): 295 ([M+H]+, 100), 237 (11), 195 (11), 169 (13), 57 (31), 
41 (22). 
[α] 20D  = _128.20 (c = 0.61, MeOH) [lit.,[139] +113.2 (c = 1.22, dichloromethane)]. 
EA calcd (%) for C17H30N2O2: C, 69.35; H, 10.27; N, 9.51; O, 10.87. Found: C, 69.32; H, 
10.13; N, 9.43; O, 10.97. 
The spectroscopic data are in agreement with that previously reported in the literature.[139] 
 
2,2-Bis{2-[4(S)-(2’-naphthyl)-1,3-oxazolinyl]}propane (32d) 
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By general method II malonamide 45d (280 mg, 0.595 mmol), 4-(dimethylamino)pyridine 
(5.40 mg, 59.6 µmol) and triethylamine (0.34 mL, 2.62 mmol) in dichloromethane (3 mL) and 
a solution of  p-toluenesulfonyl chloride (239 mg, 1.19 mmol) in dichloromethane (1 mL) 
gave the crude product. It was purified by flash column chromatography (SiO2, 1 × 10 cm, 
ethyl acetate/hexanes 1:3 → 2:3) and treated with Et2O (to dissolve a yellow impurity) to give 
ligand 32d (151 mg, 58%) as a colourless amorphous solid. 
C29H26N2O2 (434.53): 
m.p. 170-172 °C (Et2O) [lit.,[141] 173-174 °C].  
Rf = 0.30 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.70 (s, 6 H, CH3), 4.24 (dd, 3J = 8.4 Hz, 3J = 7.6 Hz, 2 
H, CH), 4.75 (dd, 2J = 10.1 Hz, 3J = 8.6 Hz, 2 H, CHH), 5.39 (dd, 2J = 10.1 Hz, 3J = 7.6 Hz, 2 
H, CHH), 7.38-7.48 (m, 6 H, Har), 7.73-7.83 (m, 8 H, Har). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 24.3 (CH3, 1), 39.1 (C, 2), 69.8 (CH, 5), 75.3 (CH2, 
4), 124.8 (CarH), 125.5 (CarH), 125.9 (CarH), 126.2 (CarH), 127.6 (CarH), 127.9 (CarH), 128.6 
(CarH), 132.9 (Car), 133.4 (Car), 140.2 (Car), 170.4 (C, 3). 
IR (KBr): ν~ = 3352 bs, 2933s, 1714m, 1425s, 1347s, 1056s. 
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MS (EI, 70 eV, ca. 250 °C), m/z (%): 434 ([M]+, 53), 307 (8), 265 (20), 239 (100), 154 (100), 
69 (13), 41 (7). 
[α] 20D  = _240.0 (c = 0.22, CH2Cl2, >99% ee) [lit.,[141] _232.5 (c = 0.55, CHCl3)].   
EA calcd (%) for C29H26N2O2: C, 80.16; H, 6.03; N, 6.45. Found: C, 78.35; H, 6.01; N, 6.35. 
HPLC: Chiralcel AD, i-propanol/heptane (20:80), 1.00 mL/min, 20 °C, 220 nm, tR = 7.7 min 
(major). 
The spectroscopic data are in agreement with that previously reported in the literature.[141] 
 
2,2-Bis{2-[4(R)-t-butyl-1,3-oxazolinyl]}propane ((R)-32b)  
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By general method II diamide (R)-45b (260 mg, 0.787 mmol), 4-(dimethylamino)pyridine 
(9.60 mg, 79.0 µmol), triethylamine (0.47 mL, 3.46 mmol) in dichloromethane (3 mL) and a 
solution of p-toluenesulfonyl chloride (299 mg, 1.57 mmol) in dichloromethane (1 mL) gave 
(R,R)-t-Bu-box ligand (R)-32b (212 mg, 91%) as colourless plates.  
C17H30N2O2 (294.43): 
m.p. 79-81 °C (dichloromethane). 
1H NMR (400.1 MHz, CDCl3): δ = 0.87 (s, 18 H, CH3), 1.52 (s, 6 H, CH3), 3.83 (dd, 3J = 
10.1 Hz, 3J = 6.8 Hz, 2 H, CH), 4.06-4.17 (m, 4 H, CH2O). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 24.4 (CH3, 7), 25.6 (CH3, 1), 33.9 (C, 2), 69.0 (CH2, 
4), 75.3 (CH, 5), 168.6 (C, 5). 
IR (KBr): ν~ = 3418s, 2958s, 1661s, 1480s, 1359m, 1299m, 1252s, 1211m, 1145s, 980s, 923s. 
MS (FAB, NBA (subtr)), m/z (%): 313 ([M+H2O]+, 18), 295 ([M]+, 100), 237 (12), 195 (14), 
169 (17), 112 (16), 83 (14), 57 (37). 
[α] 20D  = +100.0 (c = 0.25, dichloromethane). 
EA calcd (%) for C17H30N2O2: C, 69.35; H, 10.27; N, 9.51; O, 10.87. Found: C, 69.08; H, 
9.94; N, 9.31; O, 11.34. 
The spectroscopic data are in agreement with that of the enantiomer previously reported in the 
literature.[139] 
 
Chapter 5 
 
126
2,2-Bis[2-(4-dimethyl-1,3-oxazolinyl)]propane (50)[142] 
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2-Amino-2-methyl-1-propanol (3.00 mL, 31.9 mmol) was added dropwise to a solution of 
dimethylmalononitrile (1.00 g, 10.6 mmol) and dry ZnCl2 (1.45 g, 10.6 mmol) in 
chlorobenzene (6 mL) which was heated at reflux. After 30 hours at this temperature and 
cooling to room temperature, the mixture was washed twice with 25% (w/w) aqueous NH4OH 
and the aqueous layer was extracted twice with dichloromethane. The combined organic 
extracts were washed with water, the aqueous layer was extracted with dichloromethane. The 
combined organic extracts were dried (Na2SO4) and concentrated under reduced pressure to 
give a brown oil. A Kugelrohr distillation (10-1 Torr, 100 °C → 140 °C) of the crude product 
gave ligand 50 (1.62 g, 64%) as a colourless transparent oil which solidified at -20 °C. 
C13H22N2O2 (238.33): 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.21 (s, 12 H, CH3), 1.41 (s, 6 H, CH3), 3.89 (s, 4 H, 
CH2). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 24.1 (CH3, 6), 27.9 (CH3, 1), 38.3 (C, 5), 67.0 (C, 
2), 79.3 (CH2, 3), 167.3 (C, 4). 
IR (NaCl): ν~ = 3436 b s, 2070s, 1659s, 1463s, 1362s, 1294s, 1250m, 1192s, 1129s, 1103s, 
979s, 930s. 
MS (FAB, NBA (subtr)), m/z (%): 239 ([M+H]+, 100), 167 (34), 55 (21). 
EA calcd (%) for C13H22N2O2: C, 65.51; H, 9.30; N, 11.75. Found: C, 64.90; H, 9.14; N, 
11.54.  
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5.3.2 Bis(imine) Ligand Synthesis 
(S,S)-(1,2)-N,N’-Dibenzylidene-cyclohexane-1,2-diamine (34a) 
2
3
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General Method III: Benzaldehyde (0.44 mL, 4.38 mmol) was added to a solution of 
(1S,2S)-(+)-1,2-diaminocyclohexane (250 mg, 2.19 mmol) in refluxing MeOH (2 mL). After 
heating at reflux for 30 minutes, the reaction mixture was cooled to room temperature and 
solvent was removed under reduced pressure until a precipitate formed. The solid was filtered 
off and washed with cold hexanes to give bis(imine) ligand 34a (263 mg, 41%) as colourless 
rhomboids. 
C20H22N2 (290.40): 
m.p. 102-103 °C (hexanes). 
1H NMR (400.1 MHz, CDCl3): δ = 1.49 (dd, 2J = 9.3 Hz, 3J = 8.1 Hz, 2 H, CH2), 1.85-1.88 
(m, 6 H, CH2), 3.41-3.43 (m, 2 H, CH), 7.30-7.32 (m, 6 H, Har), 7.57-7.59 (m, 4 H), 8.34 (s, 2 
H, N=CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 24.5 (CH2, 1), 33.0 (CH2, 2), 73.8 (CH, 3), 127.9 
(CarH, 7), 128.4 (CarH, 6), 129.0 (C, 5), 130.2 (CarH, 8), 161.0 (CH, 4). 
IR (KBr): ν~ = 2926s, 2852s, 1642s, 1575m, 1449s, 1374s, 1290m, 1214m, 1161m, 1063m, 
939m, 756s, 693s. 
MS (FAB, NBA (subtr)), m/z (%): 291 ([M+H]+, 100), 203 (10), 187 (22), 106 (34), 91 (23). 
[α] 20D  = +276.4 (c = 1.00, dichloromethane). 
EA calcd (%) for C20H22N2: C, 82.72; H, 7.64; N, 9.65. Found: C, 82.85; H, 7.77; N, 9.59. 
The spectroscopic data are in agreement with that previously reported in the literature.[184] 
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(S,S)-N,N’-Bis-(2-fluoro-benzylidene)-cyclohexane-1,2-diamine (34b) 
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By general method III (1S,2S)-(+)-1,2-diaminocyclohexane (250 mg, 2.19 mmol) and 
1-fluoro-benzaldehyde (0.46 mL, 4.38 mmol) in MeOH (1.2 mL) gave bis(imine) ligand 34b 
(133 mg, 19%) as colourless rhomboids after stored overnight at -20 °C without prior removal 
of solvent. 
C20H20F2N2 (326.38): 
m.p. 86-87° C (MeOH). 
1H NMR (400.1 MHz, CDCl3): δ = 1.48-1.53 (m, 2 H, CH2), 1.75-1.87 (m, 6 H, CH2), 3.38-
3.43 (m, 2 H, CH), 6.97-7.02 (m, 2 H, Har), 7.10 (dt, 3J = 7.3 Hz, 4J = 0.7 Hz, 2 H, Har), 7.29-
7.35 (m, 2 H, Har), 7.84 (dt, 3J = 7.6 Hz, 4J = 1.8 Hz, 2 H, Har), 8.48 (s, 2 H, N=CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 25.0 (CH2, 1), 33.5 (CH2, 2), 74.7 (CH, 3), 116.0 
(JC-F = 21.1 Hz, CarH, 9), 124.6 (JC-F = 9.0 Hz, C, 5), 124.7 (JC-F = 3.5 Hz, CarH, 7), 128.1 (JC-F 
= 3.1 Hz, CarH, 6), 132.3 (JC-F = 8.4 Hz, CarH, 8), 154.2 (JC-F = 4.6 Hz, CH, 4), 162.6 (JC-F = 
251 Hz, C, 10). 
IR (KBr): ν~ = 2928s, 2853s, 1639s, 1577s, 1483s, 1453s, 1374s, 1274s, 1226s, 1181m, 
1072s, 803m, 763s. 
MS (FAB, NBA (subtr)), m/z (%): 327 ([M+H]+, 100), 221 (8), 205 (21), 124 (30), 109 (16). 
[α] 20D  = +238.8 (c = 1.00, dichloromethane). 
EA calcd (%) for C20H20F2N2: C, 73.60; H, 6.18; N, 8.58. Found: C, 73.54; H, 6.16; N, 8.46. 
The spectroscopic data are in agreement with that previously reported in the literature.[184] 
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(S,S)-N,N’-Bis-(4-cyano-benzylidene)-cyclohexane-1,2-diamine (34c) 
3
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By general method III (1S,2S)-(+)-1,2-diaminocyclohexane (250 mg, 2.19 mmol) and 
4-cyano-benzaldehyde (574 mg, 4.38 mmol) in MeOH (1.2 mL) gave a yellow solid after 
stored overnight at -20 °C without prior removal of solvent. The crude product was purified 
by recrystallisation (ethyl acetate/hexanes) to give bis(imine) ligand 34c (272 mg, 37%) as 
colourless rhomboids. 
C22H20N4 (340.42): 
m.p. 145-146 °C (ethyl acetate/hexanes). 
1H NMR (400.1 MHz, CDCl3): δ = 1.48-1.53 (m, 2 H, CH2), 1.83-1.90 (m, 6 H, CH2), 3.48 
(s, 2 H, CH), 7.61 (d, 3J = 8.4 Hz, 4 H, Har(7)), 7.70 (d, 3J = 8.1 Hz, 4 H, Har(6)), 8.20 (s, 2 H, 
N=CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 24.2 (CH2, 1), 32.6 (CH2, 2), 73.9 (CH, 3), 113.7 (C, 
8), 118.4 (C, 9), 128.2 (CarH, 7), 132.3 (CarH, 6), 139.9 (C, 5), 159.0 (CH, 4). 
IR (KBr): ν~ = 2924s, 2847s, 2223s, 1642s, 1375s, 1079s, 940s, 832s, 555s. 
MS (FAB, NBA (subtr)), m/z (%): 494 (9), 341 ([M+H]+, 100), 228 (13), 211 (15), 131 (20). 
[α] 20D  = +439.9 (c = 1.00, dichloromethane). 
EA calcd (%) for C22H20N4: C, 77.62; H, 5.92; N, 16.46. Found: C, 77.52; H, 5.92; N, 16.60. 
 
(S,S)-N,N’-Bis(2,6-dichloro-benzylidene)-cyclohexane-1,2-diamine (34d) 
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By general method III (1S,2S)-(+)-1,2-diaminocyclohexane (250 mg, 2.19 mmol) and 
2,6-dichloro-benzaldehyde (767 mg, 4.38 mmol) in MeOH (1.2 mL) gave the crude product. 
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The crude product was purified by washing with cold ethyl acetate/hexanes (1:9) and 
recrystallisation (ethyl acetate/hexanes 4:3) to give bis(imine) ligand 34d (940 mg, 100 %) as 
colourless rhomboids. 
C20H18Cl4N2 (428.18): 
m.p. 153-155° C (ethyl acetate/hexanes). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.51-1.54 (m, 2 H, CH2), 1.85-1.88 (m, 6 H, CH2), 3.53-
3.55 (m, 2 H, CH), 7.19 (dd, 3J = 8.8 Hz, 3J = 7.1 Hz, 2 H, Har), 7.29 (d, 3J = 8.3 Hz, 4 H, 
Har), 8.43 (s, 2 H, N=CH). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 24.8 (CH2, 1), 33.4 (CH2, 2), 75.6 (CH, 3), 129.2 
(CarH, 7), 130.5 (CarH, 8), 133.4 (C, 6), 135.3 (C, 5), 156.5 (CH, 4). 
IR (KBr): ν~ = 2928s, 2855s, 2360s, 1645s, 1580s, 1555s, 1429s, 1375s, 1191m, 1090m, 
927m, 842m, 774s. 
MS (FAB, NBA (subtr)), m/z (%): 429 ([M+H]+, 100), 271 (17), 255 (27), 174 (65), 81 (61). 
[α] 20D  = _15.4 (c = 1.00, dichloromethane). 
EA calcd (%) for C20H18Cl4N2: C, 56.10; H, 4.24; N, 6.54. Found: C, 56.06; H, 4.22; N, 6.48.  
The spectroscopic data are in agreement with that previously reported in the literature.[184] 
 
(S,S)-N,N’-Bis-naphthalen-1-ylmethyl ene-cyclohexane-1,2-diamine (34e) 
3
N N4
514
9
8 7
6
1
2
1312
11
10
 
1-Naphtaldehyde (0.59 mL, 4.38 mmol) was added in small portions to a solution of 
(1S,2S)-(+)-1,2-diaminocyclohexane (250 mg, 2.19 mmol) in refluxing EtOH (10 mL). After 
heating at reflux for 1 hour, the reaction mixture was cooled down to room temperature and 
water was added. A white-yellow solid precipitated, which was filtered off and recrystallised 
(ethyl acetate/hexanes) to give bis(imine) ligand 34e (166 mg, 16%) as colourless rhomboids. 
C28H26N2 (390.52): 
m.p. 130-131 °C (ethyl acetate/hexanes). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.57-1.63 (m, 2 H, CH2), 1.92-2.00 (m, 6 H, CH2), 3.57-
3.59 (m, 2 H, CH), 7.30-7.44 (m, 6 H, Har), 7.69 (dd, 3J = 7.3 Hz, J = 1.0 Hz, 2 H, Har), 7.79 
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(dd, 3J = 8.3 Hz, J = 1.0 Hz, 4 H, Har), 8.79 (dd, 3J = 8.6 Hz, J = 1.0 Hz, 2 H, Har), 8.82 (s, 2 
H, N=CH). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 25.1 (CH2, 1), 33.7 (CH2, 2), 75.7 (CH, 3), 125.2 
(CarH), 125.6 (CarH), 126.4 (CarH), 127.2 (CarH), 128.8 (CarH), 129.0 (CarH), 130.9 (CarH), 
131.7 (C), 132.7 (C), 134.2 (C), 160.9 CH, 4). 
IR (KBr): ν~ = 3039s, 2922s, 2833s, 1634s, 1444m, 1377s, 1333s, 1233s, 1085s, 1010s, 935s, 
776s. 
MS (FAB, NBA (subtr)), m/z (%): 391 ([M+H]+, 100),  237 (27), 141 (29), 81 (12). 
[α] 20D  = +226.0 (c = 1.00, dichloromethane). 
EA calcd (%) for C28H26N2: C, 86.12; H, 6.71; N, 7.17. Found: C, 86.12; H, 6.75; N, 6.97.  
The spectroscopic data are in agreement with that previously reported in the literature.[184] 
 
(R,R)-N,N’-Dibenzylidene-1,2-diphenylethane-1,2-diamine (34f) 
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Benzaldehyde (0.19 mL, 1.88 mmol) was added to a solution of 
(1R,2R)-(+)-1,2-diphenylethaneamine (200 mg, 0.94 mmol) in refluxing EtOH (4.7 mL). 
After heating at reflux for 1 hour, the reaction mixture was cooled down to room temperature. 
At this temperature a precipitate formed which was filtered and wash with cold 
ethyl acetate/hexanes 1:1 to give bis(imine) ligand 34f (326 mg, 81%) as colourless prisms. 
C28H24N2 (388.50): 
m.p. 160-161 °C (ethyl acetate/hexanes) [lit.,[185] 158-159 °C (racemic compound)] 
1H NMR (400.1 MHz, CD2Cl2): δ = 4.76 (s, 2 H, NCH), 7.12-7.20 (m, 6 H, Har), 7.28-7.36 
(m, 10 H, Har), 7.66-7.68 (m, 4 H, Har), 8.28 (s, 2 H, N=CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 81.7 (CH, 8), 127.5 (CarH), 128.4 (CarH), 128.6 
(CarH), 128.9 (CarH), 129.0 (CarH), 131.0 (CarH), 136.9 (C, 6), 141.8 (C, 14), 162.1 (C, 7). 
IR (KBr): ν~ = 3448 bs, 3026s, 2846s, 2362s, 1644s, 1489m, 1451s, 1377m, 1312m, 1216m, 
1050s, 755s, 696s. 
MS (FAB, NBA (subtr)), m/z (%): 389 ([M+H]+, 26), 301 (13), 284 (14), 194 (100), 91 (30). 
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[α] 20D  = _0.30 (c = 1.10, dichloromethane) 
EA calcd (%) for C28H24N2: C, 86.56; H, 6.23; N, 7.21. Found: C, 86.26; H, 6.22; N. 7.15.  
The spectroscopic data are in agreement with that previously reported for the racemic 
compound.[185] 
 
(R,R)-N,N’-Bis(2-fluoro-benzylidene)1,2-diphenyl-ethane-1,2-diamine (34g) 
5
N
4
N
3
2
1
6
7
10
9
8
F F
11
12
 
To a solution of (1R,2R)-(+)-1,2-diphenylethaneamine (200 mg, 0.94 mmol) in refluxing 
EtOH (4.7 mL) was added 2-fluoro-benzaldehyde (0.20 mL, 1.88 mmol). After heating at 
reflux for 1 hour, the reaction mixture was cooled down to room temperature. At this 
temperature a precipitate formed which was filtered off and washed with cold 
ethyl acetate/hexanes 1:1 to give bis(imine) ligand 34g (255 mg, 64%) as colourless prisms. 
C28H22F2N2 (424.48): 
m.p. 124-125 °C (ethyl acetate/hexanes). 
1H NMR (400.1 MHz, CDCl3): δ = 4.82 (m, 1 H, NCH), 5.25 (m, 1 H, NCH), 6.80-6.88 (m, 2 
H, Har), 6.97-7.02 (m, 1 H, Har), 7.07-7.19 (m, 6 H, Har), 7.21-7.37 (m, 5 H, Har), 7.65-7.77 
(m, 3 H, Har), 7.95-8.04 (m, 1 H, Har), 8.30-8.31 (m, 1 H, N=CH), 8.59-8.61 (m, 1 H, N=CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 72.1 (JC-F = 10.4 Hz, CH, 5) 115.4 (JC-F = 22.0 Hz, 
CarH), 116.2 (JC-F = 22.0 Hz, CarH), 124.5 (CarH), 124.8 (CarH), 128.4 (JC-F = 3.1 Hz, Car), 
128.7 (JC-F = 2.7 Hz, Car), 129.2 (CarH), 130.8 (CarH), 131.2 (JC-F = 3.8 Hz, CarH),  131.3 (Car), 
163.4 (CH, 6). 
IR (KBr): ν~ = 3424bs, 3028s, 2848s, 1643s, 1581s, 1487s, 1381s, 1228s, 1049m, 757s, 695s. 
MS (FAB, NBA (subtr)), m/z (%): 461 (8), 443 (23), 425 ([M+1]+, 19), 320 (14), 230 (61), 
212 (100). 
[α] 20D  = +1.7 (c = 0.94, dichloromethane). 
EA calcd (%) for C28H22F2N2: C, 79.23; H, 5.22; N, 6.60. Found: C, 77.24; H, 5.09; N, 6.47. 
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5.3.3 Synthesis of Dienophiles 
(E)-Ethyl 3-(4-ethylphenyl)-acrylate (51)  
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General Method IV: According to a procedure by SCHULTZ,[143] Pd(PPh3)4 (32.2 mg, 
28.0 µmol) in N,N-dimethylacetamide (10 mL) was added to a solution of 
1-ethyl-4-iodobenzene (6.00 g, 26.0 mmol), ethyl acrylate (3.15 mL, 29.0 mmol) and sodium 
acetate (2.87 g, 35.0 mmol) in N,N-dimethylacetamide (80 mL) at 140 °C. After 24 hours at 
this temperature, the reaction mixture was cooled to room temperature and diluted with 
hexanes (250 ml). The solution was washed with water (3 × 150 mL), dried (Na2SO4) and the 
solvent removed under reduced pressure. The crude product was purified by flash column 
chromatography (SiO2, 8 × 20 cm, ethyl acetate/hexanes 1:10) to give acrylate 51 (3.24 g, 
61%) as a colourless oil. 
C13H16O2 (204.26): 
Rf = 0.45 (ethyl acetate/pentane 1:10). 
1H NMR (400.1 MHz, CDCl3): δ = 1.24 (t, 3J = 7.6 Hz, 3 H, CH3), 1.32 (t, 3J = 7.1 Hz, 3 H, 
CH3), 2.66 (q, 3J = 7.6 Hz, 2 H, CH2CH3), 4.26 (q, 3J = 7.1 Hz, 2 H, OCH2CH3), 6.39 (d, 
3Jtrans = 16.2 Hz, 1 H, CHC=O), 7.21 (d, 3J = 8.1 Hz, 2 H, Har), 7.45 (d, 3J = 8.1 Hz, 2 H, Har), 
7.67 (d, 3Jtrans = 15.9 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 14.3 (CH3, 1), 15.3 (CH3, 11), 28.8 (CH2, 2), 60.4 
(CH2, 10), 117.2 (CH, 8), 128.1 (CarH, 4), 128.4 (CarH, 5), 131.9 (C, 6), 144.6 (CH, 7), 146.9 
(C, 3), 167.2 (C, 9). 
MS (EI, 70 eV, r.t.), m/z (%): 204 ([M]+, 75), 189 ([M_CH3]+, 11), 176 ([M]+, 22), 159 
([M_C2H5O]+, 100), 131 ([M_C3H3O2]+, 45), 115 (31), 91 ([C7H7]+, 16). 
IR (NaCl): ν~ = 2967s, 1724s, 1633s, 1568m, 1513s, 1456m, 1418m, 1366s, 1318s, 1262s, 
1037s, 984s, 828s. 
EA calcd (%) for C13H16O2: C, 76.44; H, 7.89; O, 15.66. Found: C, 76.16; H, 7.90; O, 15.89. 
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(E)-n-Butyl 3-(4-n-propylphenyl)-acrylate (52) 
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Using general method IV Pd(PPh3)4 (26.0 mg, 23.0 µmol) in N,N-dimethylacetamide 
(10 mL) added to 4-bromo-1-n-propylbenzene (3.52 mL, 22.6 mmol), n-butyl acrylate 
(3.87 mL, 27.1 mmol) and sodium acetate (2.60 g, 31.6 mmol) in N,N-dimethylacetamide 
(65 mL) gave a brown oil. The crude product was purified by flash column chromatography 
(SiO2, 5 × 18 cm, ethyl acetate/hexanes 1:10) to give acrylate 52 (2.74 g, 49%) as a yellow 
transparent oil.  
C16H22O2 (246.34): 
Rf = 0.55 (ethyl acetate/hexanes 1:3). 
1H NMR (400.1 MHz, CDCl3): δ = 0.95 (t, 3J = 7.8 Hz, 3 H, CH3), 0.97 (t, 3J = 7.8 Hz, 3 H, 
CH3), 1.39-1.49 (m, 2 H, CH2CH3), 1.60-1.73 (m, 4 H, CH2CH2CH2, CH2CH3), 2.60 (t, 3J = 
7.6 Hz, 2 H, CH2(3)CH2CH3), 4.20 (t, 3J = 6.6 Hz, 2 H, OCH2), 6.40 (d, 3Jtrans = 15.9 Hz, 1 
H, CHC=O), 7.19 (d, 3J = 7.6 Hz, 2 H, Har), 7.44 (d, 3J = 7.6 Hz, 2 H, Har), 7.66 (d, 3Jtrans = 
15.9 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.7 (CH3), 13.8 (CH3), 19.2 (CH2, 13), 24.3 (CH2, 
2), 30.8 (CH2, 12), 37.9 (CH2, 3), 64.3 (CH2, 11), 117.2 (CH, 9), 128.0 (CarH), 129.0 (CarH), 
132.0 (C, 7), 144.6 (CH, 8), 145.4 (C, 4), 167.3 (C, 10). 
MS (EI, 70 eV, r.t.), m/z (%): 246 ([M]+, 35), 217 ([M_C2H5]+, 15), 190 ([M_C4H8]+, 100), 
173 (57), 161 (67), 131 ([M_C9H7O]+, 22), 115 (33), 91 (5), 43 (9). 
IR (NaCl): ν~ = 2960s, 2871s, 1713s, 1637s, 1461m, 1315m, 1272m, 1170s, 984m, 828m. 
EA calcd (%) for C16H22O2: C, 78.01; H, 9.00. Found: C, 78.00; H, 9.14.  
 
(E)-n-Butyl 3-(4-i-propylphenyl)-acrylate (53) 
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Using general method IV Pd(PPh3)4 (24.0 mg, 20.0 µmol) in N,N-dimethylacetamide (5 mL) 
was added to 4-iodo-1-i-propyl-benzene (4.92 g, 20.0 mmol), n-butyl acrylate (3.42 mL, 
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24.0 mmol) and sodium acetate (2.30 g, 28.0 mmol) in N,N-dimethylacetamide (60 mL) to 
give the crude product as a brown oil. The crude product was purified by flash column 
chromatography (SiO2, 5 × 20 cm, ethyl acetate/hexanes 1:10) to give acrylate 53 (1.18 g, 
24%) as a colourless transparent oil.  
C16H22O2 (246.34): 
Rf = 0.8 (ethyl acetate/hexanes 1:3). 
1H NMR (400.1 MHz, CDCl3): δ = 0.97 (t, 3J = 7.8 Hz, 3 H, CH3), 1.25 (d, 3J = 6.8 Hz, 6 H, 
CHCH3), 1.39-1.49 (m, 2 H, CH2CH3), 1.66-1.72 (m, 2 H, CH2CH2CH3), 2.92 (sept, 3J = 6.8 
Hz, CHCH3), 4.21 (t, 3J = 6.6 Hz, 2 H, OCH2), 6.40 (d, 3Jtrans = 16.2 Hz, 1 H, CHC=O), 7.24 
(d, 3J = 8.2 Hz, 2 H, Har), 7.46 (d, 3J = 8.3 Hz, 2 H, Har), 7.66 (d, 3Jtrans = 15.9 Hz, 1 H, 
C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.7 (CH3, 14), 19.2 (CH2, 13), 23.8 (CH3, 1 or3), 
23.8 (CH3, 1 or 3), 30.8 (CH2, 12), 34.1 (CH, 2), 64.3 (CH2, 11), 117.2 (CH, 9), 127.0 (CarH), 
128.1 (CarH), 132.1 (C, 7), 144.5 (CH, 8), 151.5 (C, 4), 167.3 (C, 10). 
IR (NaCl): ν~ = 2961s, 2363s, 1712s, 1636s, 1462m, 1314m, 1271m, 1170s, 1059m, 984m, 
828s. 
MS (EI, 70 eV, r.t.), m/z (%): 246 ([M]+, 56), 231 ([M_CH3]+, 70), 190 ([M_C4H8]+, 100), 175 
(82), 131 ([M_C9H7O]+, 60), 115 (12), 91 (6), 43 (11). 
EA calcd (%) for C16H22O2: C, 78.01; H, 9.00. Found: C, 78.09; H, 9.06.  
 
(E)-n-Butyl 3-(4-n-butylphenyl)-acrylate (54) 
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Using general method IV Pd(PPh3)4 (41.0 mg, 35.0 µmol) in N,N-dimethylacetamide 
(10 mL) added to 4-iodo-1-nbutyl-benzene (6.22 g, 35.0 mmol), n-butyl acrylate (6.00 mL, 
42.0 mmol) and sodium acetate (4.02 g, 49.0 mmol) in N,N-dimethylacetamide (110 mL) 
gave a brown oil. The crude product was purified by flash column chromatography (SiO2, 
5 × 20 cm, ethyl acetate/hexanes 1:10) to give acrylate 54 (5.60 g, 62%) as a colourless 
transparent oil.  
C17H24O2 (260.37): 
Rf = 0.77 (ethyl acetate/hexanes 1:3). 
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1H NMR (400.1 MHz, CDCl3): δ = 0.93 (t, 3J = 7.3 Hz, 3 H, CH3), 0.97 (t, 3J = 7.3 Hz, 3 H, 
CH3), 1.31-1.49 (m, 4 H, CH2CH3), 1.56-1.72 (m, 4 H, CH2CH2CH3), 2.62 (t, 3J = 7.6 Hz, 2 
H, C6H4CH2), 4.20 (t, 3J = 6.8 Hz, 2 H, OCH2), 6.39 (d, 3Jtrans = 15.9 Hz, 1 H, CHC=O), 7.19 
(d, 3J = 8.1 Hz, 2 H, Har), 7.44 (d, 3J = 8.1 Hz, 2 H, Har),  7.66 (d, 3Jtrans = 15.9 Hz, 1 H, 
C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.7 (CH3), 13.9 (CH3),19.2 (CH2, 14), 22.3 (CH2, 
2), 30.8 (CH2, 13), 33.4 (CH2, 3), 35.5 (CH2, 4), 64.3 (CH2, 12), 117.2 (CH, 10), 128 (CarH,), 
128.9 (CarH,), 131.9 (C, 8), 144.6 (CH, 9), 145.6 (C, 5), 167.3 (C, 11). 
IR (NaCl): ν~ = 2958s, 1713s, 1637s, 1462m, 1315s, 1269m, 1169s, 984s, 827m. 
MS (EI, 70 eV, ca. 50 °C), m/z (%): 260 ([M]+, 34), 217 ([M_C3H7]+, 19), 204 ([M_C4H8]+, 
100), 187 (46), 161 (57), 131 (18), 115 (27), 91 (4), 41 (8). 
EA calcd (%) for C17H24O2: C, 78.42; H, 9.29. Found: C, 78.41; H, 9.33. 
The spectroscopic data are in agreement with that previously reported in the literature.[186] 
 
(E)-3-(4-Ethylphenyl)-acrylic acid (56)  
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General Method V: Acrylate 51 (1.00 mg, 4.90 mmol) was dissolved in 1 M aqueous NaOH 
(19.6 mL, 19.6 mmol) and ethanol (40 mL) and the reaction mixture was heated at reflux for 
4 hours. After cooling, the solvent was removed under reduced pressure and the remaining 
white slurry was completely dissolved in water. The pH-value of the solution was reduced to 
1 with conc. HCl and the aqueous phase was extracted with Et2O (5 × 80 mL). The combined 
organic layers were washed with brine, dried (Na2SO4) and the solvent was removed under 
reduced pressure to give acid 56 (0.860 g, 99%) as an amorphous colourless solid. 
C11H12O2 (176.21): 
m.p. 155.5-156.5 °C (Et2O). 
1H NMR (400.1 MHz, CDCl3): δ = 1.25 (t, 3J = 7.6 Hz, 3 H, CH2CH3), 2.68 (q, 3J = 7.6 Hz, 2 
H, CH2CH3), 6.42 (d, 3Jtrans = 15.9 Hz, 1 H, CHC=O), 7.24 (d, 3J = 8.1 Hz, 2 H, Har), 7.48 (d, 
3J = 8.1 Hz, 2 H, Har), 7.77 (d, 3Jtrans = 15.9 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 15.3 (CH3, 1), 28.8 (CH2, 2), 116.1 (CH, 8), 128.5 
(CarH, 4), 128.5 (CarH, 5), 131.5 (C, 6), 147.2 (CH, 7), 147.6 (C, 3), 172.2 (C, 9). 
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IR (KBr): ν~ = 2958s, 1675s, 1628s, 1513m, 1426s, 1320s, 1291s, 1226s, 1180s, 942s, 822s, 
687s, 546s. 
MS (EI, 70 eV, r.t.), m/z (%): 176 ([M]+, 97), 161 ([M_CH3]+, 100), 147 ([M_C2H5]+, 17), 131 
([M]+, 16), 115 (33), 91 ([C7H7]+, 10). 
EA calcd (%) for C11H12O2: C, 74.98; H, 6.86; O, 18.16. Found: C, 74.81; H, 6.86; O, 18.21. 
 
(E)-3-(4-n-Propylphenyl)-acrylic acid (57) 
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By general method V acrylate 52 (2.50 g, 10.1 mmol) was dissolved in 1 M aqueous NaOH 
(40.4 mL, 40.4 mmol) and ethanol (82 mL) to give acid 57 (1.84 g, 96%) as colourless prisms. 
C12H14O2 (190.24): 
m.p. 168.5-169.5 °C (ethanol). 
Rf = 0.32 (ethyl  acetate/hexanes 1 : 3). 
1H NMR (400.1 MHz, CDCl3): δ = 0.95 (t, 3J = 7.3 Hz, 3 H, CH3), 1.65 (sext, 3J = 7.3 Hz, 2 
H, CH2CH3), 2.62 (t, 3J = 7.3 Hz, 2 H, CH2CH2CH3), 6.42 (d, 3Jtrans = 15.9 Hz, 1 H, CHC=O), 
7.21 (d, 3J = 8.1 Hz, 2 H, Har), 7.47 (d, 3J = 8.1 Hz, 2 H, Har), 7.78 (d, 3Jtrans = 15.9 Hz, 1 H, 
C6H4CH), 9.94 (br s, 1 H, OH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.8 (CH3, 1), 24.3 (CH2, 2), 37.9 (CH2, 3), 116.1 
(CH, 9), 128.4 (CarH), 129.1 (CarH), 131.6 (C, 7), 146.0 (C, 4), 147.1 (CH, 8), 172.4 (C, 10). 
IR (KBr): ν~ = 2960s, 2584s, 1680s, 1619s, 1511m, 1418s, 1310s, 1280s, 1215s, 941s, 810s, 
686s. 
MS (EI, 70 eV, ca. 50 °C), m/z (%): 190 ([M]+, 42), 161 ([M_C2H5]+, 100), 115 (28), 91 
([C7H7]+, 6). 
EA calcd (%) for C12H14O2: C, 75.76; H, 7.42. Found: C, 75.83; H, 7.50.  
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(E)-3-(4-i-Propylphenyl)-acrylic acid (58)  
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By general method V acrylate 53 (1.18 g, 4.79 mmol) dissolved in 1 M aqueous NaOH 
(19.2 mL, 19.2 mmol) and ethanol (40 mL) gave acid 58 (0.813 g, 89%) as colourless 
crystals. 
C12H14O2 (190.24): 
m.p. 152-153 °C (ethanol). 
1H NMR (400.1 MHz, CDCl3): δ = 1.26 (d, 3J = 6.8 Hz, 6 H, CH3), 2.94 (sept, 3J = 7.1 Hz, 1 
H, CHCH3), 6.41 (d, 3Jtrans = 16.2 Hz, 1 H, CHC=O), 7.27 (d, 3J = 8.1 Hz, 2 H, Har), 7.49 (d, 
3J = 8.1 Hz, 2 H, Har), 7.77 (d, 3Jtrans = 15.9 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 23.7 (CH3, 1 and 3), 34.1 (CH, 2), 116.1 (CH, 9), 
127.1 (CarH), 128.5 (CarH), 131.7 (C, 7), 147.1 (CH, 8), 152.2 (C, 4), 172.0 (C, 10). 
IR (KBr): ν~ = 3459s, 2956s, 2586s, 1681s, 1621s, 1421s, 1312s, 1279s, 1218s, 1053m, 
983m, 941s, 826s, 673s. 
MS (EI, 70 eV, ca. 100 °C), m/z (%): 190 ([M]+, 41), 175 ([M_CH3]+, 100), 129 (16), 115 (8), 
91 ([C7H7]+, 7). 
EA calcd (%) for C12H14O2: C, 75.76; H, 7.42. Found: C, 75.71; H, 7.34. 
 
(E)-3-(4-n-Butylphenyl)-acrylic acid (59) 
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By general method V acrylate 54 (5.60 g, 21.5 mmol) dissolved in 1 M aqueous NaOH 
(86.2 mL, 86.2 mmol) and ethanol (180 mL) gave acid 59 (4.29 g, 97%) as a crystalline solid. 
C13H16O2 (204.26): 
m.p. 137-138 °C (ethanol). 
Rf = 0.20 (ethyl acetate/hexanes 1:3). 
1H NMR (400.1 MHz, CDCl3): δ = 0.93 (t, 3J = 7.3 Hz, 3 H, CH3), 1.35 (sext, 3J = 7.8 Hz, 2 
H, CH2CH3), 1.57-1.65 (m, 2 H, CH2CH2CH3), 2.64 (t, 3J = 7.6 Hz, 2 H, CH2CH2CH2CH3), 
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6.41 (d, 3Jtrans = 15.9 Hz, 1 H, CHC=O), 7.21 (d, 3J = 8.1 Hz, 2 H, Har), 7.47 (d, 3J = 8.1 Hz, 2 
H, Har), 7.77 (d, 3Jtrans= 15.9 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.9 (CH3, 1), 22.3 (CH2, 2), 33.3 (CH2, 3), 35.6 
(CH2, 4), 116.0 (CH, 10), 128.4 (CarH), 129.1 (CarH), 131.5 (C, 8), 146.3 (C, 5), 147.1 (CH, 
9), 171.9 (C, 11). 
IR (KBr): ν~ = 3448s, 2926s, 2586m, 1685s, 1623s, 1511m, 1422s, 1314s, 1281m, 1222m, 
939s, 810m. 
MS (EI, 70 eV, ca. 100 °C), m/z (%): 204 ([M]+, 43), 161 ([M_C3H7]+, 100), 115 (17). 
EA calcd (%) for C13H16O2: C, 76.44; H, 7.89. Found: C, 76.32; H, 7.88. 
 
3-[(E)-3-p-Tolylacryloyl]-2-oxazolidinone (60)  
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General Method VI: According to a procedure by EVANS,[144] oxalyl chloride (0.78 mL, 
9.25 mmol) and N,N-dimethylformamide (2 drops) were added dropwise to a suspension of 
4-methylcinnamic acid (200 mg, 1.23 mmol) in dichloromethane (5 mL) at 0 °C. After 
stirring for 3 hours at ambient temperature, the solvent and excess oxalyl chloride were 
removed under reduced pressure. The 4-methylcinnamic acid chloride was obtained as a 
colourless amorphous solid and used immediately.  
n-BuLi (1.6 M in hexane, 0.70 mL, 1.12 mmol) was added to a solution of 2-oxazolidinone 
(98.0 mg, 1.12 mmol) in THF (5 mL) at -78 °C. After stirring for 15 minutes at this 
temperature 4-methylcinnamic acid chloride (222 mg, 1.23 mmol) in THF (2 mL) was added. 
The yellow suspension was stirred for 30 minutes at -78 °C and 15 minutes at 0 °C. After 
quenching with saturated aqueous NH4Cl, the organic layer was washed with saturated 
aqueous Na2CO3 (2 ×) and then with brine, dried (Na2SO4) and removal of the solvent under 
reduced pressure gave a yellow gum. The crude product was purified by flash column 
chromatography (SiO2, 2 × 20 cm, ethyl acetate/hexanes 1:1) to give oxazolidinone 60 
(197 mg, 76%) as colourless prisms. 
C13H13NO3 (213.25): 
m.p. 178.5-179.5 °C. 
Rf = 0.18 (ethyl acetate/hexanes 1:1). 
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1H NMR (400.1 MHz, CDCl3): δ = 2.38 (s, 3 H, CH3), 4.13 (t, 3J = 8.0 Hz, 2 H, NCH2), 4.45 
(t, 3J = 8.0 Hz, 2 H, OCH2), 7.20 (d, 3J = 8.1 Hz, 2 H, Har), 7.52 (d, 3J = 8.1 Hz, 2 H, Har), 
7.85 (s, 2 H, CH=CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 21.5 (CH3, 1), 42.8 (CH2, 9), 62.0 (CH2, 10), 115.4 
(CH, 7), 128.7 (CarH), 129.6 (CarH), 131.8 (C, 5), 141.2 (CH, 6). 146.4 (C, 2), 153.6 (C, 11), 
165.5 (C, 8). 
IR (KBr): ν~ = 1769s, 1674s, 1616s, 1512m, 1481m, 1392s, 1354s, 1203s, 1108m, 1038s, 
818s, 757s, 690s, 498s. 
MS (EI, 70 eV, ca. 100 °C), m/z (%): 213 ([M]+, 28), 145 ([M-C3H4NO2]+, 100), 115 (25). 
EA calcd (%) for C13H13NO3: C, 67.52; H, 5.67; N, 6.06; O, 20.76. Found: C, 67.66; H, 5.79; 
N, 6.10; O, 20.56.  
 
3-[(E)-3-(4-Ethylphenyl)acryloyl]-2-oxazolidinone (61)[144] 
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By general method VI acid chloride (553 mg, 2.84 mmol), generated from acid 56, in THF 
(2 mL) was added to 2-oxazolidinone (247 mg, 2.84 mmol) and n-BuLi (1.6 M in hexane, 
1.75 mL, 2.84 mmol) in THF (8 mL) to give a yellow gum. The crude product was purified by 
recrystallisation (pentane/dichloromethane) to give oxazolidinone 61 (398 mg, 72%) as 
colourless prisms. 
C14H15NO3 (245.27): 
m.p. 123-124 °C (pentane/dichloromethane). 
Rf = 0.15 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.24 (t, 3J = 7.6 Hz, 3 H, CH2CH3), 2.67 (q, 3J = 7.6 Hz, 2 
H, CH2CH3), 4.13 (t, 3J = 8.0 Hz, 2 H, NCH2), 4.45 (t, 3J = 8.0 Hz, 2 H, OCH2), 7.22 (d, 3J = 
8.1 Hz, 2 H, Har), 7.54 (d, 3J = 8.1 Hz, 2 H, Har), 7.86 (s, 2 H, CH=CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 15.3 (CH3, 1), 28.8 (CH2, 2), 42.8 (CH2, 10), 62.0 
(CH2, 11), 115.5 (CH, 8), 128.4 (CarH), 128.8 (CarH), 132.0 (C, 6), 146.4 (CH, 7), 147.6 (C, 
3), 153.6 (C, 12), 165.6 (C, 9). 
IR (KBr): ν~ = 2924s, 1783s, 1668s, 1615s, 1478m, 1348s, 1215s, 1117m, 1938s, 984m, 824s, 
755s, 686s, 550m. 
MS (EI, 70 eV, r.t.), m/z (%): 245 ([M]+, 36), 159 ([M-C3H4NO2]+, 100), 131 (20), 115 (14). 
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EA calcd (%) for C14H15NO3: C, 68.56; H, 6.16; N, 5.71; O, 19.57. Found: C, 68.56; H, 6.25; 
N, 5.65; O, 19.57.  
 
3-[(E)-3-Phenyl-2-propenoyl]-2-thiazolidinethione (41)[91]  
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General Method VII: Oxalyl chloride (1.15 mL, 13.5 mmol) and N,N-dimethylformamide 
(3 drops) were added dropwise to cinnamic acid (1.00 g, 6.75 mmol) in dichloromethane 
(25 mL) at 0 °C. After stirring for 3 hours at ambient temperature, the solvent and excess 
oxalyl chloride were removed under reduced pressure. The remaining off-white solid was 
dissolved in dichloromethane (15 mL) and cooled to -78 °C. 2-Thiazolidinethione (805 mg, 
6.75 mmol) was added, followed by dropwise addition of triethylamine (0.85 mL, 
7.43 mmol). The reaction mixture became bright yellow and a suspension formed. After 
stirring for 30 min at -78 °C and 30 min at 0 °C the transparent yellow solution was diluted 
with Et2O (20 mL), washed with saturated aqueous NaHCO3 (20 mL) and water (20 mL). 
Drying (Na2SO4) and removal of the solvent under reduced pressure gave a yellow oil. The 
crude product was purified by column chromatography (SiO2, 4 × 12 cm, 
ethyl acetate/hexanes 1:4) followed by recrystallisation (dichloromethane/pentane) to give 
thiazolidinethione 62 (659 mg, 39%) as yellow prisms. 
C12H11NOS2 (249.35): 
m.p. 81-82 °C (pentane/dichloromethane) [lit.,[91] 80-83 °C]. 
Rf = 0.19 (ethyl acetate/hexanes 1:4). 
1H NMR (400.1 MHz, CDCl3): δ = 3.38 t, 3J = 7.3 Hz, 2 H, SCH2), 4.60 (t, 3J = 7.3 Hz, 2 H, 
NCH2), 7.39-7.40 (m, 3 H, Har), 7.55-7.57 (m, 2 H, Har), 7.69 (d, 3Jtrans = 15.6 Hz, 1 H, 
CHC=O), 7.87 (d, 3Jtrans = 15.6 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 29.1 (CH2, 9), 56.0 (CH2, 8), 119.9 (CH, 6), 128.5 
(CarH), 128.9 (CarH), 130.5 (CarH), 134.7 (C, 4), 144.1 (CH, 5), 167.3 (C, 7), 201.8 (C, 10). 
IR (KBr): ν~ = 3086w, 1675s, 1611s, 1570s, 1438s, 1371s, 1327s, 1272s, 1225s, 1168s, 
1043s, 970s, 918s, 848s, 764s. 
MS (EI, 70 eV, ca. 100 °C), m/z (%): 249 ([M]+, 43), 131 ([C6H5CH=CHC=O]+, 100), 103 
([C6H5CH=CH]+, 37), 77 ([C6H5]+,16). 
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EA calcd (%) for C12H11NOS2: C, 57.80; H, 4.45; N, 5.62; O, 6.42. Found: C, 57.84; H, 4.44; 
N, 5.62; O, 6.32.  
The spectroscopic data are consistent with that reported in the literature.[91] 
 
3-[(E)-3-p-Tolyl-2-propenoyl]-2-thiazolidinethione (63) 
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By general method VII the acid chloride was generated from 4-methylcinnamic acid (1.00 g, 
6.17 mmol), oxalyl chloride (1.04 mL, 12.3 mmol) and N,N-dimethylformamide (3 drops) in 
dichloromethane (25 mL). After dissolving the acid chloride in dichloromethane (12 mL) 
2-thiazolidinethione (736 mg, 6.17 mmol) and triethylamine (0.95 mL, 6.79 mmol) were 
added to give a yellow oil. The crude product was purified by flash column chromatography 
(SiO2, 4 × 12 cm, ethyl acetate/hexanes 1:4) to give thiazolidinethione 63 (1.14 g, 70%) as a 
yellow amorphous solid. 
C13H13NOS2 (263.38): 
m.p. 107.5-109.0 °C (ethyl acetate/hexanes). 
Rf = 0.20 (ethyl acetate/hexanes 1:4). 
1H NMR (400.1 MHz, CDCl3): δ = 2.38 (s, 3 H, CH3), 3.02 (t, 3J = 7.6 Hz, 2 H, SCH2), 4.59 
(t, 3J = 7.6 Hz, 2 H, NCH2), 7.20 (d, 3J = 8.1 Hz, 2 H, Har), 7.45 (d, 3J = 7.8 Hz, 2 H, Har), 
7.68 (d, 3Jtrans = 15.4 Hz, 1 H, CHC=O), 7.83 (d, 3Jtrans = 15.4 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 21.5 (CH3, 1), 29.1 (CH2, 10), 56.0 (CH2, 9), 118.8 
(CH, 7), 128.5 (CarH), 129.7 (CarH), 132.0 (C, 5), 141.1 (C, 2), 144.3 (CH, 6), 167.4 (C, 8), 
201.7 (C, 11). 
IR (KBr): ν~ = 3480w, 2289w, 1674s, 1599s, 1376m, 1323s, 1282s, 1218s, 1162s, 1057m, 
802s. 
MS (EI, 70 eV, 100 °C), m/z (%): 263 ([M]+, 29), 145 (100), 115 (21), 91 ([C7H7]+, 11). 
EA calcd (%) for C13H13NOS2: C, 59.29; H, 4.97; N, 5.32; O, 6.07. Found: C, 59.23; H, 4.95; 
N, 5.37; O, 6.08. 
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3-[(E)-3-(4-Ethylphenyl)-2-propenoyl]-2-thiazolidinethione (64) 
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By general method VII the acid chloride was generated from acid 56 (290 mg, 1.65 mmol), 
oxalyl chloride (0.28 mL, 3.30 mmol) and N,N-dimethylformamide (3 drops) in 
dichloromethane (7 mL). After dissolving the acid chloride in dichloromethane (4 mL) 
2-thiazolidinethione (197 mg, 1.65 mmol) and triethylamine (0.25 mL, 1.82 mmol) were 
added to give a yellow oil. The crude product was purified by flash column chromatography 
(SiO2, 2 × 12 cm, ethyl acetate/hexanes 1:4) to give thiazolidinethione 64 (309 mg, 68%) as a 
yellow amorphous solid. 
C14H15NOS2 (277.41): 
m.p. 65-66 °C (ethyl acetate/hexanes). 
Rf = 0.27 (ethyl acetate/hexanes 1:4). 
1H NMR (400.1 MHz, CDCl3): δ = 1.24 (t, 3J = 7.6 Hz, 3 H, CH3), 2.66 (q, 3J = 7.6 Hz, 2 H, 
CH2CH3), 3.37 (t, 3J = 7.6 Hz, 2 H, SCH2), 4.59 (t, 3J = 7.3 Hz, 2 H, NCH2), 7.22 (d, 3J = 8.1 
Hz, 2 H, Har), 7.48 (d, 3J = 7.8 Hz, 2 H, Har), 7.68 (d, 3Jtrans = 15.6 Hz, 1 H, CHC=O), 7.84 (d, 
3Jtrans = 15.4 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 15.3 (CH3, 1), 28.8 (CH2, 2), 29.1 (CH2, 11), 56.0 
(CH2, 10), 118.9 (CH, 8), 128.5 (CarH), 128.7 (CarH), 132.2 (C, 6), 144.3 (CH, 7), 147.4 (C, 
3), 167.4 (C, 9), 201.7 (C, 12). 
IR (KBr): ν~ = 2922m, 1681s, 1611s, 1374m, 1325s, 1283m, 1163s, 1049m, 819m, 676m. 
MS (EI, 70 eV, 100 °C), m/z (%): 277 ([M]+, 39), 159 (100), 131 (22), 115 (14), 91([C7H7]+, 
10). 
EA calcd (%) for C14H15NOS2: C, 60.62; H, 5.45; N, 5.05; O, 5.77. Found: C, 60.67; H, 5.47; 
N, 5.05; O, 5.90.  
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3-[(E)-3-(4-n-Propylphenyl)-2-propenoyl]-2-thiazolidinethione (65) 
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By general method VII the acid chloride was generated from acid 57 (1.56 g, 8.21 mmol), 
oxalyl chloride (1.39 mL, 16.4 mmol) and N,N-dimethylformamide (3 drops) in 
dichloromethane (27 mL). After dissolving the acid chloride in dichloromethane (20 mL), 
2-thiazolidinethione (979 mg, 8.21 mmol) and triethylamine (1.26 mL, 9.03 mmol) were 
added to give a yellow oil. The crude product was purified by flash column chromatography 
(SiO2, 5 × 15 cm, ethyl acetate/hexanes 1:5) to give thiazolidinethione 65 (1.21 g, 51%) as 
yellow prisms. 
C15H17NOS2 (291.43): 
m.p. 77.5-78.5 °C (dichloromethane/pentane).  
Rf = 0.52 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 0.94 (t, 3J = 7.3 Hz, 3 H, CH2CH3), 1.64 (sext, 3J = 7.3 
Hz, 2 H, CH2CH3), 2.60 (t, 3J = 7.3 Hz, 2 H, CH2CH2CH3), 3.37 (t, 3J = 7.6 Hz, 2 H, SCH2), 
4.59 (t, 3J = 7.6Hz, 2 H, NCH2), 7.20 (d, 3J = 8.1 Hz, 2 H, Har), 7.48 (d, 3J = 8.1 Hz, 2 H, Har), 
7.69 (d, 3Jtrans = 15.4 Hz, 1 H, CHC=O), 7.84 (d, 3Jtrans = 15.4 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.8 (CH3, 1), 24.3 (CH2, 2), 29.1 (CH2, 3), 38.0 
(CH2, 12), 56.0 (CH2, 11), 118.8 (CH, 9), 128.6 (CarH), 129.1 (CarH), 132.3 (C, 7), 144.4 (CH, 
8), 145.9 (C, 4), 167.5 (C, 10), 201.7 (C, 13). 
IR (KBr): ν~ = 2920s, 1682s, 1607s, 1461w, 1378s, 1326s, 1280s, 1219s, 1171s, 1056s, 682s. 
MS (EI, 70 eV, 150 °C), m/z (%): 291 ([M]+, 42), 173 (100), 131 (27), 115 (23), 43 ([C3H7]+, 
9). 
EA calcd (%) for C15H17NOS2: C, 61.82; H, 5.88; N, 4.81. Found: C, 61.65; H, 5.63; N, 4.82.  
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3-[(E)-3-(4-i-Propylphenyl)-2-propenoyl]-2-thiazolidinethione (66) 
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By general method VII the acid chloride was generated from acid 58 (760 mg, 4.00 mmol), 
oxalyl chloride (0.87 mL, 10.3 mmol) and N,N-dimethylformamide (3 drops) in 
dichloromethane (16 mL). After dissolving the acid chloride in dichloromethane (10 mL), 
2-thiazolidinethione (477 mg, 4.00 mmol) and triethylamine (0.60 mL, 4.40 mmol) were 
added to give a yellow oil. The crude product was purified by flash column chromatography 
(SiO2, 4 × 12 cm, ethyl acetate/hexanes 1:5) to give thiazolidinethione 66 (750 mg, 64%) as 
yellow prisms. 
C15H17NOS2 (291.43): 
m.p. 81-83 °C. 
Rf = 0.63 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.24 (d, 3J = 6.8 Hz, 6 H, CH3), 2.93 (sept, 3J = 6.8 Hz, 1 
H, CH(CH3)2), 3.37 (t, 3J = 7.3 Hz, 2 H, SCH2), 4.55 (t, 3J = 7.3 Hz, 2 H, NCH2), 7.27 (d, 3J = 
8.6 Hz, 2 H, Har), 7.50 (d, 3J = 8.4 Hz, 2 H, Har), 7.64 (d, 3Jtrans = 15.6 Hz, 1 H, CHC=O), 7.90 
(d, 3Jtrans = 15.7 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 23.6 (CH3, 1/2), 29.3 (CH2, 12), 34.2 (CH, 3), 56.2 
(CH2, 11), 119.3 (CH, 9), 127.1 (CarH), 128.6 (CarH), 132.5 (C, 7), 143.6 (CH, 8), 152.1 (C, 
4), 167.3 (C, 10), 202.2 (C, 13). 
IR (KBr): ν~ = 3442s, 2959s, 2361s, 1682s, 1614s, 1374s, 1324s, 1284s, 1214s, 1166s, 1052s, 
824s, 676s. 
MS (EI, 70 eV, ca. 200 °C), m/z (%): 291 ([M]+, 58), 173 (76), 131 (100), 115 (10), 43 
([C3H7]+, 16). 
EA calcd (%) for C15H17NOS2: C, 61.82; H, 5.88; N, 4.81. Found: C, 61.62; H, 5.79; N. 4.89.  
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3-[(E)-3-(4-n-Butylphenyl)-2-propenoyl]-2-thiazolidinethione (67) 
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By general method VII the acid chloride was generated from acid 59 (1.22 g, 6.00 mmol), 
oxalyl chloride (1.27 mL, 15.0 mmol) and N,N-dimethylformamide (3 drops) in 
dichloromethane (24 mL). After dissolving the acid chloride in dichloromethane (15 mL), 
2-thiazolidinethione (715 mg, 6.00 mmol) and triethylamine (0.90 mL, 6.60 mmol) were 
added to give a yellow oil. The crude product was purified by flash column chromatography 
(SiO2, 5 × 12 cm, ethyl acetate/hexanes 1:5) to give thiazolidinethione 67 (1.28 g, 70%) as 
yellow prisms. 
C16H19NOS2 (305.46): 
m.p. 59.0-60.5 °C (dichloromethane/pentane). 
Rf =0.70 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 0.93 (t, 3J = 7.6 Hz, 3 H, CH3), 1.35 (sext, 3J = 7.6 Hz, 2 
H, CH2CH3), 1.56-1.64 (m, 2 H, CH2CH2CH3), 2.63 (t, 3J = 7.6 Hz, 2 H, CH2CH2CH2CH3), 
3.37 (t, 3J = 7.3 Hz, 2 H, SCH2), 4.59 (t, 3J = 7.3Hz, 2 H, NCH2), 7.20 (d, 3J = 8.1 Hz, 2 H, 
Har), 7.47 (d, 3J = 8.1 Hz, 2 H, Har), 7.68 (d, 3Jtrans = 15.6 Hz, 1 H, CHC=O), 7.83 (d, 3Jtrans = 
15.4 Hz, 1 H, C6H4CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.9 (CH3, 1), 22.3 (CH2, 2), 29.1 (CH2, 3), 33.3 
(CH2, 4), 35.6 (CH2, 13), 56.0 (CH2, 12), 118.8 (CH, 10), 128.6 (CarH), 129.0 (CarH), 132.2 
(C, 8), 144.4 (CH, 9), 146.1 (C, 5), 167.5 (C, 11), 201.7 (C, 14). 
IR (KBr): ν~ = 2943s, 1674s, 1597s, 1510m, 1461m, 1326s, 1262s, 1220s, 1151s, 1056s, 
823s, 718s. 
MS (EI, 70 eV, 150 °C), m/z (%): 305 ([M]+, 39), 187 (100), 131 (25), 115 (19), 57 ([C4H9]+, 
6). 
EA calcd (%) for C16H19NOS2: C, 62.92; H, 6.27; N, 4.59. Found: C, 62.82; H, 6.27; N, 4.57. 
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3-(2-Propenoyl)-2-oxazolidinone (35)[91] 
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Triethylamine (8.75 mL, 62.5 mmol) and then dropwise acrolyl chloride (5.05 mL, 
62.5 mmol) were added to a solution of acrylic acid (4.30 mL, 62.5 mmol) in ethyl acetate 
(300 mL) at 0 °C. After stirring for 40 minutes at 0 °C followed by 30 minutes at room 
temperature, the reaction mixture was filtered through a Büchner funnel and the filter cake 
was washed three times with ethyl acetate. The filtrate was concentrated under reduced 
pressure dissolved in hexanes (125 mL), then filtered and concentrated again. The anhydride 
was dissolved in THF (12.5 mL) and immediately used in the next step. 
To a suspension of 2-oxazolidinone (4.35 g, 50.0 mmol) and LiCl (2.65 g, 62.5 mmol) in THF 
(45 mL) was slowly added triethylamine (8.75 mL, 62.5 mmol), followed by the anhydride 
and a 4 mL wash with THF. After stirring at room temperature for 4 hours, the solvent was 
removed under reduced pressure, 1 N HCl (125 mL) was added and the aqueous solution was 
extracted with dichloromethane (3 × 100 mL). The combined organic extracts were washed 
with 1:1 saturated aqueous NaHCO3/water (160 mL), then brine (100 mL), dried (Na2SO4) 
and concentrated under reduced pressure to give an off-white solid. The crude product was 
purified by flash column chromatography (SiO2, 10 × 18 cm, ethyl acetate/hexanes 3:7) and 
recrystallised (pentane/dichloromethane) to give oxazolidinone 35 (4.45 g, 63%) as colourless 
plates. 
C6H7NO3 (141.12): 
m.p. 82-83 °C (pentane/dichloromethane) [lit.,[187] 82-83 °C] 
Rf = 0.42 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 7.49 (dd, 3Jtrans = 16.9 Hz, 3Jcis = 10.4 Hz, 1 H, CH), 6.56 
(dd, 3Jtrans = 16.9 Hz, 2J = 1.8 Hz, 1 H, CHtrans), 5.90 (dd, 3Jcis = 10.4 Hz, 2J = 1.8 Hz, 1 H, 
CHcis), 4.47-4.42 (m, 2 H, OCH2), 4.11-4.07 (m, 2 H, NCH2). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 42.6 (CH2, 2), 62.1 (CH2, 1), 126.9 (CH, 5), 131.8 
(CH2, 6), 153.4 (C, 3), 165.0 (C, 4). 
IR (KBr): ν~ = 3112m, 2983m, 2924m, 1779s, 1683s, 1612s, 1398s, 1317s, 1227s, 1120s, 
1015s, 801s, 752s, 690s. 
MS (FAB, NBA (substr)), m/z (%): 295 (8), 142 ([M+H]+, 100), 100 ([M-C2H2O]+, 10), 55 
(31). 
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EA calcd (%) for C6H7NO3: C, 51.07; H, 5.00; N, 9.93; O, 34.01. Found: C, 51.00; H, 4.96; 
N, 9.94; O, 34.01. 
The spectroscopic data are in agreement with that previously reported in the literature.[187]  
 
3-[(E)-3-(Ethoxycarbonyl)propenyl]-2-oxazolidinone (70)[91]  
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By general method VI acid chloride (406 mg, 2.50 mmol), generated from fumaric acid 
monoethyl ester, in THF (2 mL) was added to 2-oxazolidinone (218 mg, 2.50 mmol) and 
n-BuLi (1.6 M in hexane, 1.56 mL, 2.50 mmol) in THF (8 mL) to give the crude product. It 
was purified by flash column chromatography (SiO2, 2 × 14 cm, ethyl acetate/hexanes 1:4) to 
give oxazolidinone 70 (292 mg, 55%) as colourless prisms. 
C9H11NO5 (213.19): 
m.p. 60-62 °C (dichloromethane/hexanes) [lit.,[188] 62-63 °C]. 
Rf = 0.38 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.33 (t, 3J = 7.1 Hz, 3 H, CH3), 4.10 (t, 3J = 7.9 Hz, 2 H, 
NCH2), 4.27 (q, 3J = 7.3 Hz, 2 H, CH2CH3), 4.48 (t, 3J = 7.6 Hz, 2 H, OCH2CH2), 6.95 (d, 
3Jtrans = 15.4 Hz, 1 H, CH(4)=CH), 8.14 (d, 3Jtrans = 15.4 Hz, 1 H, CH(5)=CH). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 14.1 (CH3, 1), 42.6 (CH2, 7), 61.4 (CH2, 2), 62.3 
(CH2, 8), 131.7 (CH, 4), 134.5 (CH, 5), 153.0 (C, 9), 163.9 (C, 6), 164.8 (C, 3). 
IR (KBr): ν~ =  2993w, 1775s, 1720m, 1680s, 1390s, 1296s, 1228w, 1178s, 1111m, 1022s, 
756s, 666s. 
MS (EI, 70 eV, r.t.), m/z (%): 214 ([M+H]+, 100), 168 ([M-C2H6O]+, 19), 124 (27). 
EA calcd (%) for C9H11NO5: C, 50.71; H, 5.20; N, 6.57; O, 37.52. Found: C, 50.79; H, 5.16; 
N, 6.52; O, 37.42. 
The spectroscopic data are in agreement with that previously reported in the literature.[188] 
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5.3.4 Synthesis of Diels-Alder Adducts 
Racemic endo 3-(3-Phenyl-bicyclo[2.2.1]hept-5-ene-2-carbonyl)-2-oxazolidinone 
(rac-71)[144]  
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General Method VIII: Diethylaluminium chloride (1 M in hexane, 1.4 mL, 1.4 mmol) was 
added to a solution of (E)-3-phenylacryloyl-2-oxazolidinone (217 mg, 1.00 mmol) in 
dichloromethane (16 mL) at -78 °C. Pre-cooled cyclopentadiene (0.40 mL, 4.7 mmol) was 
added to the bright yellow solution. The reaction was warmed up to -20 °C and stirred for 
2.5 hours, during which time the colour completely faded. Dichloromethane (50 mL) was 
added and the mixture washed with 1 N HCl, dried (MgSO4) and concentrated under reduced 
pressure to give a yellow oil. The crude product was purified by flash column 
chromatography (SiO2, 3 × 25 cm, ethyl acetate /hexanes 1:1) to give endo DA adduct rac-71 
(237 mg, 84%) as colourless prisms. 
C17H17NO3 (283.32): 
m.p. 128-129 °C (ethyl acetate /hexanes). 
Rf = 0.58 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.56-1.60 (m, 1 H, CHCHHCH), 1.96 (d, 2J = 8.8 Hz, 1 
H, CHCHHCH), 3.00 (m, 1H, CH(6)), 3.35 (dd, 3J = 5.3 Hz, J = 1.8 Hz, 1 H, PhCH), 3.47 (s, 
1 H, CH(2)), 3.93-4.06 (m, 2 H, NCH2), 4.20 (dd, 3J = 5.3 Hz, J = 3.3 Hz, 1 H, CHC=O), 
4.36-4.45 (m, 2 H, OCH2), 5.93 (dd, 3J = 5.5 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.53 (dd, , 3J = 
5.6 Hz, J = 3.0 Hz, 1H, CH(5)=CH), 7.17-7.21 (m, 1 H, Har), 7.27-7.31 (m, 4 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 43.0 (CH2, 13), 46.9 (CH, 4), 47.5 (CH, 2), 48.1 
(CH2, 7), 49.7 (CH, 6), 50.3 (CH, 3), 61.9 (CH2, 14), 126.1 (CarH), 127.6 (CarH), 128.5 
(CarH), 132.2 (CH, 1), 140.2 (CH, 5), 143.7 (C, 8), 153.4 (C, 15), 173.9 (C, 12). 
IR (KBr): ν~ = 3420br s, 2980s, 1765s, 1690s, 1485s, 1385s, 1275s, 1210s, 1105s, 1020s, 
695s. 
MS (FAB, NBA (subtr)), m/z (%): 284 ([M+H]+, 33), 218 (100), 197 (23), 
131([C6H5CH=CH=O]+, 100), 77 ([C6H5]+, 17). 
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EA calcd (%) for C17H17NO3: C, 72.07; H, 6.05; N, 4.94; O, 16.94. Found: C, 71.76; H, 6.05; 
N, 4.97; O, 16.84.  
The spectroscopic data are consistent with that previously reported in the literature.[91] 
 
Racemic endo 3-[(3-p-Tolylbicyclo[2.2.1]hept-5-en-2-yl)carbonyl]-2-oxazolidinone 
(rac-72) 
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By general method VIII oxazolidinone 60 (231 mg, 1.00 mmol), cyclopentadiene (0.30 mL, 
4.7 mmol) and diethylaluminium chloride (1.4 M in hexane, 1.4 mL, 1.4 mmol) in 
dichloromethane (16 mL) gave the crude product. It was purified by flash column 
chromatography (SiO2, 3 × 25 cm, ethyl acetate/hexanes 1:5) to give endo DA adduct rac-72 
(235 mg, 79%, endo:exo 97:3, 100% conversion) as a colourless transparent oil. 
C18H19NO3 (297.34): 
Rf = 0.45 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.57 (dd, 2J = 8.6 Hz, J = 1.5 Hz, 1 H, CHCHHCH), 1.95 
(d, 2J = 8.6 Hz, 1 H, CHCHHCH), 2.31 (s, 3H, CH3), 2.96 (s, 1H, CH(6)), 3.31 (d, 3J = 4.6 
Hz, 1H, PhCH), 3.46 (s, 1H, CH(2)), 3.93-4.05 (m, 2H, NCH2), 4.19 (dd, 3J = 5.3 Hz, J = 3.3 
Hz, 1H, CHC=O), 4.35-4.45 (m, 2H, OCH2), 5.92 (dd, 3J = 5.5 Hz, J = 2.8 Hz, 1H, 
CH(1)=CH), 6.52 (dd, 3J = 5.5 Hz, J = 3.3 Hz, 1H, CH(5)=CH), 7.10 (d, 3J = 8.1 Hz, 2 H, 
Har), 7.16 (d, 3J = 8.1 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 20.9 (CH3, 12), 43.0 (CH2, 14), 46.6 (CH, 4), 47.4 
(CH, 2), 48.1 (CH2, 7), 49.9 (CH, 6), 50.2 (CH, 3), 61.9 (CH2, 15), 127.5 (CarH), 129.1 
(CarH), 132.1 (CH, 1), 135.7 (C, 11), 140.2 (CH, 5), 140.6 (C, 8), 153.4 (C, 16), 174.0 (C, 13). 
IR (NaCl): 2976s, 1772s, 1695s, 1511s, 1477s, 1384s, 1219s, 1112s, 1031s, 812m, 760m, 
696. 
MS (FAB, NBA (subtr)), m/z (%): 298 ([M+H]+, 49), 232 ([M-C5H6]+, 100), 211 (29), 145 
(88). 
EA calcd (%) for C18H19NO3: C, 72.71; H, 6.44; N, 4.71; O, 16.14. Found: C, 71.77; H, 6.69; 
N, 4.51. 
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Racemic endo 3-{[3-(p-Ethylphenyl)bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-
oxazolidinone (rac-73) 
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By general method VIII oxazolidinone 61 (123 mg, 0.50 mmol), cyclopentadiene (0.20 mL, 
2.35 mmol) and diethylaluminium chloride (1.4 M in hexane, 0.7 mL, 0.7 mmol) in 
dichloromethane (8 mL) gave the crude product. It was purified by flash column 
chromatography (SiO2, 2 × 20 cm, ethyl acetate/hexanes 1:5) to give endo DA adduct rac-73 
(91 mg, 58%, endo:exo 96:4, 85% conversion) as a colourless, transparent oil. 
C19H21NO3 (311.37): 
Rf = 0.58 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.22 (t, 3J = 7.6 Hz, 3 H, CH3), 1.57 (dd, 2J = 8.6 Hz, J = 
1.5 Hz, 1 H, CHCHHCH), 1.96 (d, 2J = 8.6 Hz, 1 H, CHCHHCH), 2.61 (q, 3J = 7.6 Hz, 2 H, 
CH2CH3), 2.97 (d, 3J = 1.2 Hz, 1H, CH(6)), 3.31 (d, 3J = 4.3 Hz, 1H, PhCH), 3.46 (s, 1H, 
CH(2)), 3.93-4.05 (m, 2H, NCH2), 4.20 (dd, 3J = 5.3 Hz, J = 3.6 Hz, 1H, CHC=O), 4.32-4.44 
(m, 2H, OCH2), 5.92 (dd, 3J = 5.6 Hz, J = 2.5 Hz, 1H, CH(1)=CH), 6.52 (dd, 3J = 5.6 Hz, J = 
3.0 Hz, 1H, CH(5)=CH), 7.12 (d, 3J = 8.1 Hz, 2 H, Har), 7.19 (d, 3J = 8.3 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 15.6 (CH3, 13), 28.3 (CH2, 12), 43.0 (CH2, 17), 46.6 
(CH, 4), 47.4 (CH, 2), 48.1 (CH2, 7), 49.9 (CH, 6), 50.2 (CH, 3), 61.9 (CH2, 16), 127.6 
(CarH), 129.9 (CarH), 132.1 (CH, 1), 140.2 (CH, 5), 140.9 (C, 11), 142.1 (C, 8), 153.4 (C, 15), 
174.0 (C, 14). 
IR (NaCl): ν~  = 2968s, 1773s, 1695s, 1385s, 1221s, 1112s, 1041s, 824s, 695s. 
MS (FAB, NBA (subtr)), m/z (%): 312 ([M+H]+, 33), 246 ([M-C5H6]+, 78), 225 (24), 159 
(100). 
EA calcd for C19H21NO3: C, 73.29; H, 6.80; N, 4.50. Found: C, 73.44; H, 6.85; N, 4.30. 
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Racemic endo [(3-Phenyl-bicyclo[2.2.1]hept-5-en-2-yl)carbonyl]-2-thiazolidinethione 
(rac-74) 
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By general method VIII thiazolidinethione 62 (249 mg, 1.00 mmol), cyclopentadiene 
(0.40 mL, 4.70 mmol) and diethylaluminium chloride (1.4 M in hexane, 1.40 mL, 1.40 mmol) 
in dichloromethane (16 mL) were stirred for 4 hours at -20 °C to give a yellow oil. The crude 
product was purified by flash column chromatography (SiO2, 3 × 25 cm, 
ethyl acetate/hexanes 1:5) to give endo DA adduct rac-74 (200 mg, 63%, endo:exo 92:8, 
100% conversion) as yellow needles.  
C17H17NOS2 (315.45): 
m.p. 139-140 °C (ethyl acetate/hexanes). 
Rf = 0.65 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.53 (ob. dq, 2J = 8.6 Hz, J = 1.8 Hz, 1 H, CHCHHCH), 
1.83 (d, 2J = 8.6 Hz, 1 H, CHCHHCH), 2.97 (d, J = 1.2 Hz, 1H, CH(4)), 3.33-3.58 (m, 3 H, 
PhCH, SCH2), 3.58 (s, 1H, CH(3)), 4.47-4.58 (m, 2 H, NCH2), 5.18 (dd, 3J = 5.1 Hz, J = 3.3 
Hz, 1H, CHC=O), 5.94 (dd, 3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.54 (dd, 3J = 5.6 Hz, J 
= 3.0 Hz, 1H, CH(2)=CH), 7.20-7.32 (m, 5 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 28.1 (CH2, 14), 47.5 (CH, 3), 47.6 (CH2, 7), 48.6 
(CH, 6), 50.3 (CH, 4), 51.0 (CH, 11), 56.9 (CH2, 13), 126.2 (CH, 1), 127.7 (CarH), 128.5 
(CarH), 132.2 (CarH), 140.3 (CH, 2), 143.6 (C, 7), 175.7 (C, 12), 201.6 (C, 15). 
IR (KBr): ν~ = 3500br m, 3050s, 3000s, 1710s, 1515m, 1470s, 1385s, 1330m, 1290s, 1240s, 
1185s, 1055s, 915m, 870m, 760m, 715s. 
MS (EI, 70 eV, 150 °C), m/z (%): 315 ([M]+, 4), 281([M-H2S]+, 5), 248 (53), 131 
([C6H5CH=CH=O]+, 100), 103 ([C6H5CH=CH]+, 24), 77 ([C6H5]+, 10). 
EA calcd (%) for C17H17NOS2: C, 64.73; H, 5.43; N, 4.44; O, 5.07. Found: C, 64.58; H, 5.45; 
N, 4.42; O, 5.10.  
The spectroscopic data are in agreement with that for the enantiopure compound previously 
reported in the literature.[188] 
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Racemic endo [(3-p-Tolylbicyclo[2.2.1]hept-5-en-2-yl)carbonyl]-2-thiazolidinethione 
(rac-75) 
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By general method VIII thiazolidinethione 63 (263 mg, 1.00 mmol), cyclopentadiene 
(0.39 mL, 4.70 mmol) and diethylaluminium chloride (1.4 M in hexane, 1.40 mL, 1.40 mmol) 
in dichloromethane (16 mL) gave a yellow oil. The crude product was purified by flash 
column chromatography (SiO2, 3 × 25 cm, ethyl acetate/hexanes 1:4) to give endo DA adduct 
rac-75 (248 mg, 75%, endo:exo 93:7, 96% conversion) as a yellow amorphous solid. 
C18H19NOS2 (329.48): 
m.p. 81-83 °C (ethyl acetate/hexanes). 
Rf = 0.56 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.51 (dd, 2J = 8.6 Hz, J = 1.5 Hz, 1 H, CHCHHCH), 1.82 
(d, 2J = 8.8 Hz, 1 H, CHCHHCH), 2.31 (s, 3H, CH3), 2.94 (s, 1 H, CH(4)), 3.19-3.32 (m, 3 H, 
PhCH, SCH2), 3.57 (s, 1H, CH(3)), 4.46-4.57 (m, 2 H, NCH2), 5.14-5.16 (m, 1 H, CHC=O), 
5.93 (dd, 3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.53 (dd, 3J = 5.6 Hz, J = 3.3 Hz, 1H, 
CH(2)=CH), 7.11(d, 3J = 8.1 Hz, 2 H, Har), 7.17 (d, 3J = 8.1 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 20.9 (CH3, 11), 28.1 (CH2, 15), 47.5 (CH2, 7), 47.5 
(CH, 3), 48.3 (CH, 6), 50.4 (CH, 4), 51.0 (CH, 12), 56.8 (CH2, 14), 127.6 (CarH), 129.2 
(CarH), 132.1 (CH, 1), 135.7 (C, 10), 140.3 (CH, 2), 140.5 (C, 7), 175.9 (C, 13), 201.5 (C, 16). 
IR (KBr): ν~ = 3377m, 3000s, 1697s, 1573w, 1513s, 1457s, 1366s, 1328s, 1276s, 1220s, 
1157s, 1049s, 900s, 863s, 812s 763s, 707s, 536s. 
MS (FAB, NBA (subtr)), m/z (%): 330 ([M+H]+, 22), 295 (11), 263 (20), 211 (12), 145 (100). 
EA calcd (%) for C18H19NOS2: C, 65.62; H, 5.81; N, 4.25. Found: C, 65.65; H, 5.73; N, 4.44. 
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Racemic endo 3-[(4-Ethylphenyl)bicyclo[2.2.1]hept-5-en-2-yl)carbonyl]-2-thiazolidine-
thione (rac-76) 
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By general method VIII thiazolidinethione 64 (139 mg, 0.50 mmol), cyclopentadiene 
(0.20 mL, 2.35 mmol) and diethylaluminium chloride (1.4 M in hexane, 0.70 mL, 0.70 mmol) 
in dichloromethane (8 mL) gave a yellow oil. The crude product was purified by flash column 
chromatography (SiO2, 2 × 20 cm, ethyl acetate/hexanes 1:4) to give endo DA adduct rac-76 
(127 mg, 74%, endo:exo 91:9, 100% conversion) as a yellow transparent oil. 
C19H21NOS2 (343.51): 
Rf =0.69 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.23 (t, 3J = 7.6 Hz, 3 H, CH3), 1.51 (dd, 2J = 8.8 Hz, J = 
1.5 Hz, 1 H, CHCHHCH), 1.83 (d, 2J = 8.6 Hz, 1 H, CHCHHCH), 2.62 (q, 3J = 7.6 Hz, 2 H, 
CH2CH3), 2.95 (s, 1 H, CH(4)), 3.18-3.32 (m, 3 H, PhCH, SCH2), 3.40 (s, 1H, CH(3)), 4.46-
4.57 (m, 2 H, NCH2), 5.16 (dd, 3J = 5.1 Hz, J = 3.6 Hz, 1H, CHC=O), 5.93 (dd, 3J = 5.6 Hz, J 
= 2.8 Hz, 1H, CH(1)=CH), 6.53 (dd, 3J = 5.6 Hz, J = 3.0 Hz, 1H, CH(5)=CH), 7.13 (d, 3J = 
8.1 Hz, 2 H, Har), 7.18 (d, 3J = 8.3 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 15.6 (CH3, 12), 28.1 (CH2, 11), 28.3 (CH2, 16), 47.5 
(CH, 3), 47.5 (CH2, 5), 48.4 (CH, 6), 50.5 (CH, 4), 50.9 (CH, 13), 56.8 (CH2, 15), 127.7 
(CarH), 128.0 (CarH), 132.1 (CH, 1), 140.3 (CH, 2), 140.7 (C, 10), 142.1 (C, 7), 175.8 (C, 14), 
201.5 (C, 15). 
IR (NaCl): ν~ = 2967s, 2361w, 1697s, 1513s, 1458s, 1366s, 1328sm 1276s, 1220s, 1159s, 
1050s, 899m, 863m, 827m, 762m, 702m, 586w, 544w. 
MS (FAB, NBA(subtr)), m/z (%): 344 ([M+H]+, 17), 277 (18), 225 (11), 159 (100). 
EA calcd (%) for C19H21NOS2: C, 66.44; H, 6.16; N, 4.08; O, 4.66. Found: C, 66.20; H, 6.16; 
N, 4.01; O, 4.80. 
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endo 3-{[(1S,2R,3R,4R)-3-p-Tolylbicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-oxazolidinone 
((S)-77)[91] 
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General Method IX: Cu(II)Cl2 (13.4 mg, 0.10 mmol), (S,S)-t-Bu-box ligand 32b (32.4 mg, 
0.11 mmol) and AgSbF6 (68.7 mg, 0.20 mmol) were mixed together in a glove box and the 
flask was wrapped in aluminium foil to protect the reaction mixture from light. After 
connecting the flask to a Schlenk line, dichloromethane (1 mL) was added and the blue 
reaction mixture was stirred for 6 hours at room temperature. The solution was filtered 
through a plug of celite (rinsed with dichloromethane (3 mL)) to give a clear blue solution, 
which was cooled to -78 °C. Oxazolidinone 60 (231 mg, 1.00 mmol) in dichloromethane 
(2 mL) was added and immediately after cyclopentadiene (0.83 mL, 10.0 mmol). After 
stirring for 24 hours at room temperature (28 °C), ethyl acetate/Et2O 1:1 (3 mL) was added. 
The mixture was directly applied to a short column (SiO2, 1.5 × 4 cm) and eluted with Et2O (3 
× 20 mL). After removal of the solvent under reduced pressure, the crude product was 
purified by flash column chromatography (SiO2, 3 × 25 cm, ethyl acetate/hexanes 1:5) to give 
endo DA adduct (S)-77 (174 mg, 59%, endo ee 95%, exo ee 86%, endo:exo 75:25, 100% 
conversion) as a colourless transparent oil. 
C18H19NO3 (297.35): 
Rf = 0.45 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.57 (dd, 2J = 8.6 Hz, J = 1.5 Hz, 1 H, CHCHHCH), 1.95 
(d, 2J = 8.6 Hz, 1 H, CHCHHCH), 2.31 (s, 3H, CH3), 2.96 (d, J = 1.0 Hz, 1H, CH(6)), 3.31 (d, 
3J = 4.6 Hz, 1H, PhCH), 3.46 (s, 1H, CH(2)), 3.93-4.05 (m, 2H, NCH2), 4.19 (dd, 3J = 5.3 Hz,  
J = 3.3 Hz, 1H, CHC=O), 4.35-4.45 (m, 2H, OCH2), 5.92 (dd, 3J = 5.5 Hz, J = 2.8 Hz, 1H, 
CH(1)=CH), 6.52 (dd, 3J = 5.5 Hz, J = 3.3 Hz, 1H, CH(5)=CH), 7.10 (d, 3J = 8.1 Hz, 2 H, 
Har), 7.16 (d, 3J = 8.1 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 20.9 (CH3, 12), 43.0 (CH2, 14), 46.6 (CH, 4), 47.4 
(CH, 2), 48.1 (CH2, 7), 49.9 (CH, 6), 50.2 (CH, 3), 61.9 (CH2, 15), 127.5 (CarH), 129.1 
(CarH), 132.1 (CH, 1), 135.7 (C, 11), 140.2 (CH, 5), 140.6 (C, 8), 153.4 (C, 16), 174.0 (C, 13). 
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IR (NaCl): ν~ = 2976s, 1786s, 1690s, 1515s, 1466s, 1391s, 1334s, 1277s, 1225s, 1039s, 
802m, 761m, 702s, 528s. 
MS (FAB, NBA (subtr)), m/z (%): 298 ([M+H]+, 44), 232 ([M-C5H6]+, 100), 211 (29), 145 
(100). 
[α] 20D  = _136.7 (c = 0.38, dichloromethane, 95% ee). 
EA calcd (%) for C18H19NO3: C, 72.71; H, 6.44; N, 4.71; O, 16.14. Found: C, 72.49; H, 6.44; 
N, 4.72; O, 16.00.  
HPLC: Chiralcel AD-H, i-propanol/heptane (20:80), 0.5 mL/min, 20 °C, 210 nm, tR = 17.0 
min (minor), tR = 23.9 min (major). 
 
exo 3-{[(1R,2S,3S,4S)-3-p-Tolylbicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-oxazolidinone 
((S)-77) 
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C18H19NO3 (297.35): 
Rf = 0.55 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 1.48 (dd, 2J = 8.6 Hz, 3J = 1.3 Hz, 1 H, CHCHHCH), 1.83 
(d, 2J = 8.4 Hz, 1 H, CHCHHCH), 2.29 (s, 3H, CH3), 3.10 (s, 2H, CH, bridgehead), 3.69 (d, 3J 
= 5.1 Hz, 1H, PhCH), 4.00-4.09 (m, 3H, NCH2, CHC=O), 4.33-4.44 (m, 2H, OCH2), 6.06 
(dd, 3J = 5.3 Hz, J = 2.5 Hz, 1H, CH(1)=CH), 6.48 (dd, 3J = 5.6 Hz, J = 3.2 Hz, 1H, 
CH(5)=CH), 7.05 (s, 4 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 20.9 (CH3, 12), 43.0 (CH2, 14), 46.7 (CH, 4), 46.8 
(CH2, 7), 49.1 (CH, 6), 50.0 (CH, 2), 50.2 (CH,3), 61.8 (CH2, 13), 127.9 (CarH), 128.7 (CarH), 
135.7 (C, 11), 135.8 (CH, 1), 137.1 (CH, 5), 139.9 (C, 8), 153.4 (C, 15), 174.6 (C, 16). 
IR (NaCl): ν~ = 2973s, 1776s, 1693s, 1514s, 1478s, 1387s, 1223m, 1116s, 1042s, 912s, 761m, 
730s. 
MS (FAB, NBA (subtr)), m/z (%): 298 ([M+H]+, 20), 232 ([M-C5H6]+, 68), 145 (100). 
HPLC: Chiralcel AD-H, i-propanol/heptane (20:80), 0.5 mL/min, 20 °C, 210 nm, tR = 15.5 
min (minor), tR = 20.9 min (major). 
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endo 3-{[(1S,2R,3R,4R)-3-Ethylphenylbicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-
oxazolidinone ((S)-78) 
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By general method IX Cu(II)Cl2 (3.40 mg, 25.0 µmol), AgSbF6 (17.1 mg, 50.0 µmol), 
(S,S)-t-Bu-box ligand 32b (8.1 mg, 27.5 µmol), oxazolidinone 61 (61.3 mg, 0.25 mmol) and 
cyclopentadiene (0.21 mL, 2.50 mmol) in dichloromethane (4 mL) gave a brown oil. The 
crude product was purified by flash column chromatography (SiO2, 3 × 25 cm, 
ethyl acetate/hexanes 1:5) to give endo DA adduct (S)-78 (31.0 mg, 40%, endo ee 89%, 
endo:exo 67:33, 56% conversion) as a colourless transparent oil. 
C19H21NO3 (311.37): 
Rf = 0.74 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.20 (t, 3J = 7.6 Hz, 3 H, CH3), 1.56 (dd, 2J = 8.6 Hz, J = 
1.8 Hz, 1 H, CHCHHCH), 1.92 (d, 2J = 8.6 Hz, 1 H, CHCHHCH), 2.60 (q, 3J = 7.6 Hz, 2 H, 
CH2CH3), 2.97 (d, 3J = 1.5 Hz, 1H, CH(6)), 3.29 (d, 3J = 4.8 Hz, 1H, PhCH), 3.43 (s, 1H, 
CH(2)), 3.88-3.99 (m, 2H, NCH2), 4.12 (dd, 3J = 5.3 Hz, J = 3.6 Hz, 1H, CHC=O), 4.34-4.38 
(m, 2H, OCH2), 5.91 (dd, 3J = 5.6 Hz, J = 2.5 Hz, 1H, CH(1)=CH), 6.50 (dd, 3J = 5.6 Hz, J = 
3.0 Hz, 1H, CH(5)=CH), 7.12 (d, 3J = 8.1 Hz, 2 H, Har), 7.18 (d, 3J = 8.3 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 15.6 (CH3, 13), 28.4 (CH2, 12), 43.1 (CH2, 17), 
46.4 (CH, 4), 47.5 (CH, 2), 48.1 (CH2, 7), 49.8 (CH, 6), 50.5 (CH, 3), 62.2 (CH2, 16), 127.5 
(CarH), 127.9 (CarH), 132.2 (CH, 1), 140.0 (CH, 5), 141.2 (C, 11), 142.2 (C, 8), 153.6 (C, 15), 
173.7 (C, 14). 
IR (NaCl): ν~ = 2967s, 1777s, 1695s, 1513m, 1477m, 1385s, 1222s, 1112s, 1028s, 976m, 
824m, 759m, 694s. 
MS (EI, 70 eV, ca. 100 °C), m/z (%): 245 ([M-C5H6]+, 100), 159 (100), 131 (8), 115 (7), 91 
(5). 
[α] 20D  = _162.0 (c = 0.23, dichloromethane, 89% ee).  
HPLC: Chiralcel AD-H, i-propanol/heptane (20:80), 0.5 mL/min, 20 °C, 210 nm, tR = 31.0 
min (minor), tR = 36.9 min (major). 
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endo 3-{[(1S,2R,3R,4R)-(4-Tolyl)-bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-thiazolidine-
thione ((S)-79) 
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General Method X: Cu(II)(OTf)2 (72.0 mg, 0.20 mmol) and (S,S)-t-Bu-box ligand 32b 
(65.0 mg, 0.22 mmol) were mixed together in a glove box. After connecting the flask to a 
Schlenk line, dichloromethane (2 mL) was added and the green reaction mixture was stirred 
for 2.5 hours at room temperature. The reaction mixture was cooled to -78 °C and 
thiazolidinethione 63 (263 mg, 1.00 mmol) in dichloromethane (2 mL) was added and 
immediately after cyclopentadiene (0.83 mL, 10.0 mmol). After 72 hours at –35 °C, ethyl 
acetate/Et2O (1:1, 3 mL) was added and the mixture was directly applied to a short column 
(SiO2, 1.5 × 4 cm) and eluted with Et2O (3 × 20 mL). After removal of the solvent under 
reduced pressure, the crude product was purified by flash column chromatography (SiO2, 
3 × 25 cm, ethyl acetate/hexanes 1:5) to give endo DA adduct (S)-79 (260 mg, 79%, endo ee 
95%, endo:exo 97:3, >99% conversion) as a yellow transparent oil. 
C18H19NOS2 (329.48): 
Rf = 0.66 (ethyl acetate/hexanes 1:1) 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.49 (ob. dq, 2J = 8.6 Hz, J = 1.8 Hz, 1 H, CHCHHCH), 
1.79 (d, 2J = 8.8 Hz, 1 H, CHCHHCH), 2.29 (s, 3 H, CH3), 2.92 (d, 2J = 1.0 Hz, 1 H, CH, (4)), 
3.15-3.34 (m, 3 H, PhCH, SCH2), 3.52 (s, 1H, CH(3)), 4.45-4.49 (m, 2 H, NCH2), 5.10 (dd, 3J 
= 5.1 Hz, J = 3.3 Hz, 1 H, CHC=O), 5.92 (dd, 3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.49 
(dd, 3J = 5.6 Hz, J = 3.3 Hz, 1H, CH(2)=CH), 7.08 (d, 3J = 8.1 Hz, 2 H, Har), 7.14 (d, 3J = 8.3 
Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 20.7 (CH3, 11), 28.3 (CH2, 15), 47.5 (CH2, 7), 47.5 
(CH, 3), 47.7 (CH, 6), 50.2 (CH, 4), 51.5 (CH, 12), 57.1 (CH2, 14), 127.5 (CarH), 129.1 
(CarH), 132.2 (CH, 1), 135.8 (C, 10), 140.2 (CH, 2), 140.7 (C, 7), 175.6 (C, 13), 202.0 (C, 16). 
IR (NaCl): ν~ = 2975s, 1698s, 1513m, 1458m, 1367m, 1328m, 1276m, 1220m, 1159m, 
1049m, 900m, 863m, 812m, 762m, 706m. 
MS (FAB, NBA (subtr)), m/z (%): 330 ([M+H]+, 19), 263 (20), 211 (9), 145 (100). 
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[α] 20D  = _155.5 (c = 0.50, dichloromethane, 95% ee). 
EA calcd (%) for C18H19NOS2: C, 65.62; H, 5.81; N, 4.25. Found: C, 64.89; H, 5.84; N. 4.26. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 22.3 
min (major), tR = 59.2 min (minor). 
 
endo 3-{[(1S,2R,3R,4R)-(4-Ethylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-
thiazolidinethione ((S)-80) 
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By general method X Cu(II)(OTf)2 (72.0 mg, 0.20 mmol), (S,S)-t-Bu-box 32b (65.0 mg, 
0.22 mmol), thiazolidinethione 64 (277 mg, 1.00 mmol) and cyclopentadiene (0.83 mL, 
10.0 mmol) in dichloromethane (4 mL) gave a yellow oil. The crude product was purified by 
flash column chromatography (SiO2, 3 × 25 cm, ethyl acetate/hexanes 1:5) and 
recrystallisation (Et2O/pentane) to give endo DA adduct (S)-80 (299 mg, 87%, endo ee >99%, 
endo:exo 97:3, >99% conversion) as yellow needles. 
C19H21NOS2 (343.51): 
m.p. 73-74 °C (Et2O/pentane). 
Rf = 0.63 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.20 (t, 3J = 7.8 Hz, 3 H, CH3), 1.49 (ob. dq, 2J = 8.6 Hz, 
J = 1.8 Hz, 1 H, CHCHHCH), 1.80 (d, 2J = 8.6 Hz, 1 H, CHCHHCH), 2.59 (q, 3J = 7.6 Hz, 2 
H, CH2CH3), 2.94 (d, J = 1.5 Hz, 1 H, CH(4)), 3.16-3.35 (m, 3 H, PhCH, SCH2), 3.53 (s, 1H, 
CH(3)), 4.46-4.50 (m, 2 H, NCH2), 5.13 (dd, 3J = 4.6 Hz, J = 3.3 Hz, 1H, CHC=O), 5.93 (dd, 
3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.50 (dd, 3J = 5.8 Hz, J = 3.3 Hz, 1H, CH(2)=CH), 
7.12 (d, 3J = 8.3 Hz, 2 H, Har), 7.18 (d, 3J = 8.3 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 15.5 (CH3, 12), 28.3 (CH2, 11), 28.4 (CH2, 16), 
47.5 (CH2, 5), 47.5 (CH, 3), 47.8 (CH, 6), 50.2 (CH, 4), 51.5 (CH, 13), 57.1 (CH2, 15), 127.6 
CarH), 128.0 (CarH), 132.2 (CH, 1), 140.2 (CH, 2), 141.0 (C, 10), 142.2 (C, 7), 175.6 (C, 14), 
202.0 (C, 17). 
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IR (KBr): ν~ = 2967s, 2872m, 1699s, 1512m, 1458m, 1367s, 1328m, 1277s, 1220m, 1160s, 
1049s, 826m, 761m, 702m. 
MS (FAB, NBA (subtr)), m/z (%): 344 ([M+H]+, 20), 277 (20), 225 (10), 159 (100). 
[α] 20D  = _157.3 (c = 0.50, dichloromethane, >99% ee). 
EA calcd (%) for C19H21NOS2: C, 66.44; H, 6.16; N, 4.08. Found: C, 66.25; H, 6.23; N, 3.89. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 21.8 
min (major), tR = 48.2 min (minor). 
 
endo 3-{[(1S,2R,3R,4R)-(4-n-Propylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-
thiazolidinethione ((S)-81) 
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By general method X Cu(II)(OTf)2 (36.0 mg, 0.10 mmol), (S,S)-t-Bu-box 32b (32.0 mg, 
0.11 mmol), thiazolidinethione 65 (146 mg, 0.50 mmol) and cyclopentadiene (0.42 mL, 
5.00 mmol) in dichloromethane (2 mL) gave a yellow oil. The crude product was purified by 
flash column chromatography (SiO2, 2 × 20 cm, ethyl acetate/hexanes 1:5) and 
recrystallisation (Et2O/pentane) to give endo DA adduct (S)-81 (119 mg, 67%, endo ee >99%, 
endo:exo 97:3, 99% conversion) as yellow needles. 
C20H23NOS2 (357.53): 
m.p. 91-92 °C (Et2O/pentane). 
Rf = 0.69 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 0.93 (t, 3J = 7.3 Hz, 3 H, CH3), 1.49 (ob. dq, 2J = 8.8 Hz, 
3J = 3.5 Hz, 3J = 1.8 Hz, 1 H, CHCHHCH), 1.69 (sext, 3J = 7.6 Hz, CH2CH3), 1.80 (d, 2J = 
8.6 Hz, 1 H, CHCHHCH), 2.54 (t, 3J = 7.6 Hz, 2 H, CH2CH2CH3), 2.94 (d, 3J = 1.5 Hz, 1 H, 
CH(4)), 3.16-3.35 (m, 2 H, SCH2), 3.27 (dd, 3J = 4.8 Hz, 3J = 1.3 Hz,, 1 H, PhCH), 3.54 (s, 1 
H, CH(3)), 4.46-4.50 (m, 2 H, NCH2), 5.13 (dd, 3J = 5.1 Hz, J = 3.6 Hz, 1H, CHC=O), 5.92 
(dd, 3J = 5.5 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.51 (dd, 3J = 5.6 Hz, J = 3.0 Hz, 1H, 
CH(2)=CH), 7.19 (d, 3J = 8.3 Hz, 2 H, Har), 7.17 (d, 3J = 8.1 Hz, 2 H, Har). 
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13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 13.7 (CH3, 13), 24.7 (CH2, 12), 28.3 (CH2, 17), 
37.5 (CH2, 11), 47.5 (CH, 3), 47.5 (CH2, 5), 47.8 (CH, 6), 50.3 (CH, 4), 51.4 (CH, 14), 57.1 
(CH2, 16), 127.5 (CarH), 128.5 (CarH), 132.2 (CH, 1), 140.2 (CH, 2), 140. 7 (C, 10), 141.0 (C, 
7), 175.6 (C, 15), 202.0 (C, 18). 
IR (KBr): ν~ = 2949s, 1711s, 1511s, 1459s, 1432s, 1364s, 1327s, 1278s, 1214s, 1155s, 1027s, 
803s, 707s. 
MS (FAB, NBA (subtr)), m/z (%): 358 ([M+H]+, 15), 291 (19), 239 (11), 173 ([291-C9H10]+, 
100), 91 (10), 43 ([C3H7]+, 10). 
[α] 20D  = _167.6 (c = 0.50, dichloromethane, >99% ee). 
EA calcd (%) for C20H23NOS2: C, 67.19; H, 6.48; N, 3.92. Found: C, 66.94; H, 6.51; N, 3.95. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 19.1 
min (major), tR = 39.7 min (minor). 
 
endo 3-{[(1S,2R,3R,4R)-(4-i-Propylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-
thiazolidinethione ((S)-82) 
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By general method X Cu(II)(OTf)2 (36.0 mg, 0.10 mmol), (S,S)-t-Bu-box 32b (32.0 mg, 
0.11 mmol), thiazolidinethione 66 (146 mg, 0.50 mmol) and cyclopentadiene (0.42 mL, 
5.00 mmol) in dichloromethane (2 mL) gave a yellow oil. The crude product was purified by 
flash column chromatography (SiO2, 2 × 20 cm, ethyl acetate/hexanes 1:5) and 
recrystallisation (Et2O/pentane) to give endo DA adduct (S)-82 (142 mg, 79%, endo ee >99%, 
endo:exo 97:3, 100% conversion) as yellow needles.  
C20H23NOS2 (357.53): 
m.p. 68-70 °C (Et2O/pentane). 
Rf = 0.69 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.22 (d, 3J = 7.1 Hz, 6 H, CH3), 1.49 (ob. dq, 2J = 8.8 Hz, 
3J = 1.8 Hz, 1 H, CHCHHCH), 1.80 (d, 2J = 8.8 Hz, 1 H, CHCHHCH), 2.87 (sept, 3J = 6.8 
Hz, CH(CH3)2), 2.94 (d, 3J = 1.5 Hz, 1 H, CH(4)), 3.17-3.35 (m, 2 H, SCH2), 3.27 (dd, 3J = 
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4.8 Hz, J = 1.3 Hz, 1 H, PhCH), 3.54 (s, 1 H, CH(3)), 4.46-4.50 (m, 2 H, NCH2), 5.14 (dd, 3J 
= 5.0 Hz, J = 3.6 Hz, 1H, CHC=O), 5.92 (dd, 3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.50 
(dd, 3J = 5.6 Hz, 3J = 3.3 Hz, 1H, CH(2)=CH), 7.15 (d, 3J = 8.4 Hz, 2 H, Har), 7.19 (d, 3J = 8.3 
Hz, 2 H, Har). 
13C{1H} NMR (125.8 MHz, CD2Cl2): δ = 24.3 (CH3, 12 and 13), 28.8 (CH2, 17), 34.2 (CH, 
11), 48.0 (CH2, 5), 48.3 (CH, 6), 48.3 (CH, 3), 50.8 (CH, 4), 51.9 (CH, 14), 57.6 (CH2, 16), 
127.0 (CarH), 128.1 (CarH), 132.7 (CH, 1), 140.7 (CH, 2), 141.6 (C, 10), 147.3 (C, 7), 176.1 
(C, 15), 202.5 (C, 18). 
IR (NaCl): ν~ = 2961s, 1905w, 1697s, 1512s, 1480s, 1365s, 1275s, 1219s, 1157s, 1051s, 898s, 
863m, 827s, 761m, 734m, 696s. 
MS (EI, 70eV, ca. 150 °C), m/z (%): 323 ([M-H2S]+, 9), 291 (91), 263 (5), 195 (10), 173 
(100), 131 (58), 115 (7), 91 (5), 43 ([C3H7]+, 11). 
[α] 20D  = _153.3 (c = 0.41, dichloromethane, >99% ee). 
EA calcd (%) for C20H23NOS2: C, 67.19; H, 6.48; N, 3.92. Found: C, 67.29; H, 6.33; N, 4.01. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 19.9 
min (major), tR = 35.5 min (minor). 
 
endo 3-{[(1S,2R,3R,4R)-(4-n-Butylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-
thiazolidinethione ((S)-83) 
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By general method X Cu(II)(OTf)2 (72.0 mg, 0.20 mmol), (S,S)-t-Bu-box 32b (65.0 mg, 
0.22 mmol), thiazolidinethione 67 (305 mg, 1.00 mmol) and cyclopentadiene (0.42 mL, 
5.00 mmol) in dichloromethane (4 mL) gave a yellow oil. The crude product was purified by 
flash column chromatography (SiO2, 3 × 25 cm, ethyl acetate/hexanes 1:5) and 
recrystallisation (Et2O/pentane) to give endo DA adduct (S)-83 (274 mg, 74%, endo ee >99%, 
endo:exo 96:4, 100% conversion) as yellow needles.  
C21H25NOS2 (371.56): 
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m.p. 65-66 °C (Et2O/pentane). 
Rf = 0.69 (ethyl acetate/hexanes 1:1). 
1H NMR (500.1 MHz, CD2Cl2): δ = 0.92 (t, 3J = 7.3 Hz, 3 H, CH3), 1.34 (sext, 3J = 7.3 Hz, 
CH2CH3), 1.48 (ob. dq, 2J = 8.8 Hz, J = 1.8 Hz, 1 H, CHCHHCH), 1.54-1.60 (m, 2 H, 
CH2CH2CH3), 1.80 (d, 2J = 8.8 Hz, 1 H, CHCHHCH), 2.56 (t, 3J = 7.8 Hz, 2 H, CH2CH2 
CH2CH3), 2.94 (m, 1 H, CH(4)), 3.16-3.33 (m, 2 H, SCH2), 3.27 (dd, 3J = 5.5 Hz, J = 1.5 Hz, 
1 H, PhCH), 3.53 (m, 1 H, CH(3)), 4.46-4.50 (m, 2 H, NCH2), 5.13 (dd, 3J = 5.3 Hz, J = 3.6 
Hz, 1H, CHC=O), 5.92 (dd, 3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.50 (dd, 3J = 5.6 Hz, J 
= 3.0 Hz, 1H, CH(2)=CH), 7.10 (d, 3J = 8.4 Hz, 2 H, Har), 7.17 (d, 3J = 7.8 Hz, 2 H, Har). 
13C{1H} NMR (125.8 MHz, CD2Cl2): δ = 13.8 (CH3, 14), 22.5 (CH2, 13), 28.3 (CH2, 18), 
33.8 (CH2, 12), 35.1 (CH2, 11), 47.5 (CH, 3), 47.5 (CH2, 5), 47.8 (CH, 6), 50.3 (CH, 4), 51.4 
(CH, 15), 57.1 (CH2, 17), 127.5 (CarH), 128.5 (CarH), 132.2 (CH, 1), 140.2 (CH, 2), 140.9 (C, 
10), 140.9 (C, 7), 175.6 (C, 16), 202.0 (C, 19). 
IR (KBr): ν~ = 2956s, 2361w, 1699s, 1512s, 1460s, 1367s, 1277s, 1159s, 1052s, 890s, 863s, 
828s, 761s, 705s. 
MS (EI, 70eV, ca. 150 °C), m/z (%): 337 ([M-H2S]+, 6), 305 (41), 187 (100), 131 (19), 115 
(18), 91 (5), 57 ([C4H9]+, 6). 
[α] 20D  = _148.7 (c = 0.52, dichloromethane, >99% ee). 
EA calcd (%) for C21H25NOS2: C, 67.89; H, 6.78; N, 3.77. Found: C, 67.92; H, 6.79; N, 3.80. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 19.1 
min (major), tR = 44.0 min (minor). 
 
endo 3-{[(1R,2S,3S,4S)-(4-Tolyl)-bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-thiazolidine-
thione ((R)-84) 
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By general method X Cu(II)(OTf)2 (72.0 mg, 0.20 mmol), (R,R)-t-Bu-box ligand (R)-32b 
(65.0 mg, 0.22 mmol), thiazolidinethione 63 (263 mg, 1.00 mmol) and cyclopentadiene 
(0.83 mL, 10.0 mmol) in dichloromethane (4 mL) gave a yellow oil. The crude product was 
purified by flash column chromatography (SiO2, 3 × 25 cm, ethyl acetate/hexanes 1:5) to give 
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endo DA adduct (R)-84 (292 mg, 87%, endo ee 94%, endo:exo 97:3, >99% conversion) as a 
yellow transparent oil. 
C18H19NOS2 (329.48): 
Rf = 0.61 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.49 (ob. dq, 2J = 8.6 Hz, J = 1.8 Hz, 1 H, CHCHHCH), 
1.79 (dd, 2J = 8.8 Hz, J = 0.8 Hz, 1 H, CHCHHCH), 2.30 (s, 3 H, CH3), 2.92 (d, 2J = 1.0 Hz, 
1 H, CH(4)), 3.16-3.35 (m, 3 H, PhCH, SCH2), 3.52 (s, 1H, CH(3)), 4.46-4.50 (m, 2 H, 
NCH2), 5.10 (dd, 3J = 5.0 Hz, J = 3.3 Hz, 1 H, CHC=O), 5.92 (dd, 3J = 5.8 Hz, J = 2.8 Hz, 
1H, CH(1)=CH), 6.50 (dd, 3J = 5.6 Hz, 3J = 3.3 Hz, 1H, CH(2)=CH), 7.08 (d, 3J = 8.4 Hz, 2 
H, Har), 7.14 (d, 3J = 8.3 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 20.7 (CH3, 11), 28.3 (CH2, 15), 47.5 (CH2, 7), 47.5 
(CH, 3), 47.8 (CH, 6), 50.2 (CH, 4), 51.5 (CH, 12), 57.1 (CH2, 14), 127.5 (CarH), 129.1 
(CarH), 132.2 (CH, 1), 135.8 (C, 10), 140.2 (CH, 2), 140.7 (C, 7), 175.6 (C, 13), 202.0 (C, 16). 
IR (NaCl): ν~ = 2980s, 1696s, 1513s, 1513m, 1492m, 1366m, 1329m, 1276m, 1157m, 1048s. 
MS (FAB, NBA (subtr)), m/z (%): 330 ([M+H]+, 21), 263 (21), 211 ([C8H7O]+, 10), 145 
(100). 
[α] 20D  = +153.8 (c = 0.50, dichloromethane, 99% ee). 
EA calcd (%) for C18H19NOS2: C, 65.62; H, 5.81; N, 4.25. Found: C, 65.65; H, 5.81; N, 4.36. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 22.5 
min (minor), tR = 58.4 min (major). 
 
endo 3-{[(1R,2S,3S,4S)-(4-Ethylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]-carbonyl}-2-
thiazolidinethione ((R)-85) 
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By general method X Cu(II)(OTf)2 (72.0 mg, 0.20 mmol), (R,R)-t-Bu-box (R)-32b (65.0 mg, 
0.22 mmol), thiazolidinethione 64 (277 mg, 1.00 mmol) and cyclopentadiene (0.83 mL, 
10.0 mmol) in dichloromethane (4 mL) gave a yellow oil. The crude product was purified by 
flash column chromatography (SiO2, 3 × 25 cm, ethyl acetate/hexanes 1:5) and 
recrystallisation (Et2O/pentane) to give endo DA adduct (R)-85 (255 mg, 74%, endo ee >99%, 
endo:exo  97:3, >99% conversion) as yellow needles. 
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C19H21NOS2 (343.51): 
m.p. 68-70 °C (Et2O/pentane). 
Rf = 0.57 (ethyl acetate/ hexanes 1 : 1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.20 (t, 3J = 7.6 Hz, 3 H, CH3), 1.49 (ob. dq, 2J = 8.6 Hz, 
J = 1.8 Hz, 1 H, CHCHHCH), 1.80 (d, 2J = 8.6 Hz, 1 H, CHCHHCH), 2.59 (q, 3J = 7.6 Hz, 2 
H, CH2CH3), 2.94 (d, J = 1.5 Hz, 1 H, CH(4)), 3.16-3.35 (m, 3 H, PhCH, SCH2), 3.54 (s, 1H, 
CH(3)), 4.46-4.50 (m, 2 H, NCH2), 5.13 (dd, 3J = 5.0 Hz, J = 3.3 Hz, 1H, CHC=O), 5.93 (dd, 
3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.51 (dd, 3J = 5.6 Hz, 3J = 3.0 Hz, 1H, CH(2)=CH), 
7.12 (d, 3J = 8.3 Hz, 2 H, Har), 7.18 (d, 3J = 8.1 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 15.5 (CH3, 12), 28.3 (CH2, 11), 28.4 (CH2, 16), 
47.5 (CH2, 5), 47.5 (CH, 3), 47.8 (CH, 6), 50.2 (CH, 4), 51.5 (CH, 13), 57.1 (CH2, 15), 127.6 
(CarH), 128.0 (CarH), 132.2 (CH, 1), 140.2 (CH, 2), 141.0 (C, 10), 142.2 (C, 7), 175.6 (C, 14), 
202.0 (C, 17). 
IR (KBr): ν~ = 2966s, 1696s, 1513m, 1457m, 1366m, 1276m, 1158m, 1049s. 
MS (FAB, NBA (subtr)), m/z (%): 344 ([M+H]+, 19), 277 (20), 225 (11), 159 (100). 
[α] 20D  = +150.1 (c = 0.50, dichloromethane, 99% ee). 
EA calcd (%) for C19H21NOS2: C, 66.43; H, 6.16; N, 4.08. Found: C, 66.31; H, 6.09; N, 4.17. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 21.2 
min (minor), tR = 46.9 min (major). 
 
endo 3-{[(1R,2S,3S,4S)-(4-n-Propylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-
thiazolidinethione ((R)-86) 
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By general method X Cu(II)(OTf)2 (36.0 mg, 0.10 mmol), (R,R)-t-Bu-box (R)-32b (32.0 mg, 
0.11 mmol), thiazolidinethione 65 (146 mg, 0.50 mmol) and cyclopentadiene (0.42 mL, 
5.00 mmol) in dichloromethane (2 mL) gave a yellow oil. The crude product was purified by 
flash column chromatography (SiO2, 2 × 20 cm, ethyl acetate/hexanes 1:5) and 
recrystallisation (Et2O/pentane) to give endo DA adduct (R)-86 (127 mg, 71%, endo ee >99%, 
endo:exo 97:3, 100% conversion) as yellow needles. 
C20H23NOS2 (357.53): 
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m.p. 95-96 °C (Et2O/pentane). 
Rf = 0.69 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 0.93 (t, 3J = 7.3 Hz, 3 H, CH3), 1.49 (ob. dq, 2J = 8.8 Hz, 
3J = 3.5 Hz, 3J = 1.8 Hz, 1 H, CHCHHCH), 1.69 (sext, 3J = 7.6 Hz, CH2CH3), 1.80 (d, 2J = 
8.6 Hz, 1 H, CHCHHCH), 2.54 (t, 3J = 7.6 Hz, 2 H, CH2CH2CH3), 2.94 (d, 3J = 1.5 Hz, 1 H, 
CH(4)), 3.16-3.35 (m, 2 H, SCH2), 3.27 (dd, 3J = 4.8 Hz, J = 1.3 Hz,, 1 H, PhCH), 3.54 (s, 1 
H, CH(3)), 4.46-4.50 (m, 2 H, NCH2), 5.13 (dd, 3J = 5.1 Hz, J = 3.6 Hz, 1H, CHC=O), 5.92 
(dd, 3J = 5.5 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.51 (dd, 3J = 5.6 Hz, J = 3.0 Hz, 1H, 
CH(2)=CH), 7.19 (d, 3J = 8.3 Hz, 2 H, Har), 7.17 (d, 3J = 8.1 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 13.7 (CH3, 13), 24.7 (CH2, 12), 28.3 (CH2, 17), 
37.5 (CH2, 11), 47.5 (CH, 3), 47.5 (CH2, 5), 47.8 (CH, 6), 50.3 (CH, 4), 51.4 (CH, 14), 57.1 
(CH2, 16), 127.5 (CarH), 128.5 (CarH), 132.2 (CH, 1), 140.2 (CH, 2), 140. 7 (C, 10), 141.0 (C, 
7), 175.6 (C, 15), 202.0 (C, 18). 
IR (KBr): ν~ = 2950s, 1712s, 1511m, 1459m, 1432m, 1364s, 1327s, 1278s, 1215s, 1154s, 
1027s, 803s, 755s, 707s. 
MS (FAB, NBA (subtr)), m/z (%): 358 ([M+H]+, 40), 291 ([M-C5H6]+, 26), 239 (24), 173 
([291-C9H10]+, 100), 91 (9), 43 ([C3H7]+, 11). 
[α] 20D  = +188.9 (c = 0.49, dichloromethane, >99% ee). 
EA calcd (%) for C20H23NOS2: C, 67.19; H, 6.48; N, 3.93. Found: C, 67.00; H, 6.57; N, 3.93. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 19.0 
min (minor), tR = 39.7 min (major). 
 
endo 3-{[(1R,2S,3S,4S)-(4-i-Propylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-
thiazolidinethione ((R)-87) 
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By general method X Cu(II)(OTf)2 (36.0 mg, 0.10 mmol), (R,R)-t-Bu-box (R)-32b (32.0 mg, 
0.11 mmol), thiazolidinethione 66 (146 mg, 0.50 mmol) and cyclopentadiene (0.42 mL, 
5.00 mmol) in dichloromethane (2 mL) gave a yellow oil. The crude product was purified by 
flash column chromatography (SiO2, 2 × 20 cm, ethyl acetate/hexanes 1:5) and 
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recrystallisation (Et2O/pentane) to give endo DA adduct (R)-87 (156 mg, 87%, endo >99% ee, 
endo:exo 97:3, 100% conversion) as yellow needles. 
C20H23NOS2 (357.53): 
Rf = 0.69 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.22 (d, 3J = 7.1 Hz, 6 H, CH3), 1.49 (ob. dq, 2J = 8.8 Hz, 
3J = 1.8 Hz, 1 H, CHCHHCH), 1.80 (d, 2J = 8.8 Hz, 1 H, CHCHHCH), 2.87 (sept, 3J = 6.8 
Hz, CH(CH3)2), 2.94 (d, 3J = 1.5 Hz, 1 H, CH(4)), 3.17-3.35 (m, 2 H, SCH2), 3.27 (dd, 3J = 
4.8 Hz, 3J = 1.3 Hz, 1 H, PhCH), 3.54 (s, 1 H, CH(3)), 4.46-4.50 (m, 2 H, NCH2), 5.14 (dd, 3J 
= 5.0 Hz, J = 3.6 Hz, 1H, CHC=O), 5.92 (dd, 3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.50 
(dd, 3J = 5.6 Hz, J = 3.3 Hz, 1H, CH(2)=CH), 7.15 (d, 3J = 8.4 Hz, 2 H, Har), 7.19 (d, 3J = 8.3 
Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 23.8 (CH3, 12/13), 28.3 (CH2, 17), 33.7 (CH, 11), 
47.5 (CH2, 5), 47.5 (CH2, 6), 47.8 (CH, 3), 50.3 (CH, 4), 51.4 (CH, 14), 57.1 (CH2, 16), 126.5 
(CarH), 127.6 (CarH), 132.2 (CH, 1), 140.3 (CH, 2), 141.1 (C, 7), 146.8 (C, 10), 175.6 (C, 15), 
202.0 (C, 18). 
MS (EI, 70eV, ca. 150 °C), m/z (%): 323 ([M-H2S]+, 7), 291 (70), 263 (5), 195 (8), 173 (100), 
131 (71), 115 (8), 66 (10), 43 ([C3H7]+, 12). 
[α] 20D  = +135.8 (c = 0.41, dichloromethane, >99% ee). 
EA calcd (%) for C20H23NOS2: C, 67.19; H, 6.48; N, 3.92. Found: C, 66.52; H, 6.34; N, 4.00. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 19.8 
min (minor), tR = 35.2 min (major). 
 
endo 3-{[(1R,2S,3S,4S)-(4-n-Butylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]carbonyl}-2-
thiazolidinethione ((R)-88) 
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By general method X Cu(II)(OTf)2 (72.0 mg, 0.20 mmol), (R,R)-t-Bu-box (R)-32b (65.0 mg, 
0.22 mmol), thiazolidinethione 67 (305 mg, 1.00 mmol) and cyclopentadiene (0.42 mL, 
5.00 mmol) in dichloromethane (4 mL) gave a yellow oil. The crude product was purified by 
flash column chromatography (SiO2, 3 × 25 cm, ethyl acetate/hexanes 1:5) and 
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recrystallisation (Et2O/pentane) to give endo DA adduct (R)-88 (245 mg, 66%, endo ee >99%, 
endo:exo 97:3, 100% conversion) as yellow needles.  
C21H25NOS2 (371.56): 
m.p. 66-67 °C (Et2O/pentane). 
Rf = 0.69 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 0.92 (t, 3J = 7.3 Hz, 3 H, CH3), 1.34 (sext, 3J = 7.3 Hz, 
CH2CH3), 1.48 (ob. dq, 2J = 8.8 Hz, J = 1.8 Hz, 1 H, CHCHHCH), 1.54-1.60 (m, 2 H, 
CH2CH2CH3), 1.80 (d, 2J = 8.8 Hz, 1 H, CHCHHCH), 2.56 (t, 3J = 7.8 Hz, 2 H, CH2CH2 
CH2CH3), 2.94 (m, 1 H, CH(4)), 3.16-3.33 (m, 2 H, SCH2), 3.27 (dd, 3J = 5.5 Hz, J = 1.5 Hz, 
1 H, PhCH), 3.53 (m, 1 H, CH(3)), 4.46-4.50 (m, 2 H, NCH2), 5.13 (dd, 3J = 5.3 Hz, J = 3.6 
Hz, 1H, CHC=O), 5.92 (dd, 3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.50 (dd, 3J = 5.6 Hz, J 
= 3.0 Hz, 1H, CH(2)=CH), 7.10 (d, 3J = 8.4 Hz, 2 H, Har), 7.17 (d, 3J = 7.8 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 13.8 (CH3, 14), 22.5 (CH2, 13), 28.3 (CH2, 18), 
33.8 (CH2, 12), 35.1 (CH2, 11), 47.5 (CH, 3), 47.5 (CH2, 5), 47.8 (CH, 6), 50.3 (CH, 4), 51.4 
(CH, 15), 57.1 (CH2, 17), 127.5 (CarH), 128.5 (CarH), 132.2 (CH, 1), 140.2 (CH, 2), 140.9 (C, 
10), 140.9 (C, 7), 175.6 (C, 16), 202.0 (C, 19). 
IR (KBr): ν~ = 2924m, 1686s, 1511m, 1458m, 1368s, 1264s, 1170s, 1037s, 820m, 764m, 
701s. 
MS (EI, 70eV, ca. 150 °C), m/z (%): 337 ([M-H2S]+, 6), 305 (46), 187 (100), 131 (19), 115 
(16), 66 (5), 57 ([C4H9]+, 5). 
[α] 20D  = +176.6 (c = 0.51, dichloromethane, 99% ee). 
EA calcd (%) for C21H25NOS2: C, 67.89; H, 6.78; N, 3.77. Found: C, 67.87; H, 6.70; N, 3.86. 
HPLC: Chiralcel OD-H, i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 19.3 
min (major), tR = 43.8 min (minor). 
 
3-{[(1S,2S,4S)-7-Oxa-bicyclo[2.2.1]hept-5-en-2yl]carbonyl}-2-oxazolidinone (38)[121]  
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Cu(II)Cl2 (6.70 mg, 0.05 mmol), (S,S)-t-Bu-box 32b (16.2 mg, 55.0 µmol) and AgSbF6 
(34.4 mg, 0.10 mmol) were mixed together in glove box and the flask was wrapped in 
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aluminium foil to protect the reaction mixture from light. The flask was connected to a 
Schlenk line and dichloromethane (1.5 mL) was added. After stirring for 16 hours at room 
temperature, the catalyst mixture was filtered through a plug of celite (rinsed with 
dichloromethane (3 mL)) into a solution of oxazolidinone 35 (142 mg, 1.00 mmol) and furan 
(0.80 mL, 10.0 mmol) in dichloromethane (1.2 mL) at –78 °C. After stirring for 3 hours at 
-20 °C the blue reaction mixture was quenched with 25% aqueous NH4OH (1 mL). The 
aqueous phase was extracted with dichloromethane (3 × 2 mL), the combined organic extracts 
were washed with brine and dried ( Na2SO4). After removal of the solvent under reduced 
pressure an oil with white solid was obtained. The crude product was purified by flash column 
chromatography (SiO2, 2 × 10 cm, ethyl acetate/hexanes 2:3) and recrystallisation 
(ethyl acetate/hexanes) to give DA adduct 38 (14 mg, 5%, endo ee 77%, dr 35:65, 86% 
conversion) as colourless crystals. 
C18H19NO3 (209.20): 
m.p. 90-91 °C (ethyl acetate/hexanes) [lit.,[121] 89 °C]. 
Rf = 0.22 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): major diastereoisomer δ = 1.63 (dd, 2J =11.4 Hz, 3J = 4.0 
Hz, 1 H, CHCHHCH), 2.11 (ddd, 2J =11.4 Hz, 3J = 9.1 Hz, 3J = 4.8 Hz, 1 H, CHCHHCH), 
4.02-3.86 (m, 3 H, CHC=O, NCH2), 4.44-4.34 (m, 2 H, OCH2), 5.02 (ddd, 3J = 5.8 Hz, J = 
1.5 Hz, J = 0.8 Hz, 1H, CH(6)), 5.26 (ddd, 3J = 5.6 Hz, J = 1.5 Hz, J = 0.8 Hz, 1H, CH(2)), 
6.16 (dd, 3J = 5.8 Hz, 3J = 1.5 Hz, 1H, CH=CH), 6.44 (dd, 3J = 5.8 Hz, 3J = 1.8 Hz, 1H, 
CH=CH). 
13C{1H} NMR (100.6 MHz, CD2Cl2): 1 diastereoisomer δ = 29.2 (CH2, 4), 42.9 (CH, 3), 43.3 
(CH2, 8), 62.4 (CH2, 9), 79.2 (CH , 2/6), 79.4 (CH, 2/6), 131.9 (CH, 1/5), 137.0 (CH, 1/5), 
153.0 (C, 10), 171.6 (C, 7). 
IR (KBr): ν~ = 3433s, 2920s, 1774s, 1690s, 1396s, 1231s, 1124s, 1049s, 866s, 755s, 700s. 
MS (FAB, NBA (subtr)), m/z (%): 295 (5), 210 ([M+H]+, 17). 
[α] 20D  = _81.5 (c = 1.00, CHCl3, 77% ee) [lit.,[121] -99.1 (c = 1.00, CHCl3, 97% ee)]. 
EA calcd (%) for C10H11NO4: C, 57.41; H, 5.30; N, 6.70. Found: C, 57.18; H, 5.29; N, 6.59. 
HPLC: Chiralcel OD-H, i-propanol/heptane (30:70), 0.65 mL/min, 20 °C, 210 nm, tR = 27.3 
min (major), tR = 38.7 min (minor). 
The spectroscopic data are in agreement with that previously reported in the literature.[121]  
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5.4 Synthesis of Diels-Alder Adducts for the Organocatalysed Retro-Diels-
Alder Reaction 
5.4.1 Synthesis of Diels-Alder Adducts 
endo 3-[(1S,2R,3R,4R)-(4-Ethylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]-carbaldehyde  
((S)-112) 
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General Method XI: Endo DA adduct (S)-80 (120 mg, 0.35 mmol) was added in one portion 
to a solution of di-i-butylaluminium hydride (1.7 M in toluene, 0.28 mL, 0.42 mmol) in 
toluene (0.4 mL) at -78 °C. An extra 0.6 mL of toluene were added to dissolve all solid. After 
stirring for 20 minutes at -78 °C and 3 hours at -20 °C the reaction mixture was quenched 
with 1 M H2SO4 (0.2 mL), diluted with dichloromethane (12 mL) and dried over plenty of 
Na2SO4. Removal of the solvent under reduced pressure gave a colourless oil. The crude 
product was purified by flash column chromatography (SiO2, 1 × 16 cm, 
ethyl acetate/hexanes 1:4) to give endo DA adduct (S)-112 (54 mg, 68%) as a colourless oil. 
C16H18O (226.31): 
Rf = 0.87 (ethyl acetate/hexanes 1:4). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.20 (t, 3J = 7.3 Hz, 3 H, CH3), 1.58 (ob. dq, 2J = 8.6 Hz, 
3J = 1.8 Hz, 1 H, CHCHHCH), 1.79 (dt, 2J = 8.6 Hz, 3J = 1.5 Hz, 1 H, CHCHHCH), 2.60 (q, 
3J = 7.6 Hz, 2 H, CH2CH3), 2.92-2.94 (m, 1 H, CHC(=O)H)), 2.99-3.01 (m, 1 H, PhCH), 
3.05-3.06 (m, 1 H, CH(4)), 3.30-3.31 (m, 1 H, CH(3)), 6.16 (dd, 3J = 5.5 Hz, J = 2.8 Hz, 1H, 
CH(1)=CH), 6.41 (dd, 3J = 5.6 Hz, J = 3.3 Hz, 1H, CH(2)=CH), 7.13-7.19 (m, 4 H, Har), 9.55 
(d, 3J = 2.5 Hz, 1 H, HC=O). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 15.5 (CH3, 12), 28.9 (CH2, 11), 45.7 (CH, 3), 46.1 
(CH, 6), 47.5 (CH2, 5), 49.4 (CH, 4), 61.3 (CH, 13), 127.9 (CarH), 128.5 (CarH), 134.2 (CH, 
1), 139.7 (CH, 2), 141.5 (C, 7), 142.6 (C, 10), 204.0 (C, 14).  
IR (NaCl): ν~ = 3057s, 2968s, 2873m, 2714m, 1719s, 1513m, 1455m, 1332m, 1067m, 826m, 
718m. 
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MS (EI, 70eV, ca. 100 °C), m/z (%): 176 (35), 161 ([M-C5H5]+, 53), 131 ([M-C7H10]+, 100), 
115 (20), 66 (36). 
[α] 20D  = _114.0 (c = 0.20, dichloromethane). 
EA calcd (%) for C16H18O: C, 84.91; H, 8.02. Found: C, 84.85; H, 8.20. 
 
endo 3-[(1S,2R,3R,4R)-(4-n-Propylphenyl)-bicyclo[2.2.1]hept-5-ene]-2-carbaldehyde  
((S)-113) 
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By general method XI di-i-butylaluminium hydride (1.7 M in toluene, 0.10 mL, 0.14 mmol) 
and endo DA adduct (S)-82 (42.0 mg, 0.118 mmol) in toluene (0.7 mL) gave a colourless oil. 
The crude product was purified by flash column chromatography (SiO2, 1 × 12 cm, 
ethyl acetate/hexanes 1:4) to give endo DA adduct (S)-113 (23 mg, 81%) as a colourless oil. 
C17H20O (240.34): 
Rf = 0.81 (ethyl acetate/hexanes 1:4). 
1H NMR (400.1 MHz, CDCl3): δ = 0.94 (t, 3J = 7.3 Hz, 3 H, CH3), 1.62 (m, 3 H, CH2CH3, 
CHCHHCH), 1.80 (d, 2J = 8.8 Hz, 1 H, CHCHHCH), 2.56 (t, 3J = 7.3 Hz, 2 H, CH2CH2CH3), 
2.97-2.99 (m, 1 H, CHC(=O)H), 3.05-3.06 (m, 1H, PhCH), 3.10 (s, 1 H, CH(4)), 3.31-3.32 
(m, 1 H, CH(3)), 6.16 (dd, 3J = 5.8 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.41 (dd, 3J = 5.8 Hz, J = 
3.3 Hz, 1H, CH(2)=CH), 7.11-7.18 (m, 4 H, Har), 9.58 (d, 3J = 2.2 Hz, 1 H, CH=O). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.9 (CH3, 13), 24.6 (CH2, 12), 37.5 (CH2, 11), 45.1 
(CH, 3), 45.4 (CH, 6), 47.1 (CH2, 5), 48.5 (CH, 4), 60.8 (CH, 14), 127.2 (CarH), 128.6 (CarH), 
133.7 (CH, 1), 139.2 (CH, 2), 140.6 (C, 7), 140.7 (C, 10), 203.7 (C, 15). 
IR (NaCl): ν~ = 2963s, 2879m, 1718s. 
MS (EI, 70eV, r.t.), m/z (%): 175 ([M-C5H5]+, 44), 131 ([M-C8H13], 100), 117 (8), 66 (17). 
[α] 20D  = _90.0 (c = 0.20, dichloromethane). 
EA calcd (%) for C17H20O: C, 84.96; H, 8.39. Found: C, 85.23; H, 8.59. 
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endo 3-[(1S,2R,3R,4R)-(4-n-Butylphenyl)-bicyclo[2.2.1]hept-5-ene]-2-carbaldehyde  
((S)-114) 
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By general method XI di-i-butylaluminium hydride (1.7 M in toluene, 0.09 mL, 134 µmol) 
and endo DA adduct (S)-83 (42.0 mg, 112 µmol) in toluene (0.7 mL) gave a colourless oil. 
The crude product was purified by flash column chromatography (SiO2, 1 × 12 cm, 
ethyl acetate/hexanes 1:4) to give endo DA adduct (S)-114 (21 mg, 74%) as a colourless oil. 
C18H22O (254.37): 
Rf = 0.95 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 0.92 (t, 3J = 7.3 Hz, 3 H, CH3), 1.35 (sext, 3J = 7.6 Hz, 
CH2CH3), 1.54-1.62 (m, 3 H, CH2CH2CH3, CHCHHCH), 1.80 (d, 3J = 8.8 Hz, 1 H, 
CHCHHCH), 2.58 (t, 3J = 7.8 Hz, 2 H, CH2CH2CH2CH3), 2.97-2.95 (m, 1 H, CHC(=O)H), 
3.04-3.05 (m, 1 H, PhCH), 3.09-3.10 (m, 1 H, CH(4)), 3.32 (s, 1 H, CH(3)), 6.16 (dd, 3J = 5.8 
Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.41 (dd, 3J = 5.6 Hz, J = 3.3 Hz, 1H, CH(2)=CH), 7.11 (d, 
3J = 8.1 Hz, 2 H, Har), 7.17 (d, 3J = 8.1 Hz, 2 H, Har), 9.58 (d, 3J = 2.2 Hz, 1 H, HC=O). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.9 (CH3, 14), 22.4 (CH2, 13), 33.6 (CH2, 12), 35.1 
(CH2, 11), 45.1 (CH, 3), 45.4 (CH, 6), 47.1 (CH2, 5), 48.5 (CH, 4), 60.8 (CH, 15), 127.2 
(CarH), 128.6 (CarH), 133.7 (CH, 1), 139.2 (CH, 2), 140.6 (C, 7), 140.8 (C, 10), 203.7 (C, 16). 
IR (NaCl): ν~ = 2959s, 2865s, 2713m, 1719s, 1513m, 1458m, 1333m, 1069m, 721s. 
MS (EI, 70eV, r.t.), m/z (%): 189 ([M-C5H5]+, 5), 131 ([M-C9H14]+, 100), 117 (8), 66 (12). 
[α] 20D  = _67.2 (c = 0.50, dichloromethane). 
EA calcd (%) for C18H22O: C, 84.99; H, 8.72. Found: C, 84.89; H, 8.73.  
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endo 3-[(1R,2S,3S,4S)-(4-Ethylphenyl)-bicyclo[2.2.1]hept-5-en-2-yl]-carbaldehyde  
((R)-115) 
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By general method XI di-i-butylaluminium hydride (1.7 M in toluene, 0.14 mL, 0.21 mmol) 
and endo DA adduct (R)-85 (60.0 mg, 0.175 mmol) in toluene (0.6 mL) gave a colourless oil. 
The crude product was purified by flash column chromatography (SiO2, 1 × 12 cm, 
ethyl acetate/hexanes 1:4) to give endo DA adduct (R)-115 (30 mg, 76%) as a colourless oil. 
C16H18O (266.31): 
Rf = 0.87 (ethyl acetate/hexanes 1:4). 
1H NMR (400.1 MHz, CDCl3): δ = 1.23 (t, 3J = 7.2 Hz, 3 H, CH3), 1.61 (dd, 2J = 8.6 Hz, 3J = 
1.8 Hz, 1 H, CHCHHCH), 1.81 (d, 2J = 8.6 Hz, 1 H, CHCHHCH), 2.62 (q, 3J = 7.6 Hz, 2 H, 
CH2CH3), 2.97-2.98 (m, 1 H, CHC=O), 3.05-3.06 (m, 1 H, PhCH), 3.10 (s, 1 H, CH(4)), 3.32 
(s, 1 H, CH(3)), 6.17 (dd, 3J = 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.41 (dd, 3J = 5.8 Hz, J = 
3.3 Hz, 1H, CH(2)=CH), 7.14 (d, 3J = 8.3 Hz, 2 H, Har), 7.19 (d, 3J = 8.1 Hz, 2 H, Har), 9.59 
(d, 3J = 2.3 Hz, 1 H, CH=O). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 15.6 (CH3, 12), 28.3 (CH2, 11), 45.1 (CH, 3), 45.4 
(CH, 6), 47.1 (CH2, 5), 48.5 (CH, 4), 60.8 (CH, 13), 127.3 (CarH), 128.0 (CarH), 133.7 (CH, 
1), 139.2 (CH, 2), 140.7 (C, 7), 142.6 (C, 10), 203.7 (C, 14). 
IR (NaCl): ν~ = 2966s, 1720s, 1513m, 1458m, 1244m, 1126m. 
MS (EI, 70eV, r.t.), m/z (%): 161 ([M-C5H5]+, 56), 131 ([M-C7H10]+, 100), 66 (18). 
[α] 20D  = +99.0 (c = 0.20, dichloromethane). 
EA calcd (%) for C16H18O: C, 84.91; H, 8.02. Found: C, 83.71; H, 8.16.  
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endo 3-[(1R,2S,3S,4S)-(4-n-Propylphenyl)-bicyclo[2.2.1]hept-5-ene]-2-carbaldehyde  
((R)-116) 
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By general method XI di-i-butylaluminium hydride (1.7 M in toluene, 0.06 mL, 94.0 µmol) 
and endo DA adduct (R)-87 (28.0 mg, 78.7 µmol) in toluene (0.4 mL) gave a colourless oil. 
The crude product was purified by flash column chromatography (SiO2, 1 × 10 cm, 
ethyl acetate/hexanes 1:4) to give endo DA adduct (R)-116 (16 mg, 85%) as a colourless oil. 
C17H20O (240.34): 
Rf = 0.81 (ethyl acetate/hexanes 1:4). 
1H NMR (400.1 MHz, CDCl3): δ = 0.94 (t, 3J = 7.3 Hz, 3 H, CH3), 1.60 (m, 3 H, CH2CH3, 
CHCHHCH), 1.81 (d, 3J = 8.8 Hz, 1 H, CHCHHCH), 2.56 (t, 3J = 7.3 Hz, 2 H, CH2CH2CH3), 
2.97-2.99 (m, 1 H, CHC(=O)H), 3.05 (d, 3J = 4.0 Hz, 1 H, PhCH), 3.09-3.10 (m, 1 H, CH(4)), 
3.32 (s, 1 H, CH(3)), 6.16 (dd, 3J = 5.8 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.41 (dd, 3J = 5.8 Hz, 
J = 3.3 Hz, 1H, CH(2)=CH), 7.12 (d, 3J = 8.3 Hz, 2 H, Har), 7.17 (d, 3J = 7.8 Hz, 2 H, Har), 
9.59 (d, 3J = 2.3 Hz, 1 H, CH=O). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.9 (CH3, 13), 24.5 (CH2, 12), 37.5 (CH2, 11), 45.1 
(CH, 3), 45.4 (CH, 6), 47.1 (CH2, 5), 48.5 (CH, 4), 60.8 (CH, 14), 127.2 (CarH), 128.6 (CarH), 
133.7 (CH, 1), 139.2 (CH, 2), 140.6 (C, 7), 140.7 (C, 10), 203.7 (C, 15). 
IR (NaCl): ν~ = 2962s, 2711m, 1718s, 1513s, 1332m. 
MS (EI, 70eV, r.t.), m/z (%): 175 ([M-C5H5]+, 44), 131 ([M-C9H14]+, 100), 117 (8), 66 (17). 
[α] 20D  = +103.0 (c = 0.20, dichloromethane). 
EA calcd (%) for C17H20O: C, 84.96; H, 8.39. Found: C, 84.95; H, 8.57. 
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endo 3-[(1R,2S,3S,4S)-(4-i-Propylphenyl)-bicyclo[2.2.1]hept-5-ene]-2-carbaldehyde  
((R)-117) 
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By general method XI di-i-butylaluminium hydride (1.7 M in toluene, 0.11 mL, 0.17 mmol) 
and endo DA adduct (R)-86 (50.0 mg, 0.14 mmol) in toluene (0.7 mL) gave a colourless oil. 
The crude product was purified by flash column chromatography (SiO2, 1 × 12 cm, 
ethyl acetate/hexanes 1:4) to give endo DA adduct (R)-117 (23 mg, 68%) as a colourless oil. 
C17H20O (240.34): 
Rf = 0.87 (ethyl acetate/hexanes 1:4). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.24 (d, 3J = 7.1 Hz, 3 H, CH3), 1.25 (d, 3J = 6.8 Hz, 3 H, 
CH3), 1.60 (dd, 2J = 8.6 Hz, 3J = 1.5 Hz, 1 H, CHCHHCH), 1.82 (d, 3J = 8.6 Hz, 1 H, 
CHCHHCH), 2.89 (sept, 3J = 7.1 Hz, 1 H, CHCH3), 2.97-3.00 (m, 1 H, CHC(=O)H), 3.05 (d, 
3J = 4.8 Hz, 1 H, PhCH), 3.11 (s, 1 H, CH(4)), 3.32 (s, 1 H, CH(3)), 6.17 (dd, 3J = 5.6 Hz, J = 
2.8 Hz, 1H, CH(1)=CH), 6.41 (dd, 3J = 5.6 Hz, J = 3.3 Hz, 1H, CH(2)=CH), 7.17-7.21 (m, 4 
H, Har), 9.59 (d, 3J = 2.2 Hz, 1 H, CH=O). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 24.0 (CH3, 12/13), 33.6 (CH, 11), 45.1 (CH, 3), 
45.4 (CH, 6), 47.1 (CH2, 5), 48.5 (CH, 4), 60.7 (CH, 14), 126.6 (CarH), 127.3 (CarH), 133.7 
(CH, 1), 140.8 (CH, 2), 140.8 (C, 7), 146.8 (C, 10), 203.7 (C, 15). 
IR (NaCl): ν~ = 3058s, 2963s, 2873m, 2810m, 2713m, 1719s, 1512m, 1458m, 1332m, 1064m, 
1018m, 826m, 729m. 
MS (EI, 70eV, r.t.), m/z (%):175 ([M-C5H5]+, 38), 131 (100), 115 (7), 66 (10). 
[α] 20D  = +97.0 (c = 0.20, dichloromethane). 
EA calcd (%) for C17H20O: C, 84.96; H, 8.39. Found: C, 83.85; H, 8.51. 
The spectroscopic data (1H NMR, 13C NMR) are in agreement with that previously reported 
in the literature.[112]  
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endo 3-[(1R,2S,3S,4S)-(4-n-Butylphenyl)-bicyclo[2.2.1]hept-5-ene]-2-carbaldehyde  
((R)-118) 
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By general method XI di-i-butylaluminium hydride (1.7 M in toluene, 0.07 mL, 97.0 µmol) 
and endo DA adduct (R)-88 (30.0 mg, 81.0 µmol) in toluene (0.5 mL) gave a colourless oil. 
The crude product was purified by flash column chromatography (SiO2, 1 × 10 cm, 
ethyl acetate/hexanes 1:4) to give endo DA adduct (R)-118 (18 mg, 87%) as a colourless oil. 
C18H22O (254.37): 
Rf = 0.95 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CD2Cl2): δ = 0.92 (t, 3J = 7.3 Hz, 3 H, CH3), 1.34 (sext, 3J = 7.6 Hz, 
CH2CH3), 1.53-1.61 (m, 3 H, CH2CH2CH3, CHCHHCH), 1.79 (dt, 3J = 8.6 Hz, 3J = 1.5 Hz, 1 
H, CHCHHCH), 2.57 (t, 3J = 7.8 Hz, 2 H, CH2CH2CH2CH3), 2.93-2.95 (m, 1 H, CHC(=O)H), 
3.00-3.01 (m, 1 H, PhCH), 3.05-3.06 (m, 1 H, CH(4)), 3.30-3.31 (m, 1 H, CH(3)), 6.16 (dd, 3J 
= 5.6 Hz, J = 2.8 Hz, 1H, CH(1)=CH), 6.40 (dd, 3J = 5.6 Hz, J = 3.3 Hz, 1H, CH(2)=CH), 
7.11-7.18 (m, 4 H, Har), 9.55 (d, 3J = 2.2 Hz, 1 H, CH=O). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 14.3 (CH3, 14), 22.9 (CH2, 13), 34.3 (CH2, 12), 
35.6 (CH2, 11), 45.7 (CH, 3), 46.0 (CH, 6), 47.5 (CH2, 5), 49.4 (CH, 4), 61.3 (CH, 15), 127.8 
(CarH), 129.1 (CarH), 134.2 (CH, 1), 139.7 (CH, 2), 141.4 (C, 7), 141.4 (C, 10), 204.0 (CH, 
16). 
IR (NaCl): ν~ = 2960s, 2713s, 1719s, 1513s. 
MS (EI, 70eV, r.t.), m/z (%): 189 ([M-C5H5]+, 31), 131 ([M-C9H14]+, 100), 117 (11), 66 (15). 
[α] 20D  = +79.0 (c = 0.50, dichloromethane). 
EA calcd (%) for C18H22O: C, 84.99; H, 8.72. Found: C, 84.89; H, 8.73.  
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3-(4-Propylphenyl)-propenal (119)[189] 
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Acroleindiethyl acetal (3.43 mL, 22.5 mmol), tetrabutylammoniumacetate (4.52 g, 
15.0 mmol), K2CO3 (1.56 g, 11.3 mmol), KCl (0.56 g, 7.50 mmol) and palladium acetate 
(25.0 mg, 225 µmol) were added to a solution of 1-n-propyl-4-iodobenzene (1.85 mL, 
7.50 mmol) in N,N-dimethylformamide (30 mL). After stirring for 2 hours at 90 °C and 
cooling to room temperature, 1 N HCl (25 mL) and Et2O (120 mL) were added. Washing with 
ice water (280 mL), drying (Na2SO4) and concentration under reduced pressure gave a brown 
oil. The crude product was purified by flash column chromatography (SiO2, 3 × 17 cm, 
ethyl acetate/hexanes 1:10) to give aldehyde 119 (1.05 g, 80%) as a transparent yellow oil. 
C12H14O (174.24): 
Rf = 0.67 (ethyl acetate/hexanes 1:1) 
1H NMR (400.1 MHz, CDCl3): δ = 0.95 (t, 3J = 7.6 Hz, 3 H, CH3), 1.65 (sext, 3J = 7.6 Hz, 2 
H, CH2CH3), 2.63 (t, 3J = 7.6 Hz, 2 H, CH2CH2CH3), 6.69 (dd, 3J = 15.9 Hz, 3J = 7.8 Hz, 1 H, 
CHCH=O), 7.24 (d, 3J = 8.1 Hz, 2 H, Har), 7.46 (d, 3J = 15.2 Hz, 1 H, C6H4CH), 7.48 (d, 3J = 
8.1 Hz, 2 H, Har), 9.68 (d, 3J = 7.8 Hz, 1 H, CH=O). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.9 (CH3, 10), 24.3 (CH2, 9), 38.0 (CH2, 8), 127.7 
(CH, 2), 128.5 (CarH, 5), 129.2 (CarH, 6), 131.5 (C, 4), 146.7 (C, 7), 153.0 (CH, 3), 193.8 
(CH, 1). 
IR (NaCl): ν~ = 2960s, 2868s, 2736m, 2362m, 1675s, 1618s, 1460m, 1423m, 1126s, 977s, 
816s. 
MS (EI, 70 eV, r.t.), m/z (%): 175 ([M+H]+, 10), 131 ([C9H7O]+,100), 117 (16), 91 ([C7H7]+, 
25). 
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Acroleindiethyl acetal (3.43 mL, 22.5 mmol), then tetrabutylammoniumacetate (4.52 g, 
15.0 mmol), K2CO3 (1.56 g, 11.3 mmol), KCl (0.56 g, 7.50 mmol) and palladium acetate 
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(25.0 mg, 225 µmol) were added to a solution of 1-n-butyl-4-iodobenzene (1.33 mL, 
7.50 mmol) in N,N-dimethylformamide (30 mL). After stirring for 2 hours at 90 °C and 
cooling to room temperature, 1 N HCl (30 mL) and Et2O (120 mL) were added. Washing with 
ice water (280 mL), drying (Na2SO4) and concentration under reduced pressure gave a brown 
oil. The crude product was purified by flash column chromatography (SiO2, 3 × 16 cm, 
ethyl acetate/hexanes 1:10) to give aldehyde 120 (1.31 g, 93%) as a yellow transparent oil. 
C13H16O (188.27): 
Rf = 0.83 (ethyl acetate/hexanes 1:1). 
1H NMR (400.1 MHz, CDCl3): δ = 0.93 (t, 3J = 7.3 Hz, 3 H, CH3), 1.35 (sext, 3J = 7.3 Hz, 2 
H, CH2CH3), 1.61 (m, 2 H, CH2CH2CH3), 2.65 (t, 3J = 7.6 Hz, 2 H, CH2CH2CH2CH3), 6.69 
(dd, 3J = 15.6 Hz, 3J = 7.8 Hz, 1 H, CHCH=O), 7.24 (d, 3J = 8.1 Hz, 2 H, Har), 7.45 (d, 3J = 
14.7 Hz, 1 H, C6H4CH), 7.49 (d, 3J = 8.1 Hz, 2 H, Har), 9.68 (d, 3J = 7.6 Hz, 1 H, CH=O). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 13.9 (CH3, 11), 22.3 (CH2, 10), 33.3 (CH2, 9), 35.6 
(CH2, 8), 127.7 (CH, 2), 128.6 (CarH, 5), 129.2 (CarH, 6), 131.5 (C, 4), 146.9 (C, 7), 153.0 
(CH, 3), 193.8 (CH, 1). 
IR (NaCl): ν~ = 2956s, 2930s, 2862m, 1678s, 1619s, 1511m, 1461m, 1422m, 1297m, 1250m, 
1125s, 975s, 815m. 
MS (EI, 70 eV, r.t.), m/z (%): 188 ([M]+, 7), 161 (12), 131 ([C9H7O]+, 100), 117 (24), 91 
([C7H7]+, 25).  
 
exo 3-[(1S,2S,3S,4R)-Phenyl-bicyclo[2.2.1]hept-5-ene]-2-dimethoxymethane (126a) and  
endo 3-[(1R,2S,3S,4S)-Phenyl-bicyclo[2.2.1]hept-5-ene]-2-dimethoxymethane (126b)[107, 
190]
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Cinnamaldehyde (131 µL, 1.00 mmol) was added to a solution of 
(5S)-2,2,3-trimethyl-5-benzyl-4-imidazolidinone 23·HCl (12.7 mg, 0.216 mmol) in 
MeOH/water (950 µL:50 µL). The solution was stirred for 2 minutes at room temperature 
before addition of cyclopentadiene (249 µL, 3.00 mmol). After stirring for 24 hours, the 
reaction mixture was diluted with Et2O (20 mL), washed with water (50 mL) and then with 
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brine (20 mL). The organic layer was dried (Na2SO4) and concentrated under reduced 
pressure to give a colourless oil. The crude product was purified by flash column 
chromatography (SiO2, 2 × 12 cm, ethyl acetate/hexanes 1:10) to give a mixture of endo:exo 
diacetales 126a and 126b (full conversion, endo:exo 41:59, endo ee 90%, exo ee 92%) as a 
colourless oil. 
C16H20O2 (244.33): 
Rf = 0.37 (ethyl acetate/hexanes 1:10). 
1H NMR (400.1 MHz, CDCl3): mixture of diastereoisomers δ = 1.50 (d, 3J = 8.6 Hz, 2 H, 
CH), 1.69-1.79 (m, 3 H, CH), 2.03-2.06 (m, 1 H, CH), 2.40 (d, 3J = 4.3 Hz, 1 H, CH), 2.53-
2.57 (m, 1 H, CH), 2.89 (d, J = 13.9 Hz, 2 H, CH), 2.99 (d, J = 14.6 Hz, 2 H, CH), 3.09 (s, 3 
H, CH3, exo), 3.13 (s, 3 H, CH3, exo), 3.34 (s, 3 H, CH3, endo), 3.39 (s, 3 H, CH3, endo), 3.95 
(d, 3J = 9.1 Hz, 1 H, CH(OCH3)2, endo), 4.37 (d, 3J = 8.4 Hz, 1 H, CH(OCH3)2, exo), 5.94 
(dd, 3J = 5.8 Hz, J = 3.0 Hz, 1 H, CH=CH), 6.17 (dd, 3J = 5.6 Hz, J = 2.8 Hz, 1 H, CH=CH), 
6.36 (dd, 3J = 5.6 Hz, 3J = 3.0 Hz, 2 H, CH=CH), 7.14-7.39 (m, 10 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3) mixture of diastereoiosmers: δ = 44.6 (CH), 45.3 (CH), 
47.2 (CH2), 47.3 (CH), 47.6 (CH2), 47.6 (CH), 49.2 (CH), 49.2 (CH), 49.4 (CH), 49.8 (CH), 
52.4 (CH3), 52.4 (CH3), 52.7 (CH3), 53.5 (CH3), 108 (CH, 12), 108.3 (CH, 12), 125.9 (CarH), 
127.9 (CarH), 128.0 (CarH), 128.2 (CarH), 128.3 (CarH),128.4 (CarH), 135.2 (C, 1 or 2), 135,3 
(C, 1 or 2), 137.4 (C, 1 or 2), 138.5 (C, 1 or 2), 144.3 (C, 8), 145.1 (C, 8). 
IR (KBr): ν~ = 2942s, 2829s, 1718s, 1602s, 1498s, 1458s, 1334m, 1132s, 1110s, 1060s. 
[α] 20D  = +117.7 (c = 1.03, CHCl3). 
Chiral GC: ß-CD DetTButSil (SE54) column 60 °C → 180 °C (10 min), 1.5 °C/min, tR = 
59.1 min (exo minor), tR = 61.8 (exo major), tR = 62.3 min (endo minor), tR = 62.7 (endo 
major). 
The spectroscopic data are in agreement with that previously reported for the racemic exo 
compound.[191] 
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exo 3-[(1S,2S,3S,4R)-Phenyl-bicyclo[2.2.1]hept-5-ene]-2-carbaldehyde (127a) and  
endo 3-[[1R,2S,3S,4S]-Phenyl-bicyclo[2.2.1]hept-5-ene]-2-carbaldehyde (127b)[107, 190] 
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Diacetale 126 was stirred in TFA:water:CHCl3 (1:1:2, 12 mL) for 2 hours at room 
temperature. The reaction mixture was carefully neutralised with saturated aqueous NaHCO3 
(20 mL) and extracted with Et2O (3 × 20 mL). The combined organic extracts were dried 
(Na2SO4) and concentrated under reduced pressure to give a colourless oil. The crude product 
was purified by flash column chromatography (SiO2, 2 × 12 cm, ethyl acetate/hexanes 1:10) 
to give a mixture of endo:exo DA aldehyde adducts 127a and 127b (full conversion, endo:exo 
43:57, exo ee 89%, endo ee 89%) as a colourless oil. 
C14H14O (198.26): 
Rf = 0.37 (ethyl acetate/hexanes 1:10). 
1H NMR (400.1 MHz, CDCl3): mixture of diastereoisomers δ = 1.56 ( ob. dq, 3J = 8.8 Hz, J = 
1.8 Hz, 1 H, CHCHHCH), 1.60-1.64 (m, 2 H, CHCHHCH), 1.80-1.83 (m, 1 H, CHCHHCH), 
2.60 (dt, 3J = 5.3 Hz, J = 2.0 Hz, 1 H, CH, exo), 2.97-3.00 (m, 1 H, CH, endo), 3.09-3.10 (m, 
1 H, CH, endo), 3.13-3.14 (m, 1 H, CH, endo), 3.21-3.28 (m, 2 H, CH, exo), 3.33-3.34 (m, 1 
H, CH, endo), 3.73 (dd, 3J = 5.3 Hz, J = 3.6 Hz, 1 H, CH, exo), 6.07 (dd, 3J = 5.6 Hz, J = 3.0 
Hz, 1 H, CH=CH, exo), 6.17 dd, 3J = 5.6 Hz, J = 2.8 Hz, 1 H, CH=CH, endo), 6.34 (dd, 3J = 
5.6 Hz, J = 3.8 Hz, 1 H, CH=CH, exo), 6.42 (dd, 3J = 5.6 Hz, J = 3.3 Hz, 1 H, CH=CH, endo), 
7.14-7.34 (m, 10 H, Har), 9.60 (d, 3J = 2.3 Hz, 1 H, CH=O, endo), 9.93 (d, 3J = 2.0 Hz, 1 H, 
CH=O, exo). 
13C{1H} NMR (100.6 MHz, CDCl3) mixture of diastereoiosmers: δ = 45.1 (CH, endo), 45.4 
(CH, exo), 45.5 (CH, exo), 45.6 (CH, endo), 47.1 (CH2, 5, endo), 47.6 (CH2, 5, exo), 48.3 
(CH, endo), 48.4 (CH, exo), 59.4 (CH, exo), 60.8 (CH, endo), 126.2 (CarH), 126.3 (CarH), 
127.3 (CarH), 127.9 (CarH), 128.1 (CarH), 128.6 (CarH), 133.8 (CH, 1 or 2, endo), 136.3 (CH, 
1 or 2, exo), 136.5 (CH, 1 or 2, exo), 139.2 (CH, 1 or 2, endo), 142.6 (C, 8, exo), 143.5 (C, 8, 
endo), 202.8 (C, 12, exo), 203.5 (C, 12, endo). 
IR (KBr): ν~ = 3061s, 3027s, 2972s, 2874s, 2815s, 2716s, 1717s, 1601m, 1498m, 1452m, 
1334m. 
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[α] 20D  = +164.9 (c = 1.08, CHCl3). 
Chiral GC: ß-CD DetTButSil (SE54) column 60 °C → 180 °C (10 min), 1.5 °C/min, tR = 
58.2 min (exo minor), tR = 58.5 (endo minor), tR = 59.0 min (exo major), tR = 59.6 (endo 
major). 
The spectroscopic data are in agreement with that previously reported for the endo 
compound.[192] 
5.4.2 Synthesis of Organocatalysts 
(5S)-2,2,3-Trimethyl-5-benzyl-4-imidazolidinone hydrochloride (23·HCl)[107] 
1
2 NH
3
N 5O
6
7
8
11
10
9
4
HCl
 
To (S)-phenylalanine methyl ester hydrochloride (4.80 g, 22.3 mmol) ethanolic MeNH2 (8 M, 
11 mL, 89.2 mmol) was added and stirred for 24 hours at room temperature. After removal of 
the solvent, the off-white residue was suspended in Et2O and concentrated (4 ×). The amide 
hydrochloride was treated with saturated aqueous NaHCO3 (20 mL) and extracted three times 
with dichloromethane (3 ×). The organic extracts were dried (NaSO4) and the solvent was 
removed under reduced pressure to give a colourless oil which was dissolved in Et2O. Upon 
addition of HCl solution (2 M in Et2O) imidazolidinone 23 precipitated as colourless plates. 
Imidazolidinone 23·HCl (1.04 g, 18%) was recrystallised from i-propanol. 
C13H19ClN2O (254.12): 
m.p. 144-146 °C (Et2O). 
Rf = 0.69 (dichloromethane/methanol 1:10). 
1H NMR (400.1 MHz, CDCl3): δ = 1.41 (s, 3 H, CHCH3), 1.67 (s, 3 H, CHCH3), 2.78 (s, 3 H, 
NCH3), 3.33 (dd, 2J = 15.1 Hz, 3J = 5.0 Hz, 1H, CHH), 3.47 (dd, 2J = 15.2 Hz, 3J = 6.3 Hz, 
1H, CHH), 4.40 (b s, 1H, CH), 7.24-7.35 (m, 3 H, Har), 7.46-7.47 (m, 3 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 24.2 (CH3, 6), 24.6 (CH3, 4/5), 25.1 (CH3, 4/5), 34.4 
(CH2, 7), 57.9 (C, 3), 77.7 (CH, 2), 127.7 (CH, 11), 128.9 (CarH), 129.9 (CarH), 134.4 (C, 8), 
166.0 (C, 1). 
IR (KBr): ν~ = 3422s, 2915s, 2700s, 1724s, 1590s, 1428s, 1394s, 1319m, 1265m, 1161m, 
1058m, 745m, 698m. 
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[α] 20D  = _110.6 (c = 1.00, MeOH, >99 ee). 
EA calcd (%) for C13H19ClN2O: C, 61.29; H, 7.52; N, 11.00. Found: C, 61.41; H, 7.45; N, 
11.01. 
HPLC (of the free secondary amine): Chiralcel OD-H, ethanol/heptane (4:96), 1.0 mL/min, 
20 °C, 220 nm, tR = 8.1 min (major), tR = 9.2 min (minor). 
The spectroscopic data are in agreement with that previously reported in the literature.[107] 
 
(5S)-2,2,3-Trimethyl-5-benzyl-4-imidazolidinone trifluoroacetic acid (23·TFA)[193] 
1
2 NH
3
N 5O
6
7
8
11
10
9
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O
F
F
F
4
 
(5S)-2,2,3-Trimethyl-5-benzyl-4-imidazolidinone 23·HCl[107] was dissolved in saturated 
aqueous NaHCO3. The aqueous phase was extracted three times with dichloromethane. The 
organic extracts were dried (Na2SO4) and the solvent was removed under reduced pressure to 
give a colourless oil, which was dissolved in Et2O. Upon addition of trifluoroacetic acid 
imidazolidinone 23·TFA precipitated as a colourless amorphous solid. 
C15H19F3N2O3 (332.32): 
m.p. 144-145 °C (Et2O). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.37 (s, 3 H, CH3), 1.45 (s, 3 H, CH3), 2.79 (s, 3 H, 
NCH3), 3.18 (dd, 2J = 15.2 Hz, 3J = 7.6 Hz, 1H, CH2), 3.18 (dd, 2J = 15.2 Hz, 3J = 4.8 Hz, 1H, 
CH2), 4.26 (dd, 3J = 7.3 Hz, 3J = 5.0 Hz, 1H, CH), 7.23-7.32 (m, 5 H, Har), 7.96 (b s, 2 H, 
NH2+). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 23.0 (CH3, 6), 24.8 (CH3, 4/5), 25.1 (CH3, 4/5), 
30.7 (C, 3), 34.8 (CH2, 7), 57.7 (CH, 2), 127.6 (CH, 11), 128.9 (CarH), 129.3 (CarH), 134.9 (C, 
8), 167.2 (C, 1). 
IR (KBr): ν~ = 2923s, 2748s, 2580s, 2480s, 1728s, 1658s, 1431s, 1396s, 1182s, 1129s, 839m, 
724m, 696m. 
MS (FAB, NBA (subtr)), m/z (%): 219 ([(M+H)-C2HF3O2]+, 100), 127 (25), 72 (20). 
[α] 20D  = _64.7 (c = 1.00, MeOH, >99% ee). 
EA calcd (%) for C15H19N2O3: C, 54.21; H, 5.76; N, 8.43. Found: C, 54.20; H, 5.80; N, 8.38. 
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HPLC (of the free secondary amine): Chiralcel OD-H, ethanol/heptane (4:96), 1.0 mL/min, 
20 °C, 220 nm, tR = 8.1 min (major), tR = 9.2 min (minor). 
The spectroscopic data are in agreement with that previously reported in the literature.[193] 
 
(5S)-2,2,3-Trimethyl-5-benzyl-imidazolidine-4-thione hydrochloride (128·HCl) 
11
8
9
10
7
5 N
H
4
N
26S
1
3
HCl
 
Lawessons` reagent (2,4-bis(4-methoxyphenyl)-2,4-dithioxo-1,3,2,4-dithiadiphosphetane) 
(202 mg, 0.50 mmol) was added to a solution of 
(5S)-2,2,3-trimethyl-5-benzyl-4-imidazolidinone 23·HCl[107] (127 mg, 0.50 mmol) in toluene 
(2 mL). After heating for 30 minutes at reflux and cooling to room temperature, saturated 
aqueous NaHCO3 was added and the aqueous layer was extracted three times with Et2O. The 
combined organic extracts were washed with water, dried (Na2SO4) and concentrated under 
reduced pressure to give a transparent colourless oil. The crude product was purified by flash 
column chromatography (SiO2, 1 × 5 cm, ethyl acetate/hexanes 1:3) to give a transparent oil. 
It was dissolved in Et2O and imidazoline-thione 128·HCl (84 mg, 62%) precipitated upon 
addition of HCl (2 M in Et2O) as a colourless amorphous solid. 
C13H19ClN2S (270.82): 
m.p. 133-134 °C (Et2O). 
Rf = 0.18 (ethyl acetate/hexanes 1:3). 
1H NMR (400.1 MHz, CDCl3): δ = 1.44 (s, 3 H, CH3), 1.70 (s, 3 H, CH3), 3.13 (s, 3 H, 
NCH3), 3.59-3.61 (m, 1 H, CH2), 4.76 (t, 3J = 5.6 Hz, 1 H, CH), 7.25-7.34 (m, 3 H, Har), 7.52 
(d, 3J = 7.1 Hz, 2 H, Har). 
13C{1H} NMR (100.6 MHz, CDCl3): δ = 24.0 (CH3, 2/3), 24.4 (CH3, 2/3), 30.6 (CH3, 1), 37.2 
(CH2, 7), 68.4 (CH, 5), 84.2 (C, 4), 127.8 (CarH, 11), 128.9 (CarH, 9), 130.0 (CarH, 10), 134.6 
(C, 8), 192.4 (C, 6). 
IR (KBr): ν~ = 2924s, 2517s, 2406s, 1498s, 1392s, 1271s, 1128s, 1055m, 1020m, 733s, 693s, 
476s. 
MS (EI, 70eV, ca. 100 °C), m/z (%): 234 ([M-HCl]+, 73), 219 ([M-CH3]+, 35), 117 ([M-
C3H8N]+, 100), 160 (69), 143 (79), 128 (53), 104 (27), 91 ([C7H7]+, 22), 58 ([C3H8N]+, 15). 
[α] 20D  = _109.0 (c = 0.30, MeOH). 
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EA calcd (%) for C13H19ClN2S: C, 57.66; H, 7.07; N, 10.34. Found: C, 57.23; H, 6.92; N, 
10.34.  
HPLC (of the free secondary amine): Chiralcel OD-H, i-propanol/heptane (4:96), 0.5 
mL/min, 20 °C, 220 nm, tR = 19.3 min (major), tR = 24.4 min (minor). 
 
(S)-2-(t-Butyl)-3-methyl-4-imidazolidinone hydrochloride (130·HCl)  
5
4 N
H
3N
O
6
2
1
HCl
 
 (S)-2-(t-Butyl)-3-methyl-4-imidazolidinone 130·TFA[194] was dissolved in saturated aqueous 
NaHCO3. The aqueous phase was extracted three times with dichloromethane. The organic 
extracts were dried (Na2SO4) and the solvent was removed under reduced pressure to give a 
colourless oil which was dissolved in Et2O. Upon addition of HCl solution (2 M in Et2O) 
imidazolidinone 130·HCl precipitated as a colourless amorphous solid. 
C8H17ClN2O (192.69): 
m.p. 172-173 °C (Et2O). 
1H NMR (400.1 MHz, CD2Cl2): δ = 1.19 (s, 9 H, CH3), 2.99 (s, 3 H, NCH3), 3.75 (d, 3J = 
15.9 Hz, 1H, CH2), 3.94 (d, 3J = 15.9 Hz, 1H, CH2), 4.61 (s, 1 H, CH). 
13C{1H} NMR (100.6 MHz, CD2Cl2): δ = 24.9 (CH3, 1), 31.4 (CH3, 6), 36.6 (C, 2), 53.4 
(CH2, 4), 82.1 (C, 3), 190.1 (C, 5). 
IR (KBr): ν~ = 2985s, 2928s, 2567s, 2463s, 2376s, 1710s, 1580s, 1776s, 1417s, 1327s, 1256s, 
1123m, 1032m, 677m, 627m, 571m. 
MS (FAB, NBA (subtr)), m/z (%): 310 (10), 157 ([(M+H)-HCl]+, 100), 100 (19). 
[α] 20D  = +55.8 (c = 1.00, MeOH). 
EA calcd (%) for C8H17ClN2O: C, 49.87; H, 8.89; N, 14.54; O, 8.30. Found: C, 49.93; H, 
8.75; N, 14.53.  
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5.5 General Working Methods and Conditions for ESI MS Experiments 
5.5.1 Bis(oxazoline)copper(II)-Catalysed Retro-Diels-Alder Reaction: General 
Method 
The bis(oxazoline)copper(II)-catalysed retro-Diels-Alder reactions were conducted in 10 mL 
flasks equipped with a Young valve. The standard conditions were the following: Inside the 
glove box Cu(II)(OTf)2 (1.8 mg, 5.0 µmol) and the appropriate ligand (5.5 µmol) were 
weighted into a flask. After connecting the flask to a Schlenk line dichloromethane (0.6 mL) 
was added and the reaction mixtures were stirred for 2.5 hours at room temperature. Then the 
quasienantiomers (S)-80 and (R)-88 (or (R)-85 and (S)-83, respectively) (12.5 µmol each), 
pre-mixed in dichloromethane (0.6 mL) were added to the catalyst solution. The reaction 
mixture was stirred for 1 hour at 100 °C and cooled immediately in an ice bath. For ESI MS 
analyses aliquots of the reaction mixture were diluted to 10-5 M in dichloromethane, using 
2 mL glass screw-thread-vials with septum and cut-out top caps. All solutions were filtered 
through syringe filters to eliminate any particle contaminations. The diluted solutions were 
directly injected in the mass spectrometer. The parameters used for the Varian 1200L Triple 
Quad MS/MS were: Drying Gas 100 °C, 17 psi; Capillary Voltage 38 V; Needle Voltage 
4900 V; Needle Current -2 µA, Shield Voltage 600 V; Housing 49 °C, 40 psi. Every spectrum 
consisted of at least 25 averaged scans. Best spectra were obtained by applying 35 µL/min as 
flow rate, using a single syringe pump Model 11 Plus from Harvard Apparatus.  
The selectivity of the catalyst was obtained by determination of the area-under-the-curve 
(integration) of the major mass peak of the isotope pattern for both dienophile complexes. 
Considering all four major mass peaks of the isotope pattern produced the same results. 
Generally, the spectra were recorded both in the centroid and profile mode. 
For verification of the ESI MS results, HPLC samples were prepared by filtrating the reaction 
mixture through a small plug of silica gel (ethyl acetate/Et2O 1:1, eluation with Et2O), 
followed by removal of the solvent under reduced pressure. HPLC: Chiralcel OD-H, 
i-propanol/heptane (5:95), 0.5 mL/min, 20 °C, 210 nm/259nm, tR = 34.6 min 
(n-Bu-dienophile 67), tR = 40.0 min (Et-dienophile 64). Validation curves for both 
dienophiles 64 and 67 were made to ensure the correlation of the dienophile ratio in the 
sample with the integration of the HPLC peak.  
The preparative Diels-Alder reaction was done under similar conditions as the retro reaction. 
The standard procedure was the following: Inside the glove box Cu(II)(OTf)2 (4.50 mg, 
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12.5 µmol) and the appropriate ligand (13.7 µmol) were weighted into a flask. After 
connecting the flask to a Schlenk line dichloromethane (0.3 mL) was added and the reaction 
mixture were stirred for 2.5 hours at room temperature. The reaction mixture was cooled to 
-78 °C and dienophile 67 (19.0 mg, 62.3 µmol) in dichloromethane (0.3 mL) was added and 
immediately after cyclopentadiene (0.05 mL, 0.623 mmol). After stirring the reaction mixture 
for 1 hour at 100 °C (or 20 hours at room temperature or 48 hours at -35 °C, respectively), the 
reaction mixture was filtered through a plug of silica gel (ethyl acetate/Et2O 1:1). After 
removal of the solvent under reduced pressure, the crude product was purified by flash 
column chromatography (SiO2, ethyl acetate/hexanes 1:5) to give DA adduct 83. The 
enantiomeric excess was determined by chiral HPLC (Chiralcel OD-H, i-propanol/heptane 
(5:95), 0.5 mL/min, 20 °C, 210 nm, tR = 19.1 min (major), tR = 44.0 min (minor)). 
5.5.2 Phosphinooxazolinecopper(II)-Catalysed Retro-Diels-Alder Reaction 
As described in Section 5.5.1 Cu(II)(OTf)2 (0.9 mg, 2.5 µmol) and ligands 33a-33h 
(2.75 µmol) were stirred in dichloromethane (0.3 mL) for 2 hours at room temperature. The 
quasienantiomers (S)-80 and (R)-88 (6.25 µmol each), premixed in dichloromethane (0.3 mL), 
were added to the catalyst solution. The reaction mixture was stirred for 1 hour at 100 °C and 
cooled immediately in an ice bath. ESI MS analyses were done as described in Section 5.5.1. 
The preparative, forward reaction was done according to the procedure for the 
bis(oxazoline)copper(II)-catalysed Diels-Alder reactions (Section 5.5.1). 
5.5.3 Bis(imine)copper(II)-Catalysed Retro-Diels-Alder Reaction 
As described in Section 5.5.1 Cu(II)(OTf)2 (0.9 mg, 2.5 µmol) and ligands 34d or 34e 
(2.75 µmol) were stirred in dichloromethane (0.3 mL) for 5 hours at room temperature. The 
quasienantiomers (S)-80 and (R)-88 (6.25 µmol each), premixed in dichloromethane (0.3 mL), 
were added to the catalyst solution. The reaction mixture was stirred for 1 hour at 100 °C and 
cooled immediately in an ice bath. ESI MS analyses were done as described in Section 5.5.1. 
The preparative, forward reaction was done according to the procedure for the 
bis(oxazoline)copper(II)-catalysed Diels-Alder reactions (Section 5.5.1), except that the 
catalyst solution was stirred for 5 hours at room temperature instead of 2 hours. 
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5.5.4 Organocatalysed Retro-Diels-Alder Reaction 
The organocatalysed retro-Diels-Alder reaction was conducted in 2 mL glass screw-thread-
vials with septum and cut-out top caps. The standard conditions were the following: The 
quasienantiomers (S)-113 and (R)-118 (or (R)-116 and (S)-114, respectively)(3.12 µmol each) 
were dissolved in dichloromethane (150 µL) and the organocatalyst (1.25 µmol) was added. 
The reaction mixture was stirred for 24 hours at room temperature. 
When screening mixtures of organocatalysts 10 mL flasks equipped with a Young valve were 
employed. The reaction mixture was stirred for 1 hour at 50 °C and immediately cooled to 
room temperature.  
For ESI MS analyses aliquots of the reaction mixture were diluted to 10-4 M in acetonitrile. 
For ESI MS analyses of organocatalyst mixtures the reaction mixtures were diluted to 10-3 M 
in acetonitrile. All solutions were filtered through syringe filters to eliminate any particle 
contamination. The diluted solutions were directly injected in the mass spectrometer. The 
parameters used for the Varian 1200L Triple Quad MS/MS were: Drying Gas 200 °C, 18 psi; 
Capillary Voltage 38 V; Needle Voltage 4900 V; Needle Current 1 µA, Shield Voltage 600 V; 
Housing 49 °C, 40 psi. Every spectrum consisted of at least 25 averaged scans. Best spectra 
were obtained by applying 20 µL/min as flow rate, employing a single syringe pump Model 
11 Plus from Harvard Apparatus.  
The preparative Diels-Alder reaction was done according to a varied procedure by 
MACMILLAN.[107] Cinnamaldehyde 123 (136 µL, 1.08 mmol) was added to a solution of 
(5S)-2,2,3-trimethyl-5-benzyl-4-imidazolidinone 23·HCl (55.0 mg, 0.216 mmol) in 
dichloromethane (11 mL). The solution was stirred for 2 minutes before addition of 
cyclopentadiene (0.27 mL, 3.24 mmol). After stirring for 24 hours at room temperature, the 
reaction mixture was washed with water (50 mL) and then with brine (20 mL). The organic 
layer was dried (Na2SO4) and concentrated under reduced pressure to give the crude product. 
It was purified by flash column chromatography (SiO2, 1 × 12 cm, ethyl acetate/hexanes 1:10) 
to give DA adduct 126 as a colourless transparent oil. The enantiomeric excess and 
diastereoselectivity were determined by chiral GC (ß-CD DetTButSil (SE54) column 60 °C 
→ 180 °C (10 min), 1.5 °C/min, tR = 58.2 min (exo (R)), tR = 58.5 (endo (R)), tR = 59.0 min 
(exo (S)), tR = 59.6 (endo (S)). 
Chapter 5 
 
188
5.5.5 Peptide-Catalysed Retro-Diels-Alder Reaction 
The peptide-catalysed retro-Diels-Alder reaction was conducted in 2 mL glass screw-thread-
vials with septum and cut-out top caps. The standard conditions were the following: The 
quasienantiomers (S)-113 and (R)-118 (or (R)-116 and (S)-114, respectively) (3.12 µmol 
each) were dissolved in MeOH (150 µL), then the peptide (1.25 µmol) was added and the 
reaction mixture was stirred for 24 hours at room temperature. 
When screening mixtures of peptides 10 mL flasks equipped with a Young valve were 
employed. The reaction mixture was stirred for 1 hour at 50 °C and immediately cooled to 
room temperature.  
For ESI MS analyses aliquots of the reaction mixture were diluted to 10-3-10-4 M in MeOH. 
All solutions were filtered through syringe filters to eliminate any particle contamination. The 
diluted solutions were directly injected in the mass spectrometer. The parameters used for the 
Varian 1200L Triple Quad MS/MS were: Drying Gas 200 °C, 18 psi; Capillary Voltage 40 V; 
Needle Voltage 4900 V; Needle Current -1 µA, Shield Voltage 600 V; Housing 49 °C, 40 psi. 
Every spectrum consisted of at least 25 averaged scans. Best spectra were obtained by 
applying 30 µL/min as flow rate, employing a single syringe pump Model 11 Plus from 
Harvard Apparatus.  
The preparative peptide-catalysed Diels-Alder reaction was done according to the following 
procedure: Cinnamaldehyde 123 (63.0 µL, 0.50 mmol) was added to a solution of peptide 
141·TFA (44.0 mg, 0.216 mmol) in MeOH (500 µL). The solution was stirred for 2 minutes 
before addition of cyclopentadiene (124 µL, 1.50 mmol). After stirring for 24 hours, the 
reaction mixture was diluted with Et2O (20 mL), washed with water (20 mL) and then with 
brine (20 mL). The organic layer was dried (Na2SO4) and concentrated under reduced 
pressure. The crude material was hydrolised by stirring in TFA:water:CHCl3 (1:1:2, 12 mL) 
for 2 hours at room temperature. The reaction mixture was carefully neutralised with saturated 
aqueous NaHCO3 (10 mL) and extracted with Et2O (3 × 10 mL). The combined organic 
extracts were dried (Na2SO4) and concentrated under reduced pressure. The crude product 
was purified by flash column chromatography (SiO2, 1 × 10 cm, ethyl acetate/hexanes 1:10) 
to give DA adduct 126 as a colourless transparent oil. The enantiomeric excess and 
diastereoselectivity were determined by chiral GC (ß-CD DetTButSil (SE54) column 60 °C 
→ 180 °C (10 min), 1.5 °C/min, tR = 58.2 min (exo (R)), tR = 58.5 (endo (R)), tR = 59.0 min 
(exo (S)), tR = 59.6 (endo (S)). 
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6 Appendix 
6.1 X-Ray Crystal Structures 
X-ray data analyses were carried out and crystal structures were solved by Markus Neuburger 
and Dr. Sylvia Schaffner at the Department of Chemistry of the University of Basel.  
Single crystals for (R)-86 were obtained through crystallisation by dissolving the product in 
Et2O and carefully adding a layer of pentane. Data collection was performed with a Nonius 
KappaCCD diffractometer. Measurements were recorded at 173 K. The structure was solved 
with SIR92[195] and refinded with crystals.[196] CHEBYCHEV polynomial weights were used to 
complete the refinement. Hydrogen atoms were calculated and refined as riding atoms.[197] 
The absolute configuration and enantiopurity was determined by refinement of the flack 
parameter.[198] The refined structure was checked with checkcif.[199] 
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Compound (R)-86 
Molecular Formular C20H23N1O1S2 
Formulat Weight 357.54 
Shape Plate 
Colour Colourless 
Temperature (K) 173 
Crystal Size (mm3) 0.05×0.11×0.28 
Crystal System monoclinic 
Space Group P 1 21 1 
a (Å) 6.1870(3) 
b (Å) 9.9672(3) 
c (Å) 14.8721(8) 
α (°) 90 
β (°) 92.571(4) 
γ (°) 90 
Volume (Å3) 916.20(7) 
Z 2 
Densitycalc. (mg m-3) 1.296 
Absorption coeff. (mm-1) 0.297 
Radiation type (λ [Å]) MoKα (0.71073) 
F (000) 380 
Completeness to Θmax (%) 0.99 
Reflections measured 28497 
Reflections independent 4409 
Reflections used 3981 
Number of parameters 218 
R (observed data) 0.0284 
wR (all data) 0.0306 
Goodness of fit on F 1.1035 
Residual density (e Å-3) -0.16/0.22 
Flack-parameter -0.07(4) 
CCDC deposition code - 
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